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Abstract 
Adherens junctions (AJs) are responsible for the adhesion of cells to their neighbours and influence a 
range of cellular processes. The formation and maintenance of AJs is governed by members of the 
Rho subfamily of small GTPases. Activation of the GTPases Rac1 and RhoA is necessary for the 
formation of cell-cell contacts in keratinocytes. However, how the GTPases themselves are regulated 
is not well understood. Rho GTPase activating proteins (GAPs) inactivate GTPases by promoting the 
hydrolysis of GTP to GDP. Whilst a large number of proteins containing Rho GAP domains have been 
identified, knowledge of this large family of proteins remains limited. It is predicted that multiple 
Rho GAPs are required in order to coordinate precise processes that are necessary for the formation 
and maintenance of cell-cell contacts to occur. However, relatively few Rho GAPs have been 
identified as regulators of cell-cell contacts. The aims of this project are to 1) identify GAPs involved 
in the regulation of cell-cell contact formation in keratinocytes and 2) to specifically investigate the 
role of CdGAP in junction formation and maintenance.  
To this end, 20 GAPs have been identified from a siRNA screen as potential regulators of junction 
formation, the vast majority of which have not previously been linked to this process. Subsequently, 
two Rho-specific GAPs have been investigated to probe their roles in the regulation of Rho in both 
junction formation and maintenance. The second part of this thesis focuses on the Rac and Cdc42-
specific GAP CdGAP, which I demonstrate is an important regulator of AJs in keratinocytes. I show 
that CdGAP is able to interact with the scaffold protein Ajuba. Ajuba is known to localise to cell-cell 
adhesions, where it is necessary for maintaining Rac activation at junctions. However, Ajuba itself 
has no catalytic activity. My data suggests cooperation between CdGAP and Ajuba allows Rac levels 
to be fine-tuned at AJs. Overall, this data identifies numerous Rho GAPs as potential regualtors of 
junction formation, and confirms for the first time the importance of three Rho GAPs, ARAP1, 
ARHGAP6 and CdGAP, in the regulation of cell-cell contact formation and maintenance. Ultimately, 
this work provides further insight into the regulation of AJs by GAPs and enhances our 
understanding of how scaffold proteins, such as Ajuba, are able to influence this tightly controlled 
process. 
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WASP - Wiskott–Aldrich syndrome protein 
WAVE - WASP family verprolin-homologous protein 
WT - Wild Type  
YFP – Yellow fluorescent protein 
ZEB1/2 - Zinc finger E-box-binding homeobox 1/2 
ZO – Zonula adherens 
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Introduction 
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1.1. Epithelial tissue 
Epithelial tissues, formed of tightly connected epithelial cells, are found lining internal organs and 
the external surface of the body. The epithelium provides an essential barrier protecting the 
underlying tissues from pathogenic, physical or chemical assault as well as serving a structural 
function by maintaining tissue architecture.  
The epidermis is formed of multiple layers of squamous epithelium, largely consisting of 
keratinocytes, that lies on a complex meshwork of connective tissue called the basement membrane 
(Figure 1.1). Due to the continual barrage of environmental stressors, the uppermost layer of the 
skin is constantly being renewed. This is facilitated by stem cells in the basal layer that possess the 
proliferative capacity to maintain the homeostasis of this tissue. These give rise to transit amplifying 
cells, which are destined to undergo a finite number of divisions before committing to terminal 
differentiation and migrating upwards. The constant renewal of cells of the epidermis creates a 
highly dynamic and protective structure (Blanpain and Fuchs, 2009; Watt, 1998).  
A common feature of epithelial cells is the presence of multiple adhesive structures both between 
neighbouring cells and between cells of the basal layer and the underlying basement membrane 
(Blanpain and Fuchs, 2009). The ability of cells of the epidermis to adhere strongly to one another is 
absolutely vital for their correct function. However, these dynamic intercellular adhesions are 
constantly changed, as cells move upwards upon terminal differentiation, and are susceptible to 
transient downregulation in response to certain extracellular cues, for example during wound 
healing (Fuchs and Raghavan, 2002).  
1.1.1. Cell-cell adhesive complexes 
Specialised cell-cell adhesive complexes are essential for maintaining the epidermal barrier by 
physically adjoining neighbouring cells, facilitating communication, and forming robust links to the 
cytoskeleton. These complexes also act as signalling centres in their own right, able to direct 
transcriptional changes that influence proliferation and differentiation 
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Figure 1.1 The structure of the epidermis The multiple layers of epithelium that make up the epidermis are 
anchored, via cells of the basal layer, to the basement membrane via specialised adhesive structures called 
focal adhesions and hemidesmosomes. Stem cells of the basal layer maintain homeostasis by replacing 
keratinocytes that are continually lost through differentiation or injury. This results in a stratified epithelium 
composed of terminally differentiating cells transiting from the spinous layer to the granular layer and finally 
the stratum corneum. These layers can be distinguished by the presence of different adhesive complexes and 
intermediate filaments that serve to rigidify the uppermost layers, culminating in the formation of a highly 
resistant barrier. Intercellular adhesion is mediated by adherens junctions and desmosomes, which are 
anchored to the actin cytoskeleton and intermediate filaments (keratin) respectively. Gap junctions allow the 
passage of small molecules and ions between cells. Finally, tight junctions are only formed in cells of the 
granular layer where they provide a barrier function and separate the apical and basolateral portions of the 
cell membrane  
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The main structures responsible for cell-cell adhesion and thus epithelial architecture are the 
adherens junctions (AJs) and desmosomes. Both of these junctions are formed via interactions 
between calcium-dependent cadherin transmembrane proteins that are coupled to the cytoskeleton 
(AJs to actin and desmosomes to intermediate filaments) via association with various intermediaries, 
including armadillo family proteins (Green et al., 2010).  
AJs (discussed in detail in section 1.2) are found in large numbers in cells of the basal layer and their 
assembly precedes desmosome formation (Green et al., 2010). Loss of major components of AJs or 
desmosomes impairs barrier function (Tinkle et al., 2008; Vasioukhin et al., 2001b). However, these 
structures also serve as landmarks around which additional cellular structures orient themselves. For 
example, loss of E-cadherin can severely compromise tight junction (TJ) barrier function (Michels et 
al., 2009) whilst desmosomes can regulate microtubule organisation at cell-cell contacts (Lechler and 
Fuchs, 2007). Furthermore, the expression pattern of desmosomal cadherins alters during epidermal 
differentiation, implying specific roles for different desmosomal cadherins in the regulation of 
homeostasis (Green and Simpson, 2007). Indeed, misexpression of different desmosomal cadherins 
can cause a range of phenotypes (eg. hyperproliferation, abnormal differentiation, reduction in 
barrier function and increased susceptibility to carcinogens) (Delva et al., 2009; Green and Simpson, 
2007). 
TJs are composed of junctional adhesion molecules (JAMs), occludins and claudins which are 
supported by a selection of scaffold proteins, including those from the zonula adherens family (ZO-1, 
ZO-2 and ZO-3) (Niessen, 2007). Study of claudin-1-deficient mice reveals the importance of TJs in 
providing an efficient barrier, as mice die within one week of birth due to dehydration (Furuse et al., 
2002). Interestingly, protein synthesis of TJ components precedes formation of the stratum corneum 
during epidermal regeneration, suggesting these junctions represent part of a rescue system 
(Brandner et al., 2002). TJs may also have a role in regulating polarity, as polarity proteins are 
associated with TJs in keratinocytes (Michels et al., 2009). In the epidermis TJ assembly is restricted 
to the granular layer. However, expression of some TJ components (Claudin-1, JAM-1) can be found 
in all layers implying TJ-independent functions for these proteins (Kirschner and Brandner, 2012; 
Niessen, 2007; Proksch et al., 2008).  
Gap junctions are composed of hexamers of connexins (connexons) that are trafficked to the 
membrane where they fuse with connexons on an adjacent cell. This results in the formation of a 
channel that spans the two membranes and permits the passage of small molecules and ions 
(Goodenough and Paul, 2009; Proksch et al., 2008). As well as permitting cell-cell communication, 
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Gap junctions are also necessary for barrier function (Proksch et al., 2008). The epidermis of mice 
lacking the C-terminal of connexin 43 is highly permeable compared to wild-type mice, and the 
majority of these animals die within a week of birth (Maass et al., 2004). Further, numerous skin 
disorders have been characterised that arise from mutations in connexins, for example mutations of 
connexin 26 are associated with keratisis-ichthyosis-deafness, Vohwinkel syndrome and 
palmoplantar keratoderma, amongst others (Scott et al., 2012). 
1.1.2. Cell-matrix adhesive complexes 
Keratinocytes are anchored to the basement membrane via focal adhesions and hemidesmosomes. 
The interaction between the cell and the basement membrane can have profound effects on tissue 
morphology as these structures transmit mechanical signals from the extracellular environment to 
regulate differentiation, proliferation and migration. Importantly, cell-matrix adhesions must 
coordinate signals with cell-cell adhesions in order to regulate homeostasis (Burute and Thery, 2012; 
Watt, 2002). 
Hemidesmosomes are formed from the transmembrane protein 180kDa-bullous pemhigoid antigen, 
α6β4 integrin and CD151 which are linked to keratin filaments, thus providing robust mechanical 
support and also anchoring the cell to the basement membrane (Tsuruta et al., 2011). Loss of 
hemidesmosomes leads to uncoupling of keratinocytes from the basement membrane which 
manifests as severe blistering in affected individuals (notably in epidermolysis bullosa) (Sawamura et 
al., 2010). In cultured keratinocytes hemidesmosomes do not form, instead hemidesmosome 
proteins are aggregated at the cell-substrate interface. However, these lack some ultra-structural 
features of hemidesmosomes (Tsuruta et al., 2011).  
Focal adhesions are formed from different combinations of integrins and are linked to the actin 
cytoskeleton via a complex mix of adaptor proteins (Burute and Thery, 2012; Watt, 2002). Focal 
adhesions contribute towards anchorage to the basement membrane, evidenced by findings that 
mutation in fermitin family homolog 1, a component of focal adhesions, causes the blistering disease 
Kindler syndrome (Jobard et al., 2003). However, the large variety in integrin configurations that can 
be adopted means focal adhesions can mediate the transmission of myriad extracellular signals. For 
example, signals transmitted via intergrins are important in regulating cell migration during wound 
healing (Tsuruta et al., 2011).  
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1.2. Molecular overview of AJs 
This project focuses on the regulation of AJs. The basic core of AJs is the cadherin-catenin complex, 
some form of which is conserved in all animals, and also found in other organisms, including 
arthropods (Hiroki, 2012). In epithelial cells the classical epithelial (E-)cadherin is predominant 
(Furukawa et al., 1997). Cell-cell adhesion is mediated by homophilic interactions between E-
cadherin monomers on neighbouring cells (in trans) which are later stabilised via lateral clustering 
(in cis) (Figure 1.2) (Ishiyama and Ikura, 2012; Meng and Takeichi, 2009; Zhang et al., 2009).  
E-cadherin possesses a large extracellular domain that can be subdivided into five subunits (EC1-5), 
through which the EC1 subunit mediates homophilic interactions (Nose et al., 1990). Association of 
the extracellular domains with calcium serves to rigidify this region, priming it for interactions and 
also preventing proteolytic cleavage (Ishiyama and Ikura, 2012; Nagar et al., 1996). Notably, the 
calcium dependence of E-cadherin can be exploited by researchers to specifically induce cell-cell 
contact formation in cells maintained in a low calcium environment, via the addition of calcium ions 
(O'Keefe et al., 1987). 
1.2.1. The cadherin-catenin complex 
The cytoplasmic portion of E-cadherin can be split into two major domains, the juxtamembrane 
domain, which binds p120-catenin (Reynolds et al., 1994), and the C-terminal catenin-binding 
domain, which binds β-catenin. This complex is then transiently or indirectly linked to the actin 
cytoskeleton via α-catenin (Hiroki, 2012; Meng and Takeichi, 2009). 
Interaction with p120 catenin stabilises E-cadherin; downregulation of p120 catenin results in E-
cadherin internalisation (Davis et al., 2003), whilst expression of E-cadherin binding-deficient p120 
catenin reduces the amount of surface E-cadherin in MCF-7 and MDCK cells (Ishiyama et al., 2010). 
Binding of p120 catenin occupies a large portion of the E-cadherin juxtamembrane domain (Ishiyama 
et al., 2010). One mechanism by which p120 catenin could stabilise E-cadherin may be by blocking 
the binding site on E-cadherin for Hakai, interaction with which can promote E-cadherin 
ubiquitination and degradation (Fujita et al., 2002). 
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Figure 1.2 The organisation of AJs  Calcium ions (navy blue circles) bind to the E-cadherin extracellular domain 
and rigidify this region. This facilitates homophilic binding between E-cadherin monomers on adjacent cells via 
the last subunit of the extracellular domain (EC1). The E-cadherin cytoplasmic tail interacts with p120-catenin 
and β-catenin, which is in turn bound to α-catenin. The complex is linked to the actin cytoskeleton either via 
conformational changes in α-catenin that allow it to bind simultaneously actin and β-catenin, or via additional 
interactions mediated between α-catenin and actin binding proteins (not shown).   
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1.2.2. Links to the actin cytoskeleton 
E-cadherin binds to β-catenin via the latter’s central armadillo repeats (Huber and Weis, 2001). 
Simultaneously, β-catenin can interact with α-catenin via its N-terminal region providing a link to the 
cytoskeleton (Aberle et al., 1996). However, the exact nature of this association is not clear. The N-
terminal of α-catenin facilitates homodimer assembly, which is essential for α-catenin’s binding and 
bundling of F-actin through its C-terminus. Thus, α-catenin cannot simultaneously bind β-catenin and 
F-actin (Drees et al., 2005; Yamada et al., 2005a). Potentially α-catenin may need to be ‘activated’ 
when bound to β-catenin, for example in a similar way in which vinculin binding sites on α-catenin 
are revealed upon the application of mechanical force to α-catenin (Yonemura et al., 2010). 
Alternatively, α-catenin may provide an indirect link to actin via interaction with another actin 
binding protein. Indeed several proteins able to bind both α-catenin and actin are present at cell-cell 
contacts including vinculin (le Duc et al., 2010), formin (Kobielak et al., 2004), EPLIN (Abe and 
Takeichi, 2008), α-actinin (Yamada et al., 2005a) and Ajuba (Marie et al., 2003). 
The presence of an array of actin binding proteins at AJs allows for precise manipulation of the actin 
cytoskeleton. Due to the nature in which these proteins interact with actin, different structures are 
formed. For example, the Actin-related protein 2/3 (Arp2/3) complex induces the formation of 
branched actin cables, whereas formin promotes the assembly of linear actin filaments (Han and 
Yap, 2012). Vitally, the actions of actin binding proteins must be spatially constrained as they have 
the potential to influence the organisation of the entire cytoskeleton. 
1.3. The formation and maintenance of AJs during homeostasis 
AJs are not static, but highly dynamic structures, constantly being remodeled in order for 
developmental processes to proceed and in the adult organism to maintain tissue architecture. The 
formation and maintenance of cell-cell contacts can be separated into distinct steps (Figure 1.3). 
However, it is important to note that whilst, broadly speaking, similar morphological events may 
take place during the processes of cell-cell contact formation, stabilisation and disassembly, there 
can be vast differences in terms of the regulatory machinery that governs these changes when 
comparing different cell types, or in response to different stimuli (Cavey and Lecuit, 2009).  
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1.3.1. Cell-cell contact formation 
In many stages of development as well as in the adult organism during, for example, wound healing, 
migrating cells undergo mesenchymal-to-epithelial transition and form new cell-cell contacts (Cavey 
and Lecuit, 2009). This can be recapitulated in cells in culture in calcium switch assays or by plating 
cells on cadherin-coated plates.  
During development, initial contact formation is likely the result of collisions between exploratory 
actin-based protrusions (lamellipodia, filopodia or membrane ruffles depending on cell type and 
context) (Ehrlich et al., 2002; Vasioukhin et al., 2000; Yamada and Nelson, 2007). Upon membrane 
contact E-cadherin puncta (areas enriched in E-cadherin) are established (Adams et al., 1998; Adams 
et al., 1996), this leads to activation of myosin II (MyoII) which subsequently concentrates E-cadherin 
at puncta (Miyake et al., 2006; Shewan et al., 2005). E-cadherin that was previously ‘free’ in the 
membrane quickly becomes immobilised as it is anchored to actin (Adams et al., 1998; Sako et al., 
1998). Actin polymerisation is required for junctions to form (Ivanov et al., 2005; Vasioukhin et al., 
2000) and changes in the actin cytoskeleton are observed as puncta are stabilised by newly recruited 
actin. In subconfluent cells radial bundles of actin can be seen extending from the circumfrential 
actin ring to cadherin puncta (Adams et al., 1998; Vasioukhin et al., 2000; Yonemura et al., 1995), 
although in confluent keratinocytes radial bundles are not present, actin bundles are still rapidly 
recruited at sites of contact (Zhang et al., 2005). The reorganisation of actin serves to strengthen 
cell-cell adhesion (Chu et al., 2004). 
1.3.2. Contact expansion  
Contact expansion is characterised by the recruitment of E-cadherin into portions of the membrane 
adjacent to the initial site of contact (Adams et al., 1998). Ultimately this leads to actin 
polymerisation-dependent strengthening of the contact and the appearance of a continuous line of 
E-cadherin staining delineating the membranes of neighbouring cells (Adams et al., 1998; Chu et al., 
2004). Multiple populations of actin, with different dynamics and morphologies, are coordinated in 
this process (Cavey et al., 2008; Yamada and Nelson, 2007; Zhang et al., 2005). Data from Drosophila 
melanogaster suggests that E-cadherin incorporated into puncta is stabilised by a stable patch of 
actin over the cluster and a highly dynamic population which constrains lateral movement (Cavey et 
al., 2008). Similarly, in MDCK cells actin at the site of contact becomes less dynamic, whilst a more 
dynamic actin population exists at the edges of contacts, which are also enriched in E-cadherin 
puncta (Adams et al., 1998; Yamada and Nelson, 2007). In keratinocytes in culture, a dynamic pool of 
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junctional actin and less dynamic pool of loosely packed bundles coalesce as contacts are stabilised, 
until a single population is visible (Zhang et al., 2005). 
How are these actin populations regulated? MyoII, which is localised to cell-cell contacts in 
numerous cell types, has been implicated in contact expansion (Krendel and Bonder, 1999; Yamada 
and Nelson, 2007; Zhang et al., 2005). Potentially MyoII is required to generate contractile forces at 
the cell membrane that pull away from the site of contact (Krendel and Bonder, 1999). Indeed, MyoII 
activity is increased at the contact edges (Krendel and Bonder, 1999; Yamada and Nelson, 2007). 
Interestingly a specific role for MyoII activity during contact expansion is demonstrated by the 
finding that inhibition of MyoII (via inhibition of its upstream regulator, Rho kinase (ROCK)) prevents 
new E-cadherin contacts forming at the edge of the contact but does not result in disassembly of the 
contact (Yamada and Nelson, 2007). 
Alternatively, the formation of branched actin structures adjacent to sites of contact can stimulate 
formation of new adhesions. Imaging the formation of contacts between two MDCK cells reveals 
contact formation is followed by a wave of lamellipodia adjacent to the site of contact that further 
expands the contact area (Ehrlich et al., 2002). Furthermore, actin binding proteins able to promote 
branched polymerisation, such as Arp2/3, are found at site of contacts (Kovacs et al., 2002b; Verma 
et al., 2004).  
1.3.3. Junction maturation and remodelling 
Membrane protrusions are not conducive to stable adhesion and are limited in mature junctions 
(Ehrlich et al., 2002). This is achieved by depletion from contacts of actin binding proteins that 
induce branching (eg Arp2/3) (Yamada and Nelson, 2007), and recruitment (and/or activation) of 
proteins that promote the polymerisation of linear filaments (eg. formin, Dia or Ena/Vasp) (Kobielak 
et al., 2004; Sahai and Marshall, 2002b; Vasioukhin et al., 2000). The result is the generation of thick 
actin bundles underlying the plasma membrane and an increase in actomyosin tension (Gomez et 
al., 2011; Liu et al., 2010; Smutny et al., 2010; Zhang et al., 2005).  
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Figure 1.3 Actin reorganisation during junction formation, stabilisation and maintenance A) Prior to contact 
formation cells form actin-based protrusions (ruffles, lamellipodia and filopodia) (green). B) Junction formation 
is initialised by contact between actin protrusions on adjacent cells which leads the formation of cadherin 
puncta (red), areas highly enriched in E-cadherin. The neighbouring cells form a zipper-like structure, whereby 
actin protrusions embed into the opposite cell. Early events in junction stabilisation involve MyoII-generated 
force which serves to bring to two membranes together. C) Contact expansion relies on the formation of 
branched actin filaments at the edges of cell-cell contacts whilst a more stable actin population restricts E-
cadherin movement in the centre of the contact. MyoII is found at the edge of contacts and generates the 
force to expand the contact area outwards. D) Mature junctions display a single, continuous line of E-cadherin 
and thick actin bundles adjacent to contact sites.      
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Mature AJs are considerably dynamic structures and E-cadherin is constantly being turned-over. 
Adhesion strength can be adjusted by modulating the amount of E-cadherin at the membrane. Due 
to the long half-life of E-cadherin, transcriptional changes are not suitable for enacting rapid changes 
in adhesion (Shore and Nelson, 1991). Instead this is achieved by balancing endocytosis and 
degradation with synthesis and recycling of E-cadherin (eg. (Classen et al., 2005), reviewed in: 
(Kowalczyk and Nanes, 2012).  
E-cadherin can be endocytosed via clathrin-dependent or independent pathways (Bryant et al., 
2007; Le et al., 1999; Lu et al., 2003). In both cases, evidence exists that E-cadherin engaged in trans-
interactions is less susceptible to endocytosis (Izumi et al., 2004; Paterson et al., 2003). Interestingly, 
AJ components can regulate these processes. For example loss of p120 catenin results in clathrin-
mediated internalisation of E-cadherin (Xiao et al., 2005). Upon internalisation, E-cadherin is either 
degraded or recycled back to the membrane. Shifting this balance alters the amount of E-cadherin at 
the surface. 
1.3.4. Disassembly of AJs  
AJs must also be disassembled both in development, for example during gastrulation and neural 
crest development (Kalluri and Weinberg, 2009; Lim and Thiery, 2012), and in the adult organism 
during wound healing or apoptosis (Kessler and Muller, 2009; Leopold et al., 2012). Disassembly of 
AJs is often associated with epithelial-to-mesenchymal transition and can be triggered by growth 
factors (Kalluri and Weinberg, 2009; Lim and Thiery, 2012). 
Gastrulation occurs early on in embryonic development and leads to the generation of the 
ectoderm, mesoderm and endoderm, from which all tissues arise. The first stage in gastrulation is 
the formation of a furrow in the blastula, called the primitive streak, whereby cells separate from 
the epithelial layer (delaminate) by either folding inwards (invagination) or collectively migrating into 
an adjacent area (involution) (Lim and Thiery, 2012). Cells in the primitive streak undergo successive 
epithelial-to-mesenchymal transitions whereby, through a process called ingression, single cells 
disassemble contact with the basal lamina, dismantle cell-cell adhesions and migrate. The cells that 
will become the mesoderm and the endoderm ingress at specific sites after which they revert back 
to an epithelial phenotype by undergoing mesenchymal-to-epithelial transition (Lim and Thiery, 
2012). Importantly, epithelial-to-mesenchymal transition occurs in predefined areas and only in 
specific cells. The integrity of the basal membrane is maintained and cells ultimately revert back to 
an epithelial phenotype. 
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1.4. The modulation of cell-cell contacts in cancer    
The metastatic process typically involves the breakdown of cell-cell contacts, detachment from 
adjacent cells at the primary site, invasion into surrounding tissues, entry and dissemination via the 
blood or lymphatic systems to a distinct secondary site and finally outgrowth and extravasion at the 
secondary site (Yilmaz and Christofori, 2009). Thus, numerous features associated with epithelial-to-
mesenchymal transitions, from the morphological alterations to the molecular mechanisms in place 
to downregulate key adhesive proteins, are closely mirrored in pathogenic scenarios. This suggests 
that these vital developmental processes can be subverted by tumour cells to promote metastasis 
(Kalluri and Weinberg, 2009; Lim and Thiery, 2012; Yilmaz and Christofori, 2009). As such, valuable 
insights into tumour progression can be gained from understanding epithelial-to-mesenchymal 
transition during developmental processes and vice versa (Lim and Thiery, 2012). 
Tumour progression and metastasis requires that cell-cell and cell-matrix contacts are extensively 
remodeled as cancer cells detach from their neighbours, migrate and re-adhere at secondary sites. 
In cells migrating individually this can involve complete disassembly or AJs (van Zijl et al., 2011). 
However, in other situations, for example when cancer cells migrate collectively, AJs are maintained 
(Friedl and Gilmour, 2009). As tumour progression relies on loss (or extensive modulation) of cell-cell 
contacts a central role for E-cadherin during tumour progression and metastasis is unsurprising (Berx 
and van Roy, 2009; Vasioukhin, 2012). Decreased expression of E-cadherin is found in many human 
epithelial tumours and is usually associated with poor prognosis (Berx and van Roy, 2009). Most 
likely, this is derived from E-cadherin’s ability to coordinate multiple signaling pathways, as well as 
the structural role played in mediating cell-cell contact.  
1.4.1. Downregulation of cadherins 
Mutations in CDH1, the E-cadherin gene, resulting in deletion or truncations are found in gastric, 
prostate, hepatocellular and breast cancers (Becker et al., 1994; Berx et al., 1995). However, this 
does not seem to be the predominant form of downregulation of E-cadherin, as whilst there is a high 
incidence of CDH1 mutations associated with lobular breast and diffuse gastric cancer, it is a 
relatively rare occurrence in other cancers (Berx et al., 1998; Strathdee, 2002).  
The downregulation of E-cadherin can be achieved via a number of mechanisms including epigenetic 
alterations, such as DNA methylation of the CDH1 promoter region, post-translational modification 
of AJ components or via the secretion of proteases from neighbouring cells (Strathdee, 2002; 
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Yoshiura et al., 1995). Unlike genetic mutations though, these are reversible which would allow for 
low levels of E-cadherin expression if necessary, and may account for why these are far more 
prevalent than genetic mutations. 
Transcriptional downregulation of cadherin can be achieved via upregulation of transcription factors 
capable of inhibiting E-cadherin expression by binding to the E-cadherin promoter. The transcription 
factors Zinc-finger binding protein SNAI1 (SNAIL), Zinc finger E-box-binding homeobox 1/2 (ZEB1/2), 
twist basic helix-loop-helix transcription factor 1 (Twist) and Zinc finger binding protein SNAI2 (Slug) 
are able to repress E-cadherin expression (Batlle et al., 2000; Cano et al., 2000; Comijn et al., 2001; 
Grooteclaes and Frisch, 2000; Hajra et al., 2002; Yang et al., 2004) and elevated expression levels of 
these transcription factors have been reported in a range of cancers (Blanco et al., 2002; Elloul et al., 
2005; Rosivatz et al., 2002; Spoelstra et al., 2006; Yang et al., 2004).   
Interestingly, there is a degree of cross-talk between microRNAs (miRs) and transcriptional factors. 
For example, miR-141 and miR-200c suppress ZEB1 and transforming growth factor-beta (TGF-β) 
transcription and ZEB1 directly suppresses miR-141 and miR-200c in breast cancer and colorectal 
cancer cell lines (Burk et al., 2008). Thus, inhibition of these miRs may contribute to the ability of 
ZEB1 to promote invasion. MicroRNAs can also negatively regulate E-cadherin by binding directly to 
the E-cadherin 3’ UTR (eg. mir-9 (Ma et al., 2003), mir-92a (Chen et al., 2011) and miR-495 (Hwang-
Verslues et al., 2011). 
Destabilisation of the cadherin-catenin complex by post-translational modification also reduces cell-
cell adhesion by indirectly promoting removal of E-cadherin from contact sites. Phosphorylation of E-
cadherin in the cytoplasmic tail by casein kinase II (CKII) on serine residues is necessary for β-catenin 
binding (Huber and Weis, 2001; Lickert et al., 2000). Conversely, phosphorylation within the 
juxtamembrane domain by receptor tyrosine kinases (RTKs) and/or Src kinases creates a binding site 
for Hakai, which leads to E-cadherin ubiquitination and degradation (Fujita et al., 2002). RTKs can 
also phosphorylate β-catenin which decreases its binding affinity for E-cadherin (Roura et al., 1999). 
Finally, tumour progression activates proteases (matrix metalloproteinases (MMPs), disintegrin and 
metalloproteinases and γ-secretases) in order to expedite passage through the ECM (eg. MMP2, 
MMP9 (Remacle et al., 1998), MMP7 (Ii et al., 2006) and stromelysin-3 (Basset et al., 1990) amongst 
others (reviewed in: (Nelson et al., 2000)). These also serve to directly cleave E-cadherin molecules 
of nearby cells. The cleaved cadherin extracellular domain may act negatively on neighbouring cells 
by binding to free cadherin on adjacent cell surfaces and impairing function (Noe et al., 2001), whilst 
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the cytoplasmic tail of N-cadherin can translocate to the nucleus where it can regulate transcription 
(Ferber et al., 2008; Shoval et al., 2007). 
1.4.2. Catenins and cancer 
Although loss of E-cadherin is correlated with increased invasion and metastasis, studies of mice 
with deletion of E-cadherin in skin and mammary glands reveal that loss of E-cadherin alone is not 
sufficient to induce tumourigenesis (Boussadia et al., 2002; Tinkle et al., 2008; Tunggal et al., 2005). 
However, the concomitant loss of E-cadherin with p120-catenin or α-catenin is highly tumourigenic. 
Furthermore, the loss of either p120 catenin or α-catenin is sufficient to induce invasion; 
transplantation of α-catenin-/- null keratinocytes onto nude mice cause skin lesions reminiscent of 
squamous cell carcinoma (Kobielak et al., 2004), whilst p120-/- keratinocytes cause inflammatory 
lesions and tumour-like growths (Perez-Moreno et al., 2008). These are consistent with findings that 
loss of E-cadherin also correlates with loss of α-catenin and increased invasion (Aaltomaa et al., 
1999).  
As such, modulation of the levels and functionality of catenins presents an additional mechanism to 
promote tumourigenesis which may relate to both adhesive and non-adhesive roles for these 
proteins. For example, ablation of α-catenin in mouse skin does not prevent formation of cell-cell 
contacts, and E-cadherin and β-catenin localise to cell-cell contacts. However, hyperproliferative 
cells are present in the epidermis, similar to those seen in squamous cellular carcinoma (Vasioukhin 
et al., 2001a). Interestingly, loss of α-catenin is associated with activation of nuclear factor (NF)-κβ 
signaling pathways which enhances the inflammatory response (Kobielak and Fuchs, 2006). 
Furthermore, functions related to the regulation of transcription have been described for p120 
catenin (Daniel and Reynolds, 1999; Ferber et al., 2008; Park et al., 2005). 
As opposed to the tumour suppressive roles of α- and p120 catenin, β-catenin is found upregulated 
in many cancers (Clevers, 2006). In addition to its function in AJs, β-catenin is a central component of 
the Wnt signaling pathway that controls several aspects of cell fate. Wnt signalling induces the 
cytoplasmic pool of β-catenin to translocate to the nucleus, where it directs gene transcription in 
association with T-cell factor (TCF), lymphoid enhancer factor (LEF-1) and Pangolin (Pan) (Behrens et 
al., 1996; Funayama et al., 1995; McEwen et al., 2012). This is balanced by the actions of a 
destruction complex for β-catenin composed of adenomatous polyposis coli (APC), axin, Glycogen 
synthase kinase 3-β (GSK3-β) and casein kinase (CKI) (Behrens et al., 1998; Kikuchi, 1999). Mutations 
are often found that stabilise β-catenin. Commonly these affect the ability of β-catenin to become 
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phosphorylated (which regulates its degradation) resulting in constituitve activation and Wnt 
signaling (Vasioukhin, 2012). Interaction with E-cadherin effectively sequesters β-catenin at cell-cell 
contacts, preventing it from activating Wnt genes. Thus, loss of E-cadherin, or disruption of the E-
cadherin-β-catenin interaction has the secondary effect of increasing the pool of cytoplasmic β-
catenin (McEwen et al., 2012). 
1.5. Small GTPases 
Small GTPases regulate diverse cellular function including regulation of trafficking, migration, 
proliferation and adhesion (Wennerberg et al., 2005). These proteins function as biological switches, 
and through a range of post-translational modifications, and the actions of a cohort of regulatory 
proteins, their activity can be directed in order to bring about very specific cellular responses (Vetter 
and Wittinghofer, 2001; Wennerberg et al., 2005) 
1.5.1. Diverse functions regulated by Small GTPases 
Members of the Ras superfamily of small GTPases can be subdivided into five subgroups, Ras, Rho, 
Rab, Ran and Arf, based on sequence similarity and function and are important regulators of a wide 
variety of cellular processes (Figure 1.4) (Wennerberg et al., 2005). The focus of this work is on Rho 
GTPases, and these will be discussed in detail in a section 1.7. 
Ras sarcoma (Ras) proteins are the founding members of this family and are involved in the 
coordination of many signaling pathways. Ras proteins typically regulate the transcription of genes 
that affect cell growth and survival and numerous Ras targets have been described (Schaefer and 
Sers, 2011; Wennerberg et al., 2005). Close relations of Ras are the Ras-like nuclear (Ran) proteins. 
Ran GTPases regulate nuclear transport of proteins and Ran is particularly important in regulating 
mitosis. Ran also regulates neurite outgrowth and microtubule organisation (Yudin and Fainzilber, 
2009). 
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Figure 1.4 Phylogenetic tree of small GTPasesThe Ras superfamily is grouped into five main branches; Ras, 
Rab, Arf, Ran and Rho. Within the Rho family eight subfamilies exist. The GTPases Miro1, Miro2 and RhoBTB3 
are separated due to differences in sequence and form their own branches. Figure reproduced from Vega and 
Ridley, 2005.  
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Ras homologous (Rho) family GTPases are found in all eukaryotes and are highly conserved (Hall, 
2012). Eighteen Rho GTPases exist in mammals and these can be further subdivided into 8 groups 
(Figure 1.4) (Hall, 2012; Maria Rojas et al., 2012; Wennerberg et al., 2005). Rho GTPases regulate 
actin cytoskeleton dynamics by interacting with a range of proteins that can influence the assembly, 
disassembly and reorganisation of actin (Hall, 2012; Jaffe and Hall, 2005). As coordination of the 
actin cytoskeleton is required to drive so many fundamental cellular processes (eg. migration, cell 
division, endocytosis) Rho GTPases, by regulating actin organisation, are key players in these 
processes (Hall, 2012).  
Members of the ADP-ribosylation (Arf) and Ras-like proteins in brain (Rab) familes are regulators of 
membrane trafficking. At the membrane (cell membranes or organelles) Arf proteins control the 
recruitment of lipid-modifying enzymes, effector proteins and coat proteins to vesicles which 
subsequently influences the sorting of cargo into vesicles (Donaldson and Jackson, 2011). Rabs 
coordinate the transport of vesicles from one area of the cell to another via the cytoskeleton. 
Different Rab proteins regulate distinct steps throughout the journey of a cargo protein from the 
endoplasmic reticulum (ER) to the target membrane. For example, Rab5 regulates fusion of vesicles 
to the ER, recycling of the vesicle to the plasma membrane requires Rab4, transport to the Golgi 
requires Rab9 but fusion to the Golgi requires Rab1 (Mizuno-Yamasaki et al., 2012).  
1.5.2. Small GTPases are molecular switches 
Small GTPases are molecular switches that cycle between an active and inactive state depending on 
the status of nucleotide binding (McCormick and Wittinghofer, 1996) (Figure 1.5 A). When bound to 
GTP the GTPases are active and able to interact with their effectors, whilst in the GDP-bound form 
they are inactive (McCormick and Wittinghofer, 1996). Their activation status is influenced by three 
classes of regulatory proteins (Cherfils and Zeghouf, 2013). The intrinsic hydrolysis rate of GTPases is 
highly variable, but generally slow (Vetter and Wittinghofer, 2001). This can be catalysed by the 
actions of GTPase activating proteins (GAPs) that serve as negative regulators, effectively ‘switching 
off’ the GTPase (Vetter and Wittinghofer, 2001). Guanine nucleotide exchange factors (GEFs) are 
positive regulators of GTPases. These stabilise the nucleotide-free form of the GTPase, causing them 
to release bound GDP, which is replaced by the more prevalent GTP (Vetter and Wittinghofer, 2001). 
Guanine-nucleotide dissociation inhibitors (GDIs) are the final class of regulators, these serve to 
sequester GTPases in the cytoplasm that prevents them from signalling (Vetter and Wittinghofer, 
2001).   
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Small GTPases all share a broadly conserved structure for the binding and hydrolysis of GTP, called 
the G domain (Hakoshima et al., 2003). This consists of a six-stranded β sheet and five α helices 
(Bourne et al., 1991). Binding of GTP changes the conformation of two switch regions (switch I and 
switch II), which facilitates the binding of effector proteins and subsequent downstream signalling 
(Bourne et al., 1991; Vetter and Wittinghofer, 2001). Magnesium ions are vital for binding of GTP 
and consequently activity of the GTPase as these stabilise the conformation of the GTPase 
(Hakoshima et al., 2003). GTPases all hydrolyse GTP at very different rates, and some GTPases lack 
any intrinsic hydrolysis at all (Bos et al., 2007; Scheffzek and Ahmadian, 2005). The intrinsic 
hydrolysis of GTP involves the transfer of the γ-phosphate of GTP to a water molecule present at the 
active site. The Mg2+ ion is required to polarise GTP, which then abstracts a proton from the water 
molecule. The water molecule then acts as an attacking nucleophile (Scheffzek and Ahmadian, 
2005). 
Knowledge of the structure of GTPases has aided development of constitutively active or inactive 
mutants of GTPases, as specific mutation of critical residues within the G domain can affect 
interactions with GTP, effectors or regulators. These have proven useful experimental tools (Feig, 
1999). Dominant-negative mutants (eg. Rac and Ras mutants whereby serine 17 is replaced by 
arginine) bind GEFs with high affinity, effectively sequestering Rho GEFs from binding endogenous 
GTPases (Feig, 1999). This is thought to be due to important interactions mediated by serine 17 with 
the Mg2+ ion. Conversely, constituitively active mutants were created by mutation of leucine (in the 
switch II region) to glutamine (L61 in Ras, Rac and Cdc42, L63 in Rho) or mutations of glycine to 
valine (V14 in RhoA, V12 in Rac and Cdc42) which render GTPases unable to hydrolyse GTP.  
Post-translational modifications serve to target GTPases to distinct membranes, where they exert 
their effects. Rho family proteins typically contain a CAAX motif at their C-terminus (C= cysteine, A= 
aliphatic, X= any amino acid), whilst Rabs contain similar, cysteine-containing motifs which are 
recognised by enzymes able to catalyse the addition of farnesyl or geranylgeranyl groups to these 
proteins (Magee et al., 1992; Takai et al., 2001). Conversely, Arfs are targeted via myristolation of 
their N-terminal domains (Wennerberg et al., 2005). Mutation of amino acids within these regions 
can perturb function due to mislocalisation.  
40 
 
 
Figure 1.5 GTPases are molecular switches A) GTPases cycle between an active (GTP-bound) and inactive 
(GDP-bound) form. In the active form, they interact with their effectors and influence various cellular 
processes. The activity of GTPases is governed by the actions of three classes of regulators. Positive regulators, 
the guanine nucleotide exchange factors (GEFs) catalyse the release of tightly-bound GDP which would 
otherwise be released slowly. Two classes of negative regulators exist; GTPase activating proteins (GAPs) 
enhance the inherent catalytic activity of the GTPase, thereby inactivating it. Rho and Rab family GTPases can 
be regulated by GTPase dissociation inhibitors (GDIs), which sequester GDP-bound GTPases in the cytoplasm 
and bind GTP-bound GTPases to prevent their association with effectors proteins. B) GAPs (pink) bind to the G-
domain of their target GTPase (orange) and insert a conserved arginine residue into the active site between 
the two switch regions. The interactions between different GTPases and GAPs are shown and coloured as 
follows; Ras-RasGAP (yellow), Rho-RhoGAP (red), Rac-ExoS (cyan) and Giα-RGS (magenta). Catalytic water is 
shown as a red “W”. C) GEF (pink) bound to GTPase (orange). Guanine nucleotides bind strongly to the P loop 
and magnesium ion. GEF binding disrupts this interaction, pulling switch I and pushing switch II out of position. 
B and C are adapted from Vetter and Wittinghofer, 2001.  
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1.5.3. Small GTPase regulators 
GAPs bind to GTPases and enhance, by up to five orders of magnitude, the hydrolysis of GTP to GDP 
with the effect of ‘turning off’ the GTPase and ending downstream signaling (Scheffzek and 
Ahmadian, 2005). GAPs work by stabilising the catalytic complex, and aligning the water molecule to 
optimise nucleophilic attack. A conserved arginine in the GAP (the arginine finger) is critical in this 
reaction, as this protrudes into the active site and stabilises negative charges which emerge in the 
transition state (Figure 1.5 B) (Scheffzek and Ahmadian, 2005). Mutation of the arginine finger is 
commonly used to inactivate GAPs in order to investigate GAP-domain dependent functions of a 
protein.   
GTPases bind GDP/GTP with high affinity, meaning their dissociation is slow (Bos et al., 2007). GEF 
binding reduces the affinity of the GTPase for the nucleotide so that the nucleotide is rapidly 
released and then replaced. The catalytic domains of GEFs from different families is not well 
conserved, but all use similar mechanisms to displace GDP (Bos et al., 2007; Cherfils and Zeghouf, 
2013). GEFs bind to the switch I and II regions on the GTPase and residues from the GEF are placed in 
the vicinity of the Mg2+ ion, which pushes the switch regions out of position (Figure 1.5 C) (Cherfils 
and Zeghouf, 2013; Vetter and Wittinghofer, 2001). In some GEFs, acidic residues create repulsive 
electrostatic forces within this region, whilst others induce changes in the switch II region which 
results in destabilisation of the Mg2+ ion. The result is either partial or complete obstruction of the 
active site which makes it impossible for both the phosphates and the metal ion to bind (Cherfils and 
Zeghouf, 2013; Vetter and Wittinghofer, 2001). The nucleotide is then displaced and upon binding of 
the next nucleotide the GEF becomes dissociated. 
Rho and Rab family GTPases can also be regulated by GDIs. Only three Rho GDIs and three Rab GDIs 
exist, and these are fairly well-conserved (Cherfils and Zeghouf, 2013). GDIs form two separate 
interfaces with their targets, one at the switch region and one at the prenylated C-terminus. The 
binding of GDI prevents the release of nucleotide, and by binding to the prenylated COOH-terminus 
prevents localisation of the GTPase to the membrane by shielding the hydrophobic tail. This 
effectively results in sequestration of the GTPase in the cytoplasm (Bos et al., 2007). 
As GTPases control numerous facets of cellular signalling, GTPase regulators are of vital importance 
in directing the actions of their targets. GTPase regulators control the localisation and duration of 
signalling as well as influencing the interaction with GTPase effector proteins (Rossman et al., 2005; 
Tcherkezian and Lamarche-Vane, 2007). Consequently, GAPs and GEFs can greatly influence the 
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outcome of GTPase activation (Kather and Kroll, 2013; McCormack et al., 2013; Tcherkezian and 
Lamarche-Vane, 2007; Tolias et al., 2011). For these reasons, the localisation and activity of the 
regulators must also be tightly controlled.  
1.6. Regulating the activity of GTPase regulators  
The activity of GTPase regulators is achieved via various mechanisms which may alter the 
conformation of the GEF/GAP domain, such that this is revealed or obscured, or promote the 
translocation of the regulator to a region of the cell where it is activated or sequestered (Bernards 
and Settleman, 2004; Garcia-Mata et al., 2011; Rossman et al., 2005). 
1.6.1. Auto-inhibition 
Many GEFs and GAPs can adopt autoinhibited states (Bernards and Settleman, 2004; Cherfils and 
Zeghouf, 2013; Rossman et al., 2005). For example, the Rho GAPs Oligophrenin, Cdc42 GTPase 
activating protein (CdGAP), p190 RhoGAP and β-chimearin are able to adopt auto-inhibitory 
configurations (Bustos et al., 2008; Canagarajah et al., 2004; Fauchereau et al., 2003; Southgate et 
al., 2011); expression of Oligophrenin N-terminal inhibits GAP activity when co-expressed with the 
GAP domain (Fauchereau et al., 2003) and truncation mutants of CdGAP lacking the C-terminal are 
more active on Cdc42 (Southgate et al., 2011). Similarly, several GEFs are constituitively activated 
following deletion of their N- or C-terminal regions, suggesting that these regions negatively regulate 
GEF activity (Cherfils and Zeghouf, 2013; Rossman et al., 2005). These include Rho-family GEFs APC 
stimulated exchange factor 1 (Asef1), T-cell lymphoma invasion and metastasis 1 (Tiam1), Vav1 and 
epithelial cell-transforming sequence 2 oncogene (ECT2) (Aghazadeh et al., 2000; Kawasaki et al., 
2000; Miki et al., 1993; van Leeuwen et al., 1995), Ras GEF Ras-specific guanine nucleotide-releasing 
factor 1 (GRF1) (Baouz et al., 1997) and RapGEF Exchange protein directly activated by cAMP 1 
(EPAC) (de Rooij et al., 1998). 
The highly complex domain structures exhibited in the regulators mean these proteins can form a 
range of interactions with other cellular components, and so release from an inhibited state can be 
disrupted by lipids, protein-protein interaction and phosphorylation. These are discussed below. 
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1.6.2. Regulation by phosphorylation 
Phosphorylation is an important mechanism used to activate, or inhibit regulators. The Rho GAP 
p190 can be activated via both phosphorylation (Chang et al., 1995; Haskell et al., 2001; Hu and 
Settleman, 1997) or dephosphorylation (Chiarugi et al., 2000; Shiota et al., 2003; Sordella et al., 
2003). The kinase Src phosphorylates p190 which leads to its interaction with p120RasGAP, 
translocation of this complex to the cell membrane, and activation of p190 (Chang et al., 1995; 
Haskell et al., 2001; Hu and Settleman, 1997). Subsequently, other kinases such as breast tumour 
kinase and Fyn have been found to phosphorylate p190 and promote its interaction with 
p120RasGAP, thus this appears an important mechanism by which to coordinate Rho and Ras 
signaling (Shen et al., 2008; Wolf et al., 2001). Insulin receptor can also phosphorylate p190 which 
results in its rapid translocation to membranes (Sordella et al., 2003). The dephosphorylation of 
p190 by Low molecular weight protein tyrosine phosphatase, protein tyrosine phosphatase 20 and 
protein tyrosine phosphatase 11 can all inhibit p190 (Chiarugi et al., 2000; Shiota et al., 2003; 
Sordella et al., 2003). 
The Rho-family GEF Vav1 is activated via phosphorylation (Aghazadeh 2000). Vav1 activation has 
been studied extensively (Cherfils and Zeghouf, 2013; Yu et al., 2010) and crystal structures reveal a 
tightly packed structure that requires the completion of several phosphorylation events to induce 
activation (Yu et al., 2010). This allows Vav1 to be efficiently inhibited but rapidly activated (Cherfils 
and Zeghouf, 2013). Multiple phosphorylation events are also required to activate GRF1, which is 
retained in an autoinhibitory state (Baouz et al., 2001; Baouz et al., 1997). 
Phosphorylation of RhoGDIs (for example by p21 activated kinase 1 (PAK1), protein kinase C (PKC) α 
or ζ, or Src) can reduce their affinity for GTPases, which leads to their release (DerMardirossian et al., 
2004; DerMardirossian and Bokoch, 2006; Garcia-Mata et al., 2011; Mehta et al., 2001). 
Interestingly, phosphorylation can specifically alter binding affinity for different GTPases. For 
example PAK1 can phosphorylate RhoGDI1 which promotes the release of the Rho GTPase Rac1, but 
not RhoA (DerMardirossian et al., 2004).  
1.6.3. Regulation by lipids  
Phosphatidylinotsitols are used as second messengers in signalling pathways. Diaglycerol (DAG) is 
generated at cell membranes downstream of phospholipase C (PLC) activation. Rho GAPs of the 
chimaerin family contain DAG receptor sites (Hall 1990, Leung 1993, Hall 1993). In its inactive state, 
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β2-chimaerin is inhibited by residues in the N-terminal region that obstruct the active site, binding of 
DAG to the C1 region dissociates several interactions within this area that reveals the GAP domain 
(Canagarajah et al., 2004). Binding of DAG also induces the translocation of chimaerins to the 
membrane (Caloca et al., 1997; Caloca et al., 2001) where they inactivate Rac (Wang et al., 2006). 
Interestingly, α-chimaerin is stabilised via interaction with DAG, which prevents its ubiquitination 
and degradation (Marland et al., 2011). 
Furthermore, as integral components of cellular membranes, lipids may direct Rho GAP or GEF 
activation at specific subcellular sites. For example, several regulators contain domains that facilitate 
their recruitment to lipid membranes (eg. Bin, amphiphysin, RSV161/167 (BAR) domains) which 
allows them to interact with membranes and cause membrane curvature. The specialised nature of 
this interaction may be important to spatially confine Rho GTPase activation. For example the 
recruitment of ArfGAP1 to highly curved membranes activates its GAP activity (Bigay et al., 2003). 
Similarly, the Rho-family GAP, CdGAP binds several phospholipids via a basic N-terminal region and 
incorporation of phosphatidylinositol 3,4,5-triphosphate (PIP3) into in vitro membranes enhances 
GAP activity of CdGAP (Karimzadeh et al., 2012). 
1.6.4. Regulation by protein-protein interaction 
Protein-protein interactions mediated by a range of molecules may serve to activate or inhibit 
regulators via conformational changes or by regulating localisation. Examples of protein-protein 
interactions that result in activation of regulators include the binding of Rac to p190B which releases 
p190B from its autoinhibited state and promote its association with its target, RhoA, at the 
membrane (Bustos et al., 2008). In addition, EPAC, is activated by cyclic AMP binding (de Rooij et al., 
1998) which induces large conformational changes in EPAC to reveal the GEF domain (Cherfils and 
Zeghouf, 2013). 
Protein-protein interactions can also induce the translocation of Rho GAPs to distinct cellular 
compartments which mediates their activation. An example is CdGAP which interacts with actopaxin 
(also called α-parvin), a protein found at focal adhesions in some cells. Interaction with actopaxin 
induces the localisation of CdGAP to focal adhesions where it inhibits spreading of osteosarcoma 
cells (LaLonde et al., 2006). Interaction with actopaxin has no effect on GAP activity of CdGAP in 
vitro, but loss of actopaxin increases spreading as CdGAP is not localised to focal adhesions (LaLonde 
et al., 2006). 
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CdGAP and another Rho-family GAP, RhoGAP interacting with CIP4 homologs protein 1 (Rich1, 
ARHGAP17), are also negatively regulated via interaction with the scaffold proteins intersectin (itself 
a GEF) (Hussain et al., 2001; Jenna et al., 2002; Primeau et al., 2011) and Amot (Wells et al., 2006) 
respectively. Rich1 is required for the maintenance of TJs via restriction of Cdc42 activity. However, 
expression of Amot prevents Rich1 from inactivating Cdc42 leading to loss of TJ integrity (Wells et 
al., 2006). CdGAP interacts directly with intersectin via a basic region adjacent to the GAP domain, 
which likely induces a conformational change in the protein (Primeau et al., 2011). The Rho GEFs 
Asef and Intersectin both contain Src homology 3 (SH3) domains that bind to their active sites to 
inhibit these proteins (Ahmad and Lim, 2010; Mitin et al., 2007; Murayama et al., 2007). Asef and 
Intersectin are activated via interaction with APC and the Cdc42 effector neural Wiskott–Aldrich 
syndrome protein (N-WASP) binding, respectively (Hussain et al., 2001; Zhang et al., 2012) which 
likely mediates conformational changes in these proteins. 
RabGDIs can be regulated by GDI-displacement factors which catalyse the release of Rabs from GDIs 
(Sivars et al., 2003). No such proteins have thus far been identified for RhoGDIs. The release of 
GTPase can also be achieved via formation of protein-protein interactions. For example, both the 
kinase Ephrin type-A receptor 3, and ezrin, radixin, moesin (ERM) proteins can compete with GTPase 
for the binding of RhoGDI (Kim et al., 2002; Takahashi et al., 1997). 
1.7. Cellular functions of Rho GTPases  
The most studied GTPases within this family are RhoA, Rac1 and Cdc42 and their activation has 
specific effects on the organisation of actin; RhoA stimulates the formation of highly contractile 
stress fibres, Rac1 promotes the formation of lamellipodial and Cdc42 promotes the formation of 
filopodia (Nobes and Hall, 1995; Ridley and Hall, 1992; Ridley et al., 1992).  
1.7.1. Rho GTPases 
Three highly homologous Rho proteins exist; RhoA, RhoB and RhoC (Wheeler and Ridley, 2004). 
Despite this high homology, these proteins have distinct functions. RhoB has been implicated in 
endosomal trafficking (Ellis and Mellor, 2000) and is growth-suppressive (Huang and Prendergast, 
2006), whereas RhoA and C are growth-promoting. The C-terminal regions of RhoA, B and C are 
where most differences in sequence are found, thus distinct functions may be due to the discrete 
localisation of these proteins (Wheeler and Ridley, 2004). Rho activity is necessary in cytokinesis for 
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the formation of the contractile ring (Jaffe and Hall, 2005) as well as for phagocytosis mediated by 
the complement receptor (Caron and Hall, 1998) and can inhibit neurite extension (Luo, 2000). 
The Rac subfamily consists of Rac1, Rac2, Rac3 and RhoG as well as a Rac1 splice variant, Rac1b. 
Expression of the different Rac proteins varies in different tissues, for example Rac2 is highly 
expressed in hematopoietic cells, Rac3 is highly expressed in brain and Rac1 and RhoG are 
ubiquitously expressed (Haataja et al., 1997; Heasman et al., 2010; Shirsat et al., 1990). Only Rac1 
null mice are embryonic-lethal (Sugihara et al., 1998), although tissue-specific defects are reported 
in Rac2, Rac3 and RhoG knockout mice (Heasman et al., 2010). Rac regulates neurite extension (Luo, 
2000), the passage of G2 /M phase and can accumulate in the nucleus, where it promotes mitosis 
(Mack et al., 2011)   
Cdc42 has frequently been associated with the regulation of polarity in numerous species and cell 
types (Etienne-Manneville and Hall, 2002; Heasman et al., 2010). Cells are required to polarise, that 
is to separate proteins and organelles into defined regions of the cell, during migration, cell division, 
and the formation of epithelial monolayers (Etienne-Manneville and Hall, 2002).  Par proteins are 
well-conserved proteins that play a fundamental role in the establishment and maintenance of 
polarity (McCaffrey and Macara, 2009). Cdc42 regulates interactions between Par proteins to form a 
polarity complex (formed of Par-3, Par-6 and PKC) (McCaffrey and Macara, 2009). Similar polarity 
complexes are assembled in different contexts and across the animal kingdom. Thus, regulation of 
polarity by Cdc42 is critical for development and morphogenesis of many cell types and tissues 
(Etienne-Manneville and Hall, 2002; Jaffe and Hall, 2005).  
Rho GTPases also coordinate their activity to regulate many processes, including cell migration and 
phagocytosis (Caron and Hall, 1998; Ridley, 2001; Sanz-Moreno et al., 2008). Cells can use a variety 
of mechanisms to control migration. For example, mesenchymal migration is characterised by an 
elongated morphology and protrusions at the leading edge (Ridley, 2001). In these cells, Rac 
promotes the turnover of focal adhesions and formation of lamellipodia at the leading edge of the 
cell whereas Rho generates contractile forces at the rear of the cell (Ridley, 2001; Sanz-Moreno et 
al., 2008). Also, Rac and Cdc42 activities are coordinated to bring about phagocytosis via Fc 
receptors as well as pinocytosis (Caron and Hall, 1998; Etienne-Manneville and Hall, 2002) 
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1.7.2. Rho effectors 
Rho GTPases signal through numerous effectors to bring about downstream responses. Over 70 Rho 
effectors have been described, thus only some of the best characterised are discussed below (Figure 
1.6).  
Rho activation is typically characterised by the formation of stress fibres and the generation of 
contractile forces (Ridley and Hall, 1992). Rho activation promotes actomyosin contractility via 
regulation of its effector ROCK (Ishizaki et al., 1996; Leung et al., 1995). ROCK has many targets that 
regulate the actin cytoskeleton (Amano et al., 2010). Contractility relies on the actions of myosins, 
which are molecular motor proteins able to transduce force along actin cables. Myosins are formed 
of heavy (MHC) and light (MLC) chains and their activity is generally governed by phosphorylation of 
their light chains. ROCK promotes phosphorylation of the MLC of MyoII directly by phosphorylating 
MLC, and indirectly by inhibiting myosin light chain phosphatase (MLCP) (Kaibuchi et al., 1999; 
Kimura et al., 1996) thus controlling contractility.  
Other important ROCK targets are the LIM kinases (LIMK) (Maekawa et al., 1999), these are serine 
kinases that target and inhibit actin-binding protein cofilin (Stanyon and Bernard, 1999). Cofilin 
depolymerises and severs F-actin, thus activation of LIMK by ROCK (or PAKs, discussed below) 
inhibits the effects of cofilin (Maekawa et al., 1999).  
Rho also signals through several other kinases including Citron kinase (Madaule et al., 1998) and 
PKC-related kinase (PKN) (Amano et al., 1996). Citron kinase acts downstream of Rho to regulate 
cytokinesis by regulating contraction (Madaule et al., 1998). PKN interacts with RhoA, B and C (Zhao 
and Manser, 2005) and PKN activation downstream of RhoB has been implicated in endosomal 
trafficking (Mellor et al., 1998).  
Rho can stimulate the formation of linear actin fibres and this is achieved via activation of formins 
(Goode and Eck, 2007). Rho interacts directly with the diaphanous-related formins (DRFs, including 
Dia) (Aspenstrom, 2010; Goode and Eck, 2007; Watanabe et al., 1997). Dia induces the rapid 
elongation of actin filaments which is critical for the formation of stress fibres, filopodia and the 
cytokinetic ring (Goode and Eck, 2007). DRFs are maintained in an inactive state via interaction of a 
Diaphanous autoinhibitory domain at the C-terminus with a Diaphanous inhibitory domain (Alberts, 
2001; Li and Higgs, 2003). The binding of Rho to the GTPase binding domain (GBD) at the N-terminus 
relieves autoinhibition and activates the formin (Li and Higgs, 2003). Signaling downstream of Dia 
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can also activate the transcription factor, serum response factor leading to changes in transcription 
(Tominaga et al., 2000).  
1.7.3. Rac and Cdc42 effectors 
Rac and Cdc42 share a number of effectors, although these can initiate differing cellular responses. 
As such these will be discussed together. 
PAKs are serine/threonine protein kinases and important  Rac and Cdc42 effectors (Manser et al., 
1994). Six PAK genes exist and Rac and Cdc42 interact with all members via a conserved Cdc42 and 
Rac interactive binding (CRIB) domain (Bokoch, 2003). PAKs regulate contractility, actin remodeling 
and microtubule organisation via interaction with various targets that have been described as 
signalling downstream of Rac/Cdc42 activation (Bokoch, 2003; Szczepanowska, 2009).  
PAKs regulate contractility by influencing myosin activity either directly, via phosphorylation of the 
MLC of MyoII (Chew et al., 1998; Ramos et al., 1997; Zeng et al., 2000) therefore promoting 
contractility, and indirectly, via phosphorylation of MLCK, which inhibits MLCK and therefore 
indirectly inhibits MLC phosphorylation and contractility (Bokoch, 2003; Sanders et al., 1999). PAK3 
is also able to phopsphorylate the unconventional myosin VI (Yoshimura et al., 2001).  
PAKs can regulate actin remodeling via phosphorylation and activation of LIMK (Dan et al., 2001; 
Edwards et al., 1999) which then inhibits cofilin. In addition, cortactin interacts with Arp2/3 and 
stabilises actin branching (Uruno et al., 2001). Phosphorylation of cortactin by PAK3 decreases 
cortactin binding to F-actin (Webb et al., 2006).  
Microtubule dynamics are regulated via phosphorylation of Stathmin, a microtubule-destabilising 
protein (Wittmann et al., 2004). Another PAK target is the scaffold protein Ajuba (Nola et al., 2011) 
and phosphorylation of Ajuba enhances its affinity for active Rac, promoting Rac localisation to cell-
cell contacts (Nola et al., 2011). Numerous other PAK targets have been described and are reviewed 
elsewhere (Bokoch, 2003; Szczepanowska, 2009). 
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Figure 1.6 Rho GTPase effectors and cross talk A schematic illustrating some of the downstream effectors and 
signaling pathways activated downstream of RhoA, Rac1 and Cdc42. The subsequent effects these proteins 
have on the cytoskeleton, AJs and cellular processes are described. Green arrows represent activating 
interaction, red lines with bars represent inhibitory interaction and the black arrows describe the cellular 
outcome resulting from GTPase signaling. Additional details are provided in the text. Dia, Diaphanous; LIMK, 
LIM kinase; ROCK, Rho-associated kinase; MLCP, Myosin light chain phosphatase; MLC, Myosin light chain; 
MLCK, Myosin light chain kinase; PAK, p21 activated kinase; WAVE, WASP family verprolin homologous 
protein; WASP, Wiskott-Aldrich syndrome protein; Arp, actin-related protein; IQGAP, IQ motifs and GAP-
related-domain containing protein; β-cat, β-catenin. Figure adapted from Citi et al., 2011.  
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Both Rac and Cdc42 promote the formation of branched actin structures via the activation of the 
Arp2/3 complex. However, Rac and Cdc42 signal through different effectors, Rac via WASP family 
verprolin-homologous protein (WAVE) and Cdc42 through WASP or N-WASP (Eden et al., 2002; 
Stradal and Scita, 2006). The Arp2/3 complex promotes the formation of branched actin structures 
at a 70° angle from an existing (mother) actin filament (Pollard, 2007).  Arp2/3 must be activated by 
nucleating promoting factors (of which WAVE and WASP/N-WASP are) (Welch and Mullins, 2002). 
However, WAVE and WASP/N-WASP are also maintained in inactive conformations (Pollard, 2007). 
WASP/N-WASP is autoinhibited via interactions between its GBD and the VCA domain (the region 
important for actin and Arp2/3 binding) and binding of Cdc42 to the GBD releases this inhibition to 
activate WASP (Kim et al., 2000a; Rotty et al., 2013). WAVE is maintained in an inactive multimeric 
complex (Eden et al., 2002) and Rac activates WAVE, possibly by freeing the VCA, resulting in Arp2/3 
activation (Eden et al., 2002; Pollard, 2007; Rotty et al., 2013; Stradal and Scita, 2006).   
IQ motif containing GTPase activating proteins (IQGAPs) (there are three in humans, but IQGAP1 has 
been most extensively studied) (White, Brown and Sacks 2009) contain diverse domain structures 
and are able to interact with a range of proteins including F-actin, β-catenin and MLC amongst 
others (Briggs and Sacks 2003). Rac and Cdc42 bind to IQGAP via a GAP-related domain which 
inhibits IQGAP interaction with E-cadherin and β-catenin (Kuroda 1996, 1999). However, Cdc42 can 
also promote actin cross-linking mediated by IQGAP in vitro (Fukata 1997). 
1.7.4. Rho GTPases and cancer 
The prominence of Rho GTPases in the regulation of so many fundamental processes means it is 
unsurprising these have also frequently been associated with cancers. The misregulation of Rho 
proteins can allow cancer cells to proliferate by promoting transformation, avoid signals that 
stimulate apoptosis and promote angiogenesis, that is necessary if cancer cells are to grow and 
survive (Sahai and Marshall, 2002a; Vega and Ridley, 2008). Tumour cells may then detach from their 
original location and invade secondary sites. This requires that cell-cell and cell-matrix contacts are 
remodeled and underlying basement membrane disrupted so that the tumour can enter the blood 
or lymphatic systems and travel to a distant site (Sahai and Marshall, 2002a; Vega and Ridley, 2008). 
Unlike Ras proteins, which are frequently mutated in tumours, mutations in Rho GTPases are 
relatively rare (although an increasing number of activating mutations have recently been identified 
in a range of cancers eg. (Krauthammer et al., 2012)) (Vega and Ridley, 2008). Rather, several 
examples exist where expression levels or activity of Rho GTPases are altered in tumours. For 
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example, RhoA (Fritz et al., 2002; Fritz et al., 1999; Kamai et al., 2001), RhoC (Clark et al., 2000; Fritz 
et al., 2002; Suwa et al., 1998; van Golen et al., 2000), Rac1 (Fritz et al., 2002; Fritz et al., 1999), Rac2 
(Roberts et al., 1999), Rac3 (Mira et al., 2000), Cdc42 (Fritz et al., 2002; Fritz et al., 1999), and RhoF 
(Gouw et al., 2005) are all upregulated in a range of cancers. In contrast, RhoB and RhoE are 
frequently downregulated (Baldwin et al., 2008; Bektic et al., 2005; Huang and Prendergast, 2006; 
Luo et al., 2012; Zhao et al., 2012) (Reviewed in (Gomez del Pulgar et al., 2005; Sahai and Marshall, 
2002a; Vega and Ridley, 2008). Interestingly, in some cases upregulation of a GTPase may promote 
one aspect of cancer progression but inhibit another, and cell-type specific functions are likely. For 
example, Cdc42 is upregulated in some breast cancers (Fritz et al., 1999), but its depletion in liver 
promotes tumourigenesis (Van Hengel et al., 2008).  
Rho GTPases are vital regulators of AJs (discussed below) and TJs. As such the misregulation of their 
activity can have severe consequences for cell-cell adhesion. Loss of epithelial polarity may be the 
first stage in tumourogenesis as this subsequently leads to disassembly of cell-cell contacts. TJs are 
important regulators of epithelial polarity, thus disruption of Cdc42 may promote cancer progression 
by perturbing TJ organisation. In addition, RhoE expression can antagonise RhoA and lead to loss of 
epithelial polarity (Guasch et al., 1998).  
Cancer cells typically invade either collectively or individually, but both require the generation of 
mechanical force facilitated by the actin cytoskeleton and modulation of cell-cell and cell-matrix 
contacts. Two modes of (interchangeable) individual cell migration have been described, 
mesenchymal and ameboid (Sahai and Marshall, 2003; Sanz-Moreno et al., 2008; Wolf et al., 2003). 
Mesenchymal migration is characterised by the formation of lamellipodia at the leading edge, focal 
adhesions that provide traction to enable the cell to progress, and the secretion of proteases to 
digest the surrounding ECM. This mode of migration is driven primarily by Rac activation but RhoA 
contributes to tail retraction (Sanz-Moreno et al., 2008). Cells migrating using the ameboid mode are 
characteristically round and do not excrete proteases, instead relying on actomyosin-based 
contractility to drive the cell forward (Sahai and Marshall, 2003; Wolf et al., 2003; Wyckoff et al., 
2006). This mode is driven by high Rho activity coupled with Rac inhibition (Sanz-Moreno et al., 
2008).  
In collective cell migration the leading cell of the group generates the necessary force for movement, 
whilst the trailing cells are dragged behind (Vega and Ridley, 2008). In cultures of squamous cell 
carcinomas, the leading cell relies on RhoA activity for the secretion of MMPs to facilitate passage 
through the ECM and also regulation of MLC phosphorylation to generate necessary force to carry 
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the collection forward (Gaggioli et al., 2007). In the trailing cells, depletion of Cdc42 via siRNA 
reduces the ability of squamous cell carcinoma cells to invade (Gaggioli et al., 2007).  
In order to survive, tumour cells must resist apoptotic signals and Rho GTPases have been implicated 
in this process. Several studies have found activition of Rac1 and its splice variant, Rac1b, protects 
cells from apoptosis (Friedland et al., 2007; Joneson and Bar-Sagi, 1999; Matos and Jordan, 2005). 
However, Rac1 can also promote apoptosis in PC-12 cells via p38 and c-Jun N-terminal kinase (JNK) 
signaling (Xia et al., 1995). 
1.7.5. Rho regulators in cancer 
The misregulation of Rho GTPases in cancer is often associated with perturbation in their activation 
or their inhibition (Vega and Ridley, 2008). Consequently, perturbations in the activity, localisation or 
expression of their upstream regulators, the Rho GEFs and GAPs, have been described in different 
cancers. 
Due to their ability to activate GTPases, the overexpression of Rho GEFs has generally been 
considered oncogenic. Accordingly, several Rho GEFs are upregulated in cancers (Lazer and Katzav, 
2011) including PIP3-dependent Rac exchanger 1 protein which is upregulated in prostate 
adenocarcinoma and lymph node metastases (Qin et al., 2009), ECT2 which is upregulated in lung 
and esophageal cancers (Hirata et al., 2009), and Tiam1 which is overexpressed in hepatocellular 
carcinoma, colon cancer cell lines, breast carcinomas and giant-cell lung carcinomas and is 
associated with malignancy in these cases (Adam et al., 2001; Hou et al., 2004; Lazer and Katzav, 
2011; Minard et al., 2005; Yang et al., 2010). In many cases, aberrant activation of the target GTPase 
is also observed upon Rho GEF overexpression. Leukemia associated Rho GEF (LARG) fuses to the 
mixed lineage leukemia gene in acute myloid leukemia, and results in aberrant RhoA activation 
(Reuther et al., 2001). Vav family GEFs have repeatedly been associated with cancer progression; 
Vav1, 2 and 3 are overexpressed in numerous cancers and Vav1 expression is associated with poor 
prognosis (Lazer and Katzav, 2011). The GEF activity of Vav1 seems to contribute to malignancy 
(Lazer and Katzav, 2011). 
Historically, GAPs have been considered as more likely to be tumour suppressors, due to their ability 
to ‘switch off’ GTPases. Indeed a number of these have been identified including Deleted in liver 
cancer 1 (DLC1), DLC2, p190, β1-chimaerin and slit-robo GAP 3 (SRGAP3) (El-Sitt et al., 2012; Lahoz 
and Hall, 2012; Liao and Lo, 2008; Wang et al., 1997; Yuan et al., 1995). DLC family members are best 
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studied in terms of the tumour suppressive capabilities (Liao and Lo, 2008). Re-expression of DLC1 in 
breast, prostate and liver cancer cell lines can inhibit growth (Goodison et al., 2005; Guan et al., 
2008; Wong et al., 2005).  
Conversely, relatively few GAPs have been found upregulated in tumours, including ARHGAP8, 
ARHGAP21 and CdGAP (Bigarella et al., 2009; He et al., 2011; Johnstone et al., 2004; Lazarini et al., 
2013). Expression of these GAPs often promotes migration in cancers, but the mechanisms behind 
this are not well understood. CdGAP protein and mRNA levels are increased in mammary tumour 
explants expressing an activated form of the ErbB2 receptor (He et al., 2011). In these cells CdGAP 
appears to be required for migration and invasion induced by TGF-β, suggesting CdGAP can promote 
cancer progression downstream of TGF-β (He et al., 2011). ARHGAP21 is overexpressed in head and 
neck squamous cell carcinoma and its depletion impairs migration of glioblastoma cells (Bigarella et 
al., 2009) and reduces proliferation and migration in some prostate cancer cell lines (Lazarini et al., 
2013). Both ARHGAP24 and ARHGAP22 are activated downstream of Rho and inhibit Rac activity 
resulting in promotion of amoeboid-like migration in melanoma (ARHGAP22), breast, lung, prostate 
and colorectal carcinomas (ARHGAP24) (Saito et al., 2012; Sanz-Moreno et al., 2008). 
1.8. Rho GAPs 
This project focuses on the role of Rho GAPs of which more than 60 are predicted (Bernards, 2003). 
Rho GAPs out-number their GTPase targets by around 3 to 1 meaning each is likely to regulate 
GTPases in a specific signaling pathway. Indeed, Rho GAPs contain a mixture of structural domains, 
allowing them to perform a wide range of functions and mediate cross talk between other small 
GTPase families (Bernards, 2003; Tcherkezian and Lamarche-Vane, 2007) (Figure 1.7). Rho GAPs can 
be divided into several subfamilies based on sequence similarities (Bernards, 2003) (Figure 1.7). The 
general functions of these are discussed briefly below but discussion regarding the roles of Rho GAPs 
at AJs will be discussed later (section 1.10).  
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Figure 1.7 The domain structures of Rho GAP proteinsRho GAPs contain a wide variety of functional domains 
and can be grouped based on structural similarities (described (Bernards, 2003)). PH, pleckstrin homology; DH, 
Dbl homology; C2, cysteine-rich phorbol ester binding; SH2, Src homology 2, DAG, Phorbol-ester/DAG-type zinc 
finger; BAR, Bin, amphiphysin, RSV161/167; SH3, Src homology 3; FF, two conserved Phe residues; SAM, sterile 
alpha motif; RA, Ras-associating; Sec14, Sec14-like; START, StAR (steroidogenic acute regulatory)-related lipid 
transfer; FCH, Fes/CIP4 homology; WW, two conserved Trp residues; PX, Phox homology; IQ, calmodulin-
binding motif; PDZ, post synaptic density protein, Drosophila disc large tumor suppressor, and zonula 
occludens-1 protein. Amino acid number is shown at protein C-terminals.  
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1.8.1.  ABR and BCR 
The breakpoint cluster region (BCR) gene was first identified as a cause myelogenous leukemia due 
to the fusion of BCR to ABL kinase which results in aberrant activation of the kinase (Gianfelici et al., 
2012; Groffen et al., 1984). Active BCR-related gene (ABR) is highly similar to BCR, but lacks the N-
terminal region (Heisterkamp et al., 1993). Both ABR and BCR contain GAP and GEF domains. The 
GAP domain is active against Rac and Cdc42, whilst the GEF domain targets Rho, Rac and Cdc42 
(Chuang et al., 1995). The GEF and GAP domains of ABR and BCR can bind GTPases non-
competitively, suggesting these proteins could act as dual regulators of GTPase activity (Chuang et 
al., 1995). Subsequently, ABR has been shown to control the spatial separation of Rho during single 
wound repair (Vaughan et al., 2011). In this case, ABR is targeted to areas of active Rho and 
potentiates Rho activity whilst simultaneously inhibiting Cdc42 activity in this area (Vaughan et al., 
2011).  
Both ABR and BCR have described roles in the regulation of innate immune cells (Cho et al., 2007; 
Cunnick et al., 2009). There is likely some redundancy in function between ABR and BCR, as ABR-null 
mice have no obvious phenotype. However, distinct functions have also been described, for example 
macrophages from BCR-null and double ABR/BCR-null mice produce more reactive oxygen species 
(ROS) than wild-type controls whereas ABR-null mice do not (Cunnick et al., 2009; Voncken et al., 
1995).  
1.8.2. The chimaerins 
The α-chimaerin and β-chimaerin gene products can be alternatively spliced to yield α1-, α2-, β1- 
and β2-chimaerin (Tcherkezian and Lamarche-Vane, 2007). All can act as Rac GAPs (Diekmann et al., 
1991; Leung et al., 1993). At their N-terminus chimaerins harbor cysteine-rich regions, which 
mediate interactions with phorbol esters and contribute to regulation of their activity (Ahmed et al., 
1993). Functions related to the regulation of axonal growth in the nervous system have been 
described for α-chimaerin, including regulation of axon guidance and dendritic spine development 
(Buttery et al., 2006; Diaz et al., 2002). By interacting with ephrins, α-chimaerin is required to limit 
Rac activity in order to inhibit outgrowth which is essential for the correct development of neural 
networks (Beg et al., 2007; Iwasato et al., 2007; Wegmeyer et al., 2007). Chimaerins are also able to 
regulate T-cell receptor signaling and localise to the immune synapse in T-cells (Caloca et al., 2008). 
Expression of either α- or β-chimaerin can inhibit nuclear factor of activated T-cells signaling (a 
56 
 
family of transcription factors that mediate activation and differentiation of T-cells) in a GAP-
dependent manner (Caloca et al., 2008).  
1.8.3. GRAF1, GRAF2, Oligophrenin and ARHGAP42 
As well as a Rho GAP domain, members of this group all contain PH, BAR and (with the exception of 
Oligophrenin 1) SH3 domains (Bernards, 2003). GTPase regulator associated with focal adhesion 
kinase (GRAF1, also known as ARHGAP26) and GRAF2 (ARHGAP10) are Rho and Cdc42 GAPs (Shibata 
et al., 2001) (although in vivo GRAF1 is more active on Rho (Doherty et al., 2011b)) and both interact 
with the Rho target PKNβ (Shibata et al., 2001). GRAF localises to focal adhesions where it interacts 
with focal adhesion kinase (FAK) (Hildebrand et al., 1996). GRAF2 also interacts with the FAK-related 
kinase and Protein-tyrosine kinase 2 (Ren et al., 2001) suggesting these proteins may regulate cell-
matrix adhesions. Interestingly, GRAF1 can regulate clathrin-independent endocytosis (Doherty et 
al., 2011a; Lundmark et al., 2008) and by coordinating endocytosis at adhesion sites regulate cell 
spreading and migration (Doherty et al., 2011a). GRAF is also able to promote muscle differentiation 
in C2C12 cells and its regulation of both endocytosis and muscle differentiation are dependent on 
GRAF GAP activity and the BAR domain (Doherty et al., 2011b).  
Oligophrenin 1 is predominantly expressed in the brain and is a GAP for Rac, Rho and Cdc42 
(Fauchereau et al., 2003). Loss of Oligophrenin 1 is associated with X-linked mental retardation 
(Barresi et al., 2010; Billuart et al., 1998), and results in perturbations in dendritic spine morphology. 
In primary neurons this defect can be rescued by inhibition of ROCK, suggesting Oligophrenin 1 acts 
to inhibit RhoA signaling (Govek et al., 2004). Interestingly, Oligophrenin 1 is localised  at pre- and 
post-synaptic neurons (Govek et al., 2004) and loss of Oligophrenin 1 impairs uptake of synaptic 
vesicles (Nakano-Kobayashi et al., 2009) implying a role for Oligophrenin 1 in endocytosis. So far, 
there have been no studies on ARHGAP42. 
1.8.4. RICH1, RICH2 and SH3BP1 
Members of this group all contain BAR domains at their N-terminus (Tcherkezian and Lamarche-
Vane, 2007). All can act as Rac and Cdc42 GAPs in vitro (Cicchetti et al., 1995; Harada et al., 2000; 
Richnau and Aspenstrom, 2001) whilst Rich1 and SH3 domain-binding protein 1 (SH3BP1) can act as 
Rac and Cdc42 GAPs in vivo (Parrini et al., 2011; Wells et al., 2006; Yi et al., 2011). 
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Rich1 regulates TJ organisation and epithelial polarity via Cdc42 (Wells et al., 2006). ZO-1 and 
polarity complex proteins Par3 and Pals1 are mislocalised upon depletion of Rich1, whilst expression 
of a GAP-dead Rich1, or Amot impairs barrier function. Thus, Rich1 is required to confine Cdc42 
activity in order to promote TJ maintenance and uphold barrier integrity (Wells et al., 2006). The 
inhibition of Rich1 by Amot may also have clinical significance as Amot signals downstream of the 
tumour suppressor protein Merlin. Upon formation of cell-cell contacts, Merlin localises to junctions, 
where it inhibits Extracellular signal-regulated kinase  (ERK)/ Mitogen-activated protein kinase 
(MAPK) signaling to promote cell-cell contact (Jin et al., 2006; Lallemand et al., 2003; Morrison et al., 
2007; Stokowski and Cox, 2000). At mature junctions Merlin binds Amot, which releases Rich1 and 
allows it to inactivate Rac leading to a decrease in MAPK signaling (Yi et al., 2011).  Rich2 
(ARHGAP44) also regulates epithelial polarity but in this case by coupling the lipid raft-associated 
membrane protein tetherin to the actin cytoskeleton via interaction with ezrin (Rollason et al., 
2009). Loss of Rich2 disrupts this link and leads to the accumulation of actin basally and loss of cell 
height (Rollason et al., 2009). 
SH3BP1 regulates cell migration via inactivation of Rac1, required to control actin dynamics at the 
leading edge (Parrini et al., 2011).  
1.8.5. p190A and p190B 
The GAPs p190A and p190B (ARHGAP35 and ARHGAP5 respectively) are structurally similar RhoA 
GAPs (Burbelo et al., 1995; Bustos et al., 2008; Su et al., 2009). These proteins contain four FF (two 
phenylalanine residues) and act predominantly on RhoA (Burbelo et al., 1995; Settleman et al., 1992; 
Tcherkezian and Lamarche-Vane, 2007). Diverse processes are regulated by p190A and p190B. The 
expression of p190A is regulated by the cell cycle (Su et al., 2003) and p190 has a role in cytokinesis. 
p190A can interact with general transcription factor II-I and control expression of serum-activated 
genes (Jiang et al., 2005). Both p190A and p190B are highly expressed in the nervous system and 
regulate the organisation of actin in the developing neuroepithelium (Brouns et al., 2000; Matheson 
et al., 2006). Mammary gland morphogenesis can be regulated by p190B which may be linked to 
tumour formation (Chakravarty et al., 2000).  
1.8.6. ARAP1, ARAP2 and ARAP3 
Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing proteins (ARAP) 1-3 contain a 
sterile α-motif (SAM), five PH domains, an ArfGAP domain, ankyrin repeats, a Rho GAP domain and a 
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Ras-association (RA) domain (Krugmann et al., 2002; Miura et al., 2002). This domain structure 
means that members of this group of proteins are well placed to coordinate cross-talk between 
different GTPase families. Furthermore, as well as acting as Arf and Rho GAPs, ARAP3 interacts with 
Rap1 (Krugmann et al., 2004).  
The ArfGAP activities of these proteins are regulated by PIP3 binding (Campa et al., 2009; Krugmann 
et al., 2004). ARAP1 acts on Arf1 and Arf5, ARAP2 acts on Arf6 and ARAP3 acts on Arf5 and Arf6 
(Krugmann et al., 2002; Miura et al., 2002; Yoon et al., 2006). ARAP1 and ARAP3 are Rho specific 
GAPs, whilst ARAP2 can bind RhoA, it is unable to inhibit Rho as it lacks the catalytic arginine 
(Krugmann et al., 2004; Miura et al., 2002; Yoon et al., 2006). However, ARAP2 can indirectly 
regulate Rac levels through inactivation of Arf6 (Chen et al., 2013; Yoon et al., 2006). The loss of 
ARAP2 results in an increase of Arf6 and Rac (which can be activated downstream of Arf6) (Chen et 
al., 2013; Radhakrishna et al., 1999). 
ARAP1 regulates actin cytoskeleton dynamics and endocytosis of epidermal growth factor receptor 
(EGFR) (Daniele et al., 2008; Hasegawa et al., 2012; Miura et al., 2002; Yoon et al., 2008). ARAP2 
promotes the stabilisation of focal adhesions (Chen et al., 2013) and loss of ARAP2 reduces the 
appearance of focal adhesions and stress fibres (Chen et al., 2013; Yoon et al., 2006). ARAP3 is a 
phosphatidylinositide 3-kinase (PI3K) effector (Krugmann et al., 2002) and functions in a number of 
important cellular processes including promoting cell adhesion to the ECM, consequently inhibiting 
invasion in scirrhous gastric carcinoma cells (Yagi et al., 2011). ARAP3-null mice die due to defects in 
angiogenesis (Gambardella et al., 2010). Inactivation of RhoA by ARAP3 can promote neurite 
outgrowth downstream of Rap1 (Jeon et al., 2010a; Jeon et al., 2010b).  
1.8.7. ARHGAP1 and ARHGAP8 
ARHGAP1 (also known as p50RhoGAP or Cdc42GAP) was the first RhoGAP discovered (Garrett et al., 
1989). ARHGAP1 and ARHGAP8 both contain N-terminal Sec14 domains (Tcherkezian and Lamarche-
Vane, 2007). ARHGAP1 is active against RhoA, Rac1 and Cdc42 in vitro (Ridley et al., 1993). A 
knockout ARHGAP1 mouse shows diverse roles for this protein. ARHGAP1 null mice are considerably 
smaller than their littermates due to overactivation of the JNK signaling pathway, which leads to an 
increase in apoptosis (Wang et al., 2005). Defects in Rho inactivation by ARHGAP1 in vivo is 
demonstrated in neuroepithelial cells undergoing epithelial-to-mesenchymal transition (Clay and 
Halloran, 2013). In this case, ARHGAP1 is required to restrict Rho activity to the apical portion of 
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neural crest cells and this facilitates detachment of these cells prior to epithelial-to-mesenchymal 
transition (Clay and Halloran, 2013).  
ARHGAP8 interacts with RhoA, Rac1 and Cdc42, but appears to inactivate only RhoA (Shang et al., 
2003). Interestingly, ARHGAP8 enhances cell migration by coordinating RhoA, Rac1 and Cdc42 at the 
leading edge (Lua and Low, 2004a, b; Shang et al., 2003). ARHGAP8 can also promote EGFR 
endocytosis via binding to endophilin2 (Lua and Low, 2005) and activate ERK to promote 
differentiation of PC12 cells (Lua and Low, 2005; Ravichandran and Low, 2013). 
1.8.8. DLC1, DLC2 and DLC3 
DLCs have N-terminal SAM domains which mediate protein-protein interactions, and C-terminal 
StAR-related lipid transfer (START) domains which can bind lipids. DLC proteins act primarily on Rho 
(A-C) and to a lesser extent Cdc42 (Ching et al., 2003; Kawai et al., 2007; Wong et al., 2003). DLC 
proteins inhibit proliferation and migration of tumour cells (Liao and Lo, 2008). DLC proteins are 
often localised to focal adhesions and can be targeted via protein-protein interactions mediated by 
the N-terminus (El-Sitt et al., 2012; Kawai et al., 2009; Liao and Lo, 2008).   
1.8.9. SRGAP1, SRGAP2, SRGAP3 and ARHGAP4 
Slit-Robo GAPs (SRGAP1, SRGAP2 and SRGAP3) as well as closely related ARHGAP4 (sometimes 
called SRGAP4) all contain N-terminal Fes/CIP4 homology (FCH) domains (Bernards, 2003). 
Additionally, the SRGAPs contain F-BAR domains that can induce membrane curvature. SRGAP1, 
SRGAP2 and SRGAP3 were initially identified in a yeast two-hybrid screen to identify roundabout 
(robo)-binding proteins (Robo proteins are receptors for the axon guidance cue Slit) (Wong et al., 
2001). Subsequently, Slit binding to robo was found to activate SRGAP1 in order to inactivate Cdc42 
and regulate neuronal migration (Wong et al., 2001). The F-BAR domain of SRGAP2 contributes to 
neuronal morphogenesis via the formation of filopodia (Guerrier et al., 2009). Interestingly the F-
BAR domains of SRGAP1, 2 and 3 all induce different effects on membranes of both neuronal and 
non-neuronal cells (Coutinho-Budd et al., 2012).  
1.8.10. GMIP and PARG1  
Members of this group all contain N-terminal FCH domains and C1 lipid binding domains. Gem-
interacting protein (GMIP) and PTPL1-associated RhoGAP (PARG1) both preferentially activate Rho 
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(Aresta et al., 2002; Saras et al., 1997). PARG1 was identified in a screen for protein tyrosine 
phosphatase 1 binding partners (Saras et al., 1997). Subsequently, PARG1 was found to interact 
specifically with Rap2 (but not Rap1 or Ras) (Myagmar et al., 2005), which appears to inhibit PARG1 
activity on Rho (Myagmar et al., 2005). GMIP interacts with the atypical Ras-related protein Gem 
(Aresta et al., 2002) and acts downstream of Gem and its binding partner ezrin to reorganize the 
actin cytoskeleton (Hatzoglou et al., 2007). GMIP also interacts with Slp1, a Rab27a effector, to 
regulate exocytosis (Johnson et al., 2012). By inactivating RhoA, GMIP can induce actin 
depolymerisation that is directed around Slp1-containing vesicles and facilitates their transport in 
phagocytes (Johnson et al., 2012).  
1.8.11. PI3-kinase regulatory subunits p85α and p85β 
The p85α and p85β subunits form part of the regulatory subunit of PI3K. PI3K regulates a variety of 
signaling pathways via the generation of phosphatidylinositol 3-phosphate. Structurally, both 
proteins are similarly composed of a Rho GAP domain, two SH2 domains and one SH3 domain 
(Bernards, 2003; Tcherkezian and Lamarche-Vane, 2007). Despite binding to Cdc42 and Rac (Zheng 
et al., 1994) p85α has no GAP activity, even though the protein has the critical arginine finger (Zheng 
et al., 1993). 
1.8.12. OCRL and INPP5B 
Oculocerebrorenal Lowe syndrome phosphatase (ORCL1) and inositol polyphosphate 5-phosphatase 
type II (INPP5B) are phosphoinositide phosphatases, meaning they dephosphorylate the 5 position 
of the inositol ring of phosphoinositides (Liu and Bankaitis, 2010). Loss of OCRL causes 
Oculocerebrorenal Lowe syndrome, an X-linked disorder which causes ocular and renal defects and 
mental retardation (Attree et al., 1992; Pirruccello and De Camilli, 2012) and Dent disease (Hoopes 
et al., 2005). OCRL1 and INPP5B are the only inositol polyphosphate 5-phosphatases to contain Rho 
GAP domains. Both OCRL1 and INPP5B GAP domains lack the cayalytic arginine required for GAP 
activity (Jefferson and Majerus, 1995), although OCRL does have low Rac GAP activity in vitro 
(Faucherre et al., 2003), and can interact with Rac and Cdc42 via its GAP domain (Erdmann et al., 
2007; Faucherre et al., 2003). OCRL1 also interacts with Arf GTPases 1 and 6 (Krauss et al., 2003) and 
several Rab GTPases. The latter of which is thought to result in OCRL1 membrane localisation 
(Dambournet et al., 2011; Fukuda et al., 2008; Hyvola et al., 2006; Rodriguez-Gabin et al., 2010). 
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1.8.13. ARHGAP9, ARHGAP12 and ARHGAP15 
These proteins all contain N-terminal PH domains and C-terminal GAP domains. ARHGAP9 and 
ARHGAP12 also contain WW domains (two conserved tryptophan residues) (Tcherkezian and 
Lamarche-Vane, 2007). ARHGAP15 and ARHGAP12 are Rac GAPs (Gentile et al., 2008; Seoh et al., 
2003), whereas ARHGAP9 is active against Rac and Cdc42 (Furukawa et al., 2001). ARHGAP12 is 
localised to AJs (Matsuda et al., 2008) and its overexpression suppresses cell scattering in response 
to hepatocyte growth factor (HGF, a growth factor used to promote epithelial-to-mesenchymal 
transition), which also transcriptionally downregulates ARHGAP12 expression (Gentile et al., 2008).  
ARHGAP15-null mice are viable and fertile. Analysis of macrophages and neutrophils taken from 
these mice reveal roles in limiting chemotactic responses, ROS production and phagocytosis (Costa 
et al., 2011). Interestingly, ARHGAP15 can interact with PAK1 and 2 and is directly phosphorylated by 
PAK2 downstream of Rac activation which results in inhibition of ARHGAP15 GAP activity (Radu et 
al., 2013). Interestingly, ARHGAP15 inhibits PAK activity (Radu et al., 2013) and an increase in PAK 
signaling increases ERK activation in ARHGAP15-depleted cells. ARHGAP9 also inhibits ERK signaling, 
although this is through direct interaction between ARHGAP9 WW domain and the MAP kinases 
ERK2 and p38α (Ang et al., 2007). 
1.8.14. ARHGAP30, CdGAP, RICS and ARHGAP33 
ARHGAP30 and CdGAP (ARHGAP31) are highly similar proteins and share the same binding partners 
in some cases, including intersectin and the atypical Rho GTPase Wrch1 (Naji et al., 2011; Primeau et 
al., 2011). The Rho GAP domains of RhoGAP involved in the beta-catenin-N-cadherin and NMDA 
receptor signaling (RICS, ARHGAP32) and ARHGAP33 share approximately 70% homology with 
CdGAP (Tcherkezian and Lamarche-Vane, 2007). RICS and ARHGAP33 also contain phox homology 
(PX) domains at their N-terminals (Moon et al., 2003; Tcherkezian and Lamarche-Vane, 2007). 
ARHGAP30 may regulate cell-matrix adhesions (Naji et al., 2011). Diverse functions of CdGAP have 
been described including the regulation of cell-matrix adhesions (Jenna et al., 2002; Wormer et al., 
2012), the maintenance of TJ (Togawa et al., 2010), cell spreading and migration (LaLonde et al., 
2006; Wormer et al., 2012).  
RICS-null mice appear normal and are viable. RICS is highly expressed in the brain and knockout mice 
have longer neurites with enhanced Cdc42 activity (Nasu-Nishimura et al., 2006), implicating RICS in 
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the inhibition of neurite outgrowth. ARHGAP33 is also highly expressed in the brain (Liu et al., 2006) 
and also negatively regulates neurite outgrowth (Liu et al., 2006; Shen et al., 2012).  
1.8.15. Myosin IXA and myosin IXB 
Myosin IXA (Myo9A) and Myosin IXB (Myo9B) are unconventional myosins with complex domain 
structures composed of calmodulin-binding IQ domains, myosin head-like domains, phorbol 
ester/DAG-type zinc fingers, an RA domain and Rho GAP domain. Myo9A and Myo9B are both Rho-
specific GAPs (Chieregatti et al., 1998; Post et al., 1998). Loss of Myo9A results in severe 
hydrocephalus due to abnormal epithelial organisation (Abouhamed et al., 2009). Myo9B-null mice 
are viable and fertile (Hanley et al., 2010). Myo9B is highly expressed in immune cells cells (Hanley et 
al., 2010; Wirth et al., 1996). Macrophages derived from knockout mice do not respond to 
chemotactic cues as normal, exhibiting fewer membrane protrusions and migrating more slowly 
suggesting Myo9B regulates migration (Hanley et al., 2010). These defects can be partially restored 
by inhibition of Rho via treatment with C3 (Hanley et al., 2010). Defects in cell migration are also 
observed in epithelial cells depleted of Myo9B during wound healing assays and assembly of TJs is 
also perturbed (Chandhoke and Mooseker, 2012). 
1.8.16. ARHGAP6 and ARHGAP36 
ARHGAP6 shares approximately 41% sequence similarity with ARHGAP36. No studies on ARHGAP36 
have been published. ARHGAP6 was originally discovered as part of this gene is deleted in 
microphthalmia with linear skin defects syndrome (MLS) (Prakash et al., 2000; Schaefer et al., 1997). 
Mice where the ARHGAP6 Rho GAP domain has been deleted appear normal, suggesting GAP-
independent functions of ARHGAP6 in MLS (Prakash et al., 2000). ARHGAP6 is also able to regulate 
actin remodeling and PLCδ activation via GAP-independent mechanisms (Ochocka et al., 2008; 
Prakash et al., 2000). 
1.8.17. MacGAP, ARHGAP28 and ARHGAP40 
Neither ARHGAP28, nor ARHGAP40 have been functionally characterised, and little is known about 
the function of MacGAP (ARHGAP18). MacGAP was initially identified from a library of epididymis-
specific cDNA library (Li et al., 2008; Liu et al., 2001). MacGAP is localised to the leading edge in 
migrating cells and acts as a RhoA GAP to promote migration (Maeda et al., 2011). 
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1.8.18. ARHGAP22, ARHGAP24 and ARHGAP25 
These proteins contain an N-terminal PH domain, central Rho GAP domain and C-terminal coiled-coil 
(Nakamura, 2013). All members of this group target Rac in vivo, although ARHGAP24 (FilGAP) may 
also target Cdc42 (Itoh et al., 2002; Ohta et al., 2006; Sanz-Moreno et al., 2008). Both ARHGAP24 
and ARHGAP22 are activated downstream of Rho and inactivate Rac to regulate cell polarity and 
cancer cell migration (Itoh et al., 2002; Saito et al., 2012; Sanz-Moreno et al., 2008). ARHGAP25 is 
less well studied but is highly expressed in spleen and leukocytes and its expression in primary 
macrophages inhibits phagocytosis (Csepanyi-Komi et al., 2012).     
ARHGAP24 is the best characterised of this group and binds the actin cross-linker Filamin-A, which 
regulates the activity and localisation of ARHGAP24 (Ohta et al., 2006). ARHGAP24 is localised to 
actin-rich protrusions such as lamellipodia and podocytes (Akilesh et al., 2011; Ohta et al., 2006). By 
targeting ARHGAP24 to lamellipodia, Filamin-A increases ARHGAP24 GAP activity against Rac (Ohta 
et al., 2006). Interestingly, this interaction is regulated by mechanical stress; strain disrupts the 
shape of Filamin-A, and consequently alters protein-binding sites of this protein leading to 
dissociation of ARHGAP24 from Filamin-A in response to mechanical forces (Ehrlicher et al., 2011).  
1.8.19. ARHGAP21 and ARHGAP23 
ARHGAP21 (sometimes referred to as ARHGAP10) and ARHGAP23 share approximately 45% 
sequence similarity (Bernards, 2003). No studies have been published on ARHGAP23. ARHGAP21 
may play a role in cancer progression by modulating migration. ARHGAP21 regulates cellular 
trafficking via inactivation of Cdc42 and binding to Arf1 (Dubois et al., 2005; Hehnly et al., 2009; 
Wang et al., 2012) and regulates actin dynamics via Cdc42 and Arp2/3 at the Golgi (Dubois et al., 
2005).   
1.8.20. Miscellaneous GAPs 
Several Rho GAPs lack similarity with other Rho GAP proteins. These include RacGAP1, ARHGAP20 
(RA-RhoGAP), RalBP1, ARHGAP11A, ARHGAP39, TAGAP and DEPDC1B. For some of these proteins 
little has been described regarding their functions (ARHGAP11A, ARHGAP39, TAGAP and DEPDC1B). 
However, for others diverse roles have been explored including the regulation of cytokinesis by 
RacGAP1 (Hirose et al., 2001; Lee et al., 2004; Minoshima et al., 2003). Furthermore, ARHGAP20 and 
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RalBP1 also mediate cross talk between Rho GTPases and Rap1 and Ral, respectively (Cantor et al., 
1995; Yamada et al., 2005b).  
1.9. Rho GTPases at AJs 
The formation, stabilisation, maintenance and disassembly of AJs rely on the correct coordination of 
the actin cytoskeleton. The construction of different actin structures is vital for the initiation of 
contacts through the formation of exploratory protrusions, for driving contact expansion and for 
stabilising junctions by creating strong underlying actin cables. Rho family GTPases interact with a 
host of effectors that are able to modulate the actin cytoskeleton and drive cell-cell adhesion (Figure 
1.6). The most well characterised members of this family are discussed below as well as GTPases 
from other families that can regulate AJs.   
1.9.1. RhoA 
The requirement for Rho activity during contact formation is somewhat contradictory, and may 
represent differences between cell type, stimulus and interaction with downstream effectors. In 
keratinocytes, RhoA is activated downstream of E-cadherin adhesion (Calautti et al., 2002) and may 
be required for contact stabilisation, as Rho activity remains high even 24 hours after junction 
formation (Calautti et al., 2002). Blocking Rho activity (via C3 transferase) results in removal of 
cadherins from junctions (Braga et al., 1999; Braga et al., 1997; Calautti et al., 2002; Takaishi et al., 
1997), which is partially attributed to signaling through PRK2 (a PKN-related kinase), which promotes 
phosphorylation of p120 catenin and β-catenin (Calautti et al., 2002).  However, Rho activity must be 
tightly constrained. RhoA is downregulated in some systems, and constituitive activation can 
disassemble junctions (Noren et al., 2003; Noren et al., 2001; Sahai and Marshall, 2002b). 
Furthermore, RhoA is required for disassembly of cell-cell contacts under certain stimuli (Samarin et 
al., 2007).  
In MDCK cells, RhoA activity is confined to the edges of nascent contacts, and appears to drive 
contact expansion via activation of ROCK and MyoII (Yamada and Nelson, 2007). This increases 
actomyosin contractility necessary for driving expansion of the contacting membranes (Yamada and 
Nelson, 2007). However, ROCK-mediated actomyosin contractility can be disruptive in other 
systems. Activation of ROCK by RhoC in colon carcinoma cells perturbs α-catenin localisation and 
disrupts junctions (Sahai and Marshall, 2002b). Conversely, RhoA-mediated activation of the actin-
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binding protein Dia promotes localisation of E-cadherin and α-catenin to the cell periphery in colon 
carcinoma cells (Sahai and Marshall, 2002b).  
1.9.2. Rac1 
The requirement for Rac activity at AJs is fairly well-established in various cell types. Rac activity is 
necessary for the formation, stabilisation and maintenance of AJs (Braga and Yap, 2005; Citi et al., 
2011). As Rac drives lamellipodia formation, Rac activity is important in the early stages of cell-cell 
contact formation (Ehrlich et al., 2002; Yamada and Nelson, 2007). As contacts expand, Rac activity is 
restricted to the periphery of the contacting membranes (Ehrlich et al., 2002; Yamada and Nelson, 
2007), where it overlaps with Arp2/3 and drives lamellipodia formation (Yamada and Nelson, 2007).  
Cell-cell contact and cadherin engagement results in rapid activation and localisation of Rac at 
newly-forming AJs (Betson et al., 2002; Kovacs et al., 2002b; Nakagawa et al., 2001; Noren et al., 
2001). Rac seems to be required for actin recruitment at newly forming contacts, as expression of 
dominant negative Rac blocks the recruitment of actin to clustered cadherins (Braga et al., 1997; 
Lambert et al., 2002).  
Rac is also necessary for the maintenance of stable AJs as expression of both dominant negative or 
constituitively active Rac in keratinocytes or MDCK cells perturb AJs (Braga et al., 1997; Jou and 
Nelson, 1998; Takaishi et al., 1997). PAK activation is required for Rac-mediated junction 
disassembly, indicating that aberrant expression of PAK may promote contact disassembly in the 
context of tumour progression (Lozano et al., 2008). However, PAK activation also contributes to AJ 
stabilisation via phosphorylation of Ajuba (Nola et al., 2011). PAK targets are diverse, thus activation 
of PAK downstream of Rac (or Cdc42) may regulate AJs via multiple pathways (Bokoch, 2003; 
Szczepanowska, 2009) (Figure 1.6).  
A second way in which Rac may stabilise cell-cell contacts is via binding IQGAP (Fukata et al., 1999; 
Kuroda et al., 1998; Noritake et al., 2005). IQGAP binds and cross-links actin filaments (Noritake et 
al., 2005) and interacts with β-catenin, inducing its dissociation from α-catenin (Kuroda et al., 1998). 
Active Rac binds to IQGAP, thereby preventing its interaction with β-catenin and strengthening 
contacts by stabilising actin (Fukata et al., 1999; Noritake et al., 2005). Finally, Rac can also regulate 
E-cadherin endocytosis, which may contribute to its ability to stabilise junctions (Akhtar and Hotchin, 
2001; Izumi et al., 2004).  
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1.9.3. Cdc42 
The role of Cdc42 at AJs is controversial. Expression of constituitively active or dominant negative 
forms of Cdc42 in various cell types does not consistently perturb AJs, as is the case with Rac (Chu et 
al., 2004; Jou and Nelson, 1998; Takaishi et al., 1997). Accordingly, cell-cell contact formation in 
MCF-7 cells activates Cdc42 (Kim et al., 2000b), whereas in kerationcytes Cdc42 is not activated upon 
junction formation (Erasmus et al., 2010). Thus Cdc42 may be required for junction formation in 
some, but not all cell types. 
Cdc42 directs the formation of filopodia and these may promote initial cell-cell contacts forming in 
some cell types (Vasioukhin et al., 2000). As Cdc42 shares several of the same effectors with Rac, it 
may regulate AJs using similar mechanisms. For example, Cdc42 can also bind IQGAP to prevent its 
association with β-catenin (Kuroda et al., 1998) and inhibit E-cadherin endocytosis in MDCK cells 
(Izumi et al., 2004) (Figure 1.6).  
1.9.4. Regulation of AJs by other small GTPases 
Arf6 is localised to the plasma membrane and its participation in the regulation of cell-cell adhesion 
has been extensively characterised (D'Souza-Schorey, 2005). Arf6 activation promotes E-cadherin 
internalisation leading to AJ disassembly (Palacios et al., 2001). Treatment of cells with HGF induces 
breakdown of AJs and cell scattering. HGF promotes the activation of Arf6 which in turn activates 
Rac1 and perturbs junctions via endocytosis of E-cadherin. Interestingly, Arf6 is also activated 
downstream of the Par3/Par6 polarity complex upon epithelial polarisation in Eph4 cells. Depletion 
of Arf6 in these cells impairs the formation of AJs (Ikenouchi and Umeda, 2010). Thus, Arf6 is able to 
regulate both the assembly and disassembly of AJs. 
Rabs can regulate cell-cell adhesion by controlling the destination of endocytosed E-cadherin and 
regulating the trafficking of junctional proteins. E-cadherin is recycled back to the plasma membrane 
in a Rab11-dependent manner (Desclozeaux et al., 2008) However, by directing E-cadherin to 
lysosomes for degradation via Rab5 and Rab7, cell-cell adhesion is reduced (Frasa et al., 2010; Kamei 
et al., 1999; Palacios et al., 2005). Interestingly, upon expression of v-Src (which induces epithelial-
to-mesenchymal transition), Rab5 can direct E-cadherin-containing vesicles to the lysosome for 
degradation (Palacios et al., 2005). Rab8 and Rab35 have also been described to regulate E-cadherin 
trafficking and thus AJ stability (Charrasse et al., 2013; Yamamura et al., 2008). 
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Ras-related proteins (Raps) are closely related in sequence to Ras proteins.  Rap1 and Rap1-specific 
GEFs are localised to cell-cell contacts in many epithelial cell types (Hogan et al., 2004; Yajnik et al., 
2003). Loss of Rap1 in Drosophila wing disrupts the localisation of DE-cadherin (Knox and Brown, 
2002). In mammalian cells, the expression of activated Rap1 rescues disruption of junctions by 
distinct stimuli: downstream of oncogenic Ras or following HGF treatment (Price et al., 2004). The 
expression of the Rap GEF Dedicator of cytokinesis (DOCK) 4 in osteosarcoma cells can also prevent 
junction disruption (Yajnik et al., 2003). Rap1 may regulate the endocytosis of E-cadherin, as 
interaction between Rap1 and the adaptor protein afadin/AF6 inhibits the endocytosis of E-cadherin 
(Boettner et al., 2000; Hoshino et al., 2005). 
1.10. Regulation of Rho GTPases at AJs 
As Rho GTPases are vital regulators of AJs, it is likely that a range of GEFs and GAPs are required to 
correctly coordinate their actions here. Due to the diversity of cellular processes Rho GAPs and GEFs 
are involved in there are many ways in which they may regulate AJs.  
No GEFs have been described to specifically regulate cell-cell contact formation (McCormack et al., 
2013). However, Rho GEFs that regulate the stabilisation, maintenance and disassembly of AJs have 
been reported. Similarly, several Rho GAPs have been identified to regulate various steps during cell-
cell contact formation, maintenance and disassembly (Figure 1.8). There are also examples of Rho 
GEFs and GAPs localised to AJs. However, localisation does not necessarily imply activation, as some 
GEFs and GAPs are inactivated at AJs. Discussed below are only those GEFs and GAPs whose 
functions at AJs have been described. 
1.10.1. GEFs regulating cell-cell contact stabilisation and maintenance 
Tuba is a Cdc42-specific GEF that is found at cell-cell contacts in simple epithelial cells, where it 
localises with components of AJs and TJs (Otani et al., 2006). Localisation of Tuba to cell-cell contacts 
depends on interaction with ZO-1 and depletion of Tuba perturbs the organisation of both AJs and 
TJs. The depletion of Tuba does not prevent formation of junctions, but does alter the organisation 
of E-cadherin and F-actin in the apical portion of the cell which also correlates with reduced 
localisation of Cdc42. Thus, Tuba appears to recruit Cdc42 to nascent junctions and direct Cdc42 
activity here (Otani et al., 2006).  
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ECT2 is localised at sites of cell-cell contact in MDCK cells (Liu et al., 2004), MCF-7 and Caco-2 cells 
(Ratheesh et al., 2012). Depletion of ECT2 has no effect on TJs, but E-cadherin is not concentrated as 
a single line as in control cells. Fluorescence recovery after photobleaching (FRAP) data reveals that 
E-cadherin is more mobile at junctions in the absence of ECT2. ECT2 appears to stabilise E-cadherin 
at junctions via RhoA and MyoIIA, as junctional levels of both of these proteins are also reduced 
upon depletion of ECT2 (Ratheesh et al., 2012).  
Asef is a Rac and Cdc42 GEF that is localised to cell-cell contacts and has been shown to both 
increase and decrease the levels of E-cadherin at cell-cell contacts (Kawasaki et al., 2003; Muroya et 
al., 2007). The reason for this discrepancy is not yet known, thus the role of Asef at cell-cell contacts 
remains unclear. 
In contrast to previous GEFs that regulate AJs via direct modulation of the cytoskeleton, Triple 
functioning domain protein (Trio) regulates E-cadherin transcription (Yano et al., 2011). Tara is a 
Trio-interacting protein and both proteins localise to cell-cell adhesions via interaction with E-
cadherin (Seipel et al., 2001; Yano et al., 2011). Depletion of Tara reduces E-cadherin levels (both 
total protein and mRNA) and increases Rac1 activation at cell-cell contacts (Yano et al., 2011). The 
increase in Rac1 is dependent on Trio signaling, and results in activation of p38 MAP kinase. A target 
of p38 is the transcriptional repressor Tbx3, and this is also increased in response to Tara depletion 
(Yano et al., 2011). Thus, the inhibition of Trio by Tara is likely necessary for the stabilisation of AJs. 
Loss of Tara leads to release of Trio and activation of the E-cadherin transcriptional repressor Tbx3 
via Rac and p38 with the outcome being a reduction of E-cadherin at contacts and disruption to the 
underlying actin cytoskeleton (Yano et al., 2011).  
Tiam1 regulates both AJs and TJs. Expression of Tiam1 can block HGF- and H-Ras-induced 
transformation (Hordijk et al., 1997; Sander et al., 1998). Furthermore, Src-mediated junction 
disruption induces phosphorylation and degradation of Tiam1, suggesting that Tiam1 is required to 
maintain cell-cell adhesions (Woodcock et al., 2009). Depletion of Tiam1 in transformed MDCK cells 
leads to disassembly of AJs (Malliri et al., 2004). Indeed, keratinocytes derived from Tiam1 knockout 
mice form AJs and recruit AJ and TJ components normally. However, in the Tiam1 knockout cells, 
junctions fail to mature and actin is disorganised (Mertens et al., 2005). Interestingly, Tiam1 is also 
required for junction formation induced by expression of E1A in Ras-transformed MDCK cells, 
suggesting Tiam1 could also be required for AJ formation (Malliri et al., 2004).  
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1.10.2. GEFs regulating cell-cell contact disassembly 
Invading pathogens subvert cellular machinery in order to gain access to the cell. Listeria 
monocytogenes entry into cells involves binding to the E-cadherin extracellular domain and leads to 
dynamic rearrangement of AJs and the actin cytoskeleton (Mengaud et al., 1996). The virulence 
protein InIC is essential for invasion of L. monocytogenes and infection induces the formation of 
curved junctions (similar to those seen in cells depleted of Tuba) (Otani et al., 2006; Rajabian et al., 
2009). InIC can interact with Tuba at Tuba’s N-terminus, which in turn prevents the interaction 
between Tuba and N-WASP (Rajabian et al., 2009). This leads to loss of tension, perturbation of 
junctions and promotes the spread of L. monocytogenes (Rajabian et al., 2009).   
Neuroepithelial transforming protein isoform 1 (Net1) and 2 (Net1A) are RhoA GEFs. Net1A 
depletion disrupts AJs and leads to epithelial-to-mesenchymal transition. However, Net1 expression 
can also be transforming (Qin et al., 2005). Both Net1 and Net1A are predominantly localised in the 
nucleus, and their presence in the cytoplasm is facilitated via interaction with discs large homolog 1 
(Dlg), which prevents Net1 from degradation (Carr et al., 2009; Garcia-Mata et al., 2007). Cell-cell 
contacts promote the Net1-Dlg interaction resulting in increased RhoA activation (Carr et al., 2009). 
Furthermore, treatment of HaCaTs with TGF-β leads to transcriptional upregulation of Net1A, RhoA 
activation and stabilises junctions (Papadimitriou et al., 2012). However, after 24-48 hours of TGF-β 
treatment Net1A and Net1 are degraded and epithelial-to-mesenchymal transition is initiated 
(Papadimitriou et al., 2012). Thus, Net1-mediated activation of Rho can stabilise junctions in some 
scenarios, but may be used to disassemble junctions during epithelial-to-mesenchymal transition. 
1.10.3. GAPs regulating cell-cell contact formation 
Only one GAP, the Cdc42 GAP SH3BP1, has so far been identified to specifically regulate the 
formation of cell-cell contacts. Depletion of SH3BP1 in Caco-2 and A431 cells disrupts the localisation 
of TJ and AJ markers ZO-1 and β-catenin and perturbs actin organisation (Elbediwy et al., 2012). 
Interestingly, these cells are able to form filopodia but unable to progress to form AJs. SH3BP1 is 
recruited to cell-cell contacts as part of a multiprotein complex with paracingulin and CD2AP in the 
early stages of junction formation. Forster-resonance energy transfer (FRET) analysis in A431 cells 
reveals Cdc42 is reduced at junctions in the absence of SH3BP1 suggesting SH3BP1 spatially 
regulates Cdc42 activity (Elbediwy et al., 2012). Interestingly, although a GAP for Rac and Cdc42, only 
Cdc42 levels are increased upon depletion of SH3BP1 (Elbediwy et al., 2012).  
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Figure 1.8 Diverse mechanisms are used by Rho GEFs and Rho GAPs to regulate AJs  The localisation of GEFs 
(green) and GAPs (red) to AJs is shown in the top left. Some regulators are localised to AJs via interaction with 
specific proteins (black), but for some proteins how junctional targeting occurs is not known. Inactivation of 
GEFs at junctions is shown in the top right. Inactivation can occur via interaction with specific proteins. Some 
GEFs are regulated via degradation, these are shown in the bottom right. Post-translational modification, such 
as ubiquitination, can target Rho GEFs for degradation via the proteasome. In some cases junctional regulation 
can occur at sites distinct from a location away from the junction (bottom left). An example of this is PX-RICS, 
which regulates transport of N-cadherin and β-catenin. Figure adapted from McCormack, Welsh and Braga, 
2013.   
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1.10.4. GAPs regulating cell-cell contact stabilisation and maintenance 
Myo9A localises to sites of cell-cell contact in Caco-2 (Elbediwy et al., 2012) and bronchial epithelial 
cells (Omelchenko and Hall, 2012). In Myo9A null mice AJ and TJ components are mislocalised and 
mice die from hydrocephalus due to defects in cell-cell contacts in the ependymal cells (Abouhamed 
et al., 2009), thus Myo9A is an important regulator of cell-cell contacts. Depletion of Myo9A in 
bronchial epithelial cells undergoing collisions reveals Myo9A regulates the early stages of cell-cell 
contact stabilisation (Omelchenko and Hall, 2012). In these cells, initial contacts are formed, but are 
not stabilised and cells ultimately retract from one another (Omelchenko and Hall, 2012). Myo9A 
appears to regulate stabilisation in two ways. Firstly, via its myosin head-like domains Myo9A 
regulates the formation of actin structures that are necessary for contact expansion (as depletion of 
Myo9A abolishes formation of these structures). Secondly, Myo9A is required to constrain RhoA 
activity; treatment of Myo9A-depleted cells with ROCK inhibitor partially rescues the junctional 
phenotype. FRET reveals that RhoA activity is enhanced specifically at cell-cell contacts in cells 
depleted of Myo9A (Omelchenko and Hall, 2012).  
DLC1 positively regulates the stabilisation of AJs using two mechanisms 1) DLC1 interacts with α-
catenin and may increase its presence at AJs (Tripathi et al., 2012) and 2) Expression of DLC1 raises 
protein levels of E-cadherin independently of α-catenin (although α-catenin is required for E-
cadherin localisation) (Tripathi et al., 2013). DLC1 GAP-activity is vital for these functions, as 
expression of GAP dead constructs cannot localise α-catenin or increase E-cadherin levels (Tripathi 
et al., 2012; Tripathi et al., 2013). Interestingly, inhibition of RhoC, more so than RhoA, appears to be 
critical for upregulation of E-cadherin induced by DLC1 (Tripathi et al., 2013).  
Both p190A and p190B can be activated downstream of C-, N- and E-cadherin to inactivate RhoA at 
contact sites (Noren et al., 2003; Ratheesh et al., 2012; Wildenberg et al., 2006). Depletion of p190 
perturbs p120 catenin and N-cadherin localisation in mouse embryonic fibroblasts (MEFs) 
(Wildenberg et al., 2006). Interestingly, the recruitment of p190 proteins to junctions is driven by 
Rac signalling, and p190B can bind directly to Rac (Bustos et al., 2008; Wildenberg et al., 2006). RhoA 
activity is not always downregulated at sites of contact, rather it is confined to localised regions. In 
MCF-7 cells the Rac GAP, RacGAP1 (which forms part of the centralspindlin complex) is required to 
limit Rac signalling at nascent AJs (Ratheesh et al., 2012). This prevents the localisation of p190B to 
AJs and allows high RhoA activity to be maintained. The loss of the centralspindlin complex (via 
siRNA) leads to recruitment of p190B to junctions and inhibition of RhoA (Ratheesh et al., 2012).   
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Finally, PX-RICS (a splice variant of RICS) can regulate the trafficking of E-cadherin, thus controlling 
the amount of E-cadherin present on the surface that can be engaged in adhesions (Nakamura et al., 
2010; Nakamura et al., 2008). Upon synthesis, cadherins are trafficked from the ER to the membrane 
with β-catenin (Chen et al., 1999). PX-RICS is a β-catenin binding partner necessary for trafficking of 
the N-cadherin/β-catenin complex (Nakamura et al., 2008). Depletion of PX-RICS weakens cell-cell 
contacts due to a loss of N-cadherin and β-catenin from cell-cell contacts and a build-up of cadherin 
in the perinuclear region of HeLa and A431 cells. The GAP domain of PX-RICS is necessary for this 
role as a catalytically inactive PX-RICS GAP domain is unable to rescue the localisation of N-cadherin 
and β-catenin in PX-RICS null MEFs (Nakamura et al., 2008).  
1.10.5. GAPs regulating cell-cell contact disassembly 
As well as interacting with Tuba (see above) L. monocytogenes may also gain entry into the cell via 
ARHGAP21. ARHGAP21 interacts with α-catenin and localises to junctions in Caco-2 and JEG-3 cells 
(Sousa et al., 2005). Depletion of ARHGAP21 reduces α-catenin levels at the junctions of JEG-3 cells 
(Sousa et al., 2005) and leads to weaker cell-cell adhesions (Barcellos et al., 2013). Though E-
cadherin is present, depletion of ARHGAP21 impedes entry of L. monocytogenes. Overexpression of 
the GAP domain reduces entry of L. monocytogenes compared to expression of a GAP-dead mutant 
or the N-terminal region (which lacks the GAP domain), indicating that GAP-dependent 
rearrangement of the actin cytoskeleton supports L. monocytogenes invasion (Sousa et al., 2005).  
1.11. Identification of Rho GAPs regulating cell-cell adhesion 
Whilst several GAPs regulating cell-cell adhesion have been identified, this highly complex process 
likely requires the coordination of multiple GAPs at each stage of assembly, stabilisation and 
maintenance. As such, there is still much to be understood regarding the identity of Rho GAPs 
participating in these processes. Screening approaches have been utilised to identify many Rho 
GAPs. For example, by screening for binding partners of proteins known to be enriched, or to play 
critical roles in certain cellular processes, important interactors can be identified (eg. (Aresta et al., 
2002; Pulimeno et al., 2011; Saras et al., 1997)). Alternatively, the use of small inhibitory RNAs 
(siRNAs) has allowed researchers to effectively isolate proteins regulating specific cellular processes 
by assessing what effect their loss has in different cell types during various assays (Echeverri and 
Perrimon, 2006).  
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1.11.1. The use of siRNA screens to identify novel regulators of cellular processes 
RNA interference was first described in 1998 when Fire et al. demonstrated that the injection of 
double stranded RNAs into Caenorhabditis elegans resulted in the specific degradation of messenger 
RNAs in the cytoplasm (Fire et al., 1998). Since then the use of RNA interference as a tool for the 
study of gene function has increased substantially. In mammalian cells mRNAs can be specifically 
targeted for degradation using siRNA. These siRNAs present a robust method for gene silencing, 
enabling the function of a specific protein to be elucidated (Hammond et al., 2001; Hannon, 2002). 
The implementation of high-throughput screens using siRNAs has allowed whole genomes to be 
surveyed to identify novel components in signalling pathways, furthering our knowledge of, for 
example, development, cell division and migration and facilitated discovery of potential therapeutic 
targets (Berns et al., 2004; Boutros et al., 2004; Nybakken et al., 2005; Paddison et al., 2004). The 
quantitative assessment of particular cellular features is highly advantageous, as this can facilitate 
the identification of more subtle phenotypes, may be implemented more quickly than visual 
analyses, therefore allowing more targets to be tested and can remove any experimenter bias. The 
inclusion of a validation step also strengthens confidence in the data; genes are targeted using more 
than one distinct reagent and only if the phenotype is reproduced in two or more scenarios is the 
target protein classified a hit (Echeverri and Perrimon, 2006). 
The motility of migrating cells during wound healing was assessed using a high-throughput siRNA 
screening approach whereby kinases, phosphatases and migration- and adhesion-related genes 
were targeted (Simpson et al., 2008). In this screen, motility was inferred based on the objective 
quantification of the area of the wound that had been closed (Simpson et al., 2008). Many genes 
were identified that had not previously been linked to migration, including several genes known to 
regulate cell-cell adhesions, and many genes found to enhance migration negatively regulated cell-
cell adhesion (Simpson et al., 2008). The organisation of focal adhesions were also assessed using 
the same library and the morphology and distribution of focal adhesions assessed, as well as cell 
spreading and elongation (Winograd-Katz et al., 2009). This facilitated clustering of target proteins 
based on their effects on different parameters (Winograd-Katz et al., 2009). In both of these screens 
the experimental parameters investigated were such that objective quantification was possible. This 
meant that the application of computational biological techniques complemented data derived from 
wet lab experiments in order to survey the effects of a vast number of genes on particular cellular 
processes.  
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The success of many screens has relied on the measurement of a single experimental parameter, 
and allowed whole genomes to be analysed. However, more complex phenotypes are increasingly 
being examined (Bakal et al., 2007; Fuchs et al., 2010). Such approaches have relied on the use of 
sophisticated computer software to classify specific phenotypes (Bakal et al., 2007). The assessment 
of more complex or multiple parameters gives a greater overiew of the cellular process being 
studied and has led to the identification of known and unexpected proteins (D'Ambrosio and Vale, 
2010). For example, in a screen for regulators of cell spreading in Drosophila S2 cells, several 
computational stratergies were used to classify images according to specific phenotypes (eg. stellate 
cell morphology, ability to spread and presence of membrane ruffles) (D'Ambrosio and Vale, 2010). 
This led to the identification of actin-related proteins (eg. Arp2/3 complex proteins), as well as 
several uncharacterised genes, and proteins involved in the synthesis of lipids and regulating 
membrane synthesis (D'Ambrosio and Vale, 2010).  
1.11.2. Screens for regulators of cell-cell adhesion 
Several screens have been conducted with the aim of identifying novel regulators of cell-cell 
adhesion in different species. These range from whole genome screens to the study of a targeted 
subset of genes and have led to the successful identification of bona fide regulators of cell-cell 
contact formation (Elbediwy et al., 2012; Lynch et al., 2012; Omelchenko and Hall, 2012). However, 
several of these screens relied on the time-consuming task of visually assessing the phenotypes 
induced following the knockdown of target proteins (Elbediwy et al., 2012; Omelchenko and Hall, 
2012). It would be far more effective to develop an automated, semi-quantitative approach in order 
to screen for regulators of cell-cell contact. However, disruption of proteins regulating the formation 
and maintenance of cell-cell adhesions may not induce readily measurable changes, rather 
alterations may be more subjective, and thus harder to assess. 
Many high-throughput systems have been in place for a number of years that are capable of 
quantifying various cellular effects, such as tube formation, proliferation and migration with 
software often coupled to the microscope used to acquire images (Krausz, 2007). In order to make 
quantitative measurements related to the processes of cell-cell contact formation or maintenance it 
is first necessary to identify sites of cell-cell contact. However, the identification of the boundary 
between cells present in a confluent monolayer has proven challenging (Dima et al., 2011).  
Although nuclei can be used to identify individual cells, many available algorithms segment isolated 
cells, which is obviously not appropriate for the identification of cells in confluent monolayers (Dima 
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et al., 2011; Krausz, 2007). The automated identification of the cell boundary is not trivial, and made 
more complicated by the fact that a hit protein may significantly perturb this boundary. Other 
factors, such as the large variation in size of keratinocytes, that cells are often found above the 
monolayer (that have died and been extruded), or that cell boundaries can overlap, complicate 
analysis meaning it is often inaccurate. 
Current methods for segmenting confluent cells are still being developed (Karakaya et al., 2012) but 
one way of circumventing the problem of defining the cell edge is to apply thresholding-based 
methods. These work on the assumption that the intensity of E-cadherin (or other junctional 
proteins) staining at the junction is higher than in the rest of the cell. Pixels of intensity below the 
threshold are removed, leaving only the intense, junctional region. Although this means the junction 
area is only approximate, it is relatively efficient to apply to a large number of images simultaneously 
and allows the comparison of multiple siRNA treatments based on the relative amount of the image 
that is thresholded.  
Overall, siRNA screening provides an excellent means of investigating the functions of multiple genes 
that may regulate cell-cell contact organisation and further use of systems biology may allow novel 
components of AJs to be identified. 
1.12. Hypothesis and aims 
The processes of cell-cell contact formation and maintenance are highly complex and regulated via 
the coordinated efforts of different GTPases. Clearly the actions of Rho GTPases must be tightly 
constrained in order for AJs to function correctly as these structures can influence so many cellular 
processes. The evidence so far suggests that multiple Rho GAPs are likely required to regulate very 
precise processes that must occur in order for cell-cell contact formation, stabilisation, maintenance 
and disassembly to proceed correctly.  
The broad aims of this thesis are:  
1. Identify Rho GAPs that can regulate specific steps in cell-cell contact formation in 
keratinocytes using a siRNA screening approach 
2. Investigate the function of CdGAP at cell-cell contacts   
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2.1. Cell culture 
Human keratinocytes isolated from neonatal foreskin (strain SF, passages 3-6) were maintained on 
mitomycin-C (Sigma, Dorset, UK) treated J2 mouse fibroblasts in standard medium (Dulbecco’s 
Modified Eagle Medium (DMEM) DMEM:F12 BioWittaker, Lonza, Germany) supplemented with 
1.8mM CaCl2, 10% foetal calf serum (FCS), 5mM glutamine, 100 units/ml penicillin, 100µg/ml 
streptomycin,  5µg/ml insulin, 10ng/ml epidermal growth factor (EGF), 0.5µg/ml hydrocortisone (all 
Sigma) and 0.1nM cholera toxin (Quadratech Diagnostics Ltd, Surrey, UK) as described (Watt, 1994). 
Low calcium medium (approximately 0.1mM CaCl2) had the same formulation as standard medium 
but contained FCS pre-treated with Chelex-100 resin (BioRad, Hemel Hempstead, UK) to deplete 
divalent calcium ions (Hodivala and Watt 1994). Cells to be grown in low calcium were seeded in 
standard medium and switched to low calcium when approximately 20 cells per colony were seen. 
Cells were seeded on 9cm dishes at a density of 2 x 105, on 2cm2 coverslips at a density of 3 x 104 or 
on 96 well plates (Corning Incorporated, Corning, NY) at a density of 2.2 x 103 cells per well. Cells 
were maintained at 37°C, 5% CO2. J2 mouse fibroblasts were maintained in medium consisting of 
Dulbecco’s modified medium (DMEM, Sigma-Aldrich), 10% DCS (Sera Laboratories International Ltd, 
West Sussex, UK) and 5mM L-glutamine (Sigma-Aldrich). 
COS-7 cells were cultured in DMEM supplemented with 10% FCS, glutamine and the antibiotics 
penicillin and streptomycin. For pull-down experiments, cells were seeded in six-well plates (3cm 
area per well) and transfected when 70% confluent. 
For RNAi experiments, keratinocytes were seeded at 3 x 104 on glass coverslips in standard medium 
for 3-5 days. Cells were then switched to low calcium medium. Cells were cultured until confluent. 
For all other experiments, keratinocytes were seeded at 1-3 x 104 on glass coverslips or 2 x 105 in 
9cm dishes. 
2.2. DNA constructs and cloning 
2.2.1. DNA constructs 
Mammalian expression plasmids used are displayed in Table 2.1. All constructs used were verified by 
sequencing carried out by Beckman-Coulter. 
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Protein Plasmid Product 
size (kDa) 
Source 
Ajuba pCS2myc 58 
G. Longmore, Washington 
University 
Ajuba mRFP 66 
G. Longmore, Washington 
University 
Ajuba pGEX-2T 66 
G. Longmore, Washington 
University 
Ajuba LIM pCS2myc 25 
G. Longmore, Washington 
University 
Ajuba LIM pGEX-2T 15 
G. Longmore, Washington 
University 
Ajuba Pre-LIM pCS2myc 35 
G. Longmore, Washington 
University 
ARAP1 pEGFP 162 
S. Vermeren, University of 
Edinburgh 
ARAP1 GAP-dead pEGFP 162 
S. Vermeren, University of 
Edinburgh 
ARHGAP6 Flag 106 
J-P Vincent, National Institute of 
Medical Research 
ARHGAP6 RC V5 122 
J-P Vincent, National Institute of 
Medical Research 
ARHGAP6 RD V5 143 
J-P Vincent, National Institute of 
Medical Research 
ARHGAP6 RE V5 129 
J-P Vincent, National Institute of 
Medical Research 
CdGAP1-221 pGEX-4T3 15 N. Lamarche, McGill University 
CdGAP1160-1425 pGEX-4T3  25 N. Lamarche, McGill University 
CdGAP1160-1425 pRK5 myc 40 N. Lamarche, McGill University 
CdGAP1160-1425
R1172A pGEX-4T3  25 
J. McCormack, Imperial College 
London 
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CdGAP1160-1425
R1172A pRK5 myc 40 J. McCormack, Imperial College 
CdGAP1160-1425
R1412A pRK5 myc 40 J. McCormack, Imperial College 
CdGAP1253-1425 pGEX-4T3 15 N. Lamarche, McGill University 
CdGAP-l eGFP 250 N. Lamarche, McGill University 
CdGAP-l pRK5 myc 250 N. Lamarche, McGill University 
CdGAP-l GAP-Dead eGFP 250 N. Lamarche, McGill University 
CdGAP-s eGFP 125 N. Lamarche, McGill University 
CdGAP-s pRK5 myc 125 N. Lamarche, McGill University 
Empty vector eGFP 30  
Empty vector pRK5 myc 30  
GST pGEX-4T1  25   
mRFP-PAK1-Rac-GFP Rac 
tail Raichu 45 T. Ng, King's College London 
PAK-CRIB  pGEX2T 15 
J. Collard, Netherlands Cancer 
Institute, Netherlands 
Table 2.1 DNA constructs used in this study The vector, size of the protein in kilodaltons (excluding tag) and 
who the construct was obtained from is shown.  
 
2.2.2. Site-directed mutagenesis  
Primers were designed to mutate Arginine (R) residues in the CdGAP C-terminus (identified as being 
important for CdGAP-CdGAP and CdGAP-Ajuba binding) to Alanine (A) (Table 2.2).  
Polymerase chain reaction (PCR) was carried out using pRK5myc-CdGAP-l, pRK5myc-CdGAP1160-1425 or 
GST-CdGAP1160-1425 as the template as follows; 50ng template, 1x polymerase buffer (New England 
Biolabs (NEB), Hitchin, UK), 1-2µl Phusion DNA polymerase (NEB), 3µl forward primer (5µM stock), 
3µl reverse primer (5µM stock) (Invitrogen), 1µl dNTPs (20µM stock), 1µl Dimethyl sulphoxide 
(DMSO), made up to 50µl with dH20. Samples were subjected to PCR as follows: 95°C for 30 seconds, 
followed by 30 cycles of 95°C for 30 seconds, 72-75°C for 1 minute and 68°C for 9 minutes.  
A 5µl sample was taken following PCR for future analysis. The remainder of the reaction was 
subjected to digestion by the DpnI enzyme (NEB) for 1 hour at 37°C in order to remove bacterially 
80 
 
derived template DNA and leave only the product of the PCR reaction. A 5µl sample was removed 
following this reaction and run alongside its undigested counterpart on an agarose gel. Where 
necessary, the DpnI digested product was gel-purified using the StrataPrep® DNA Gel Extraction kit 
(Stratagene, Cheshire, UK)) and the entirety of the purified product used to transform library 
efficient DH5-α (NEB) using a standard protocol; DpnI digested product was added to competent 
bacteria on ice and incubated for 20 minutes followed by heat shock at 37°C for 1 minute and a 
further 2 minutes incubation on ice. Sample were shaken in 160µl LB for 40 minutes at 37°C before 
being spread onto ampicillin plates (0.1mg/ml) and grown overnight at 37°C. The following day, 
several colonies were picked from each plate and grown overnight in 5ml of luria broth (LB) 
containing ampicillin in order to derive DNA. Samples were verified by sequencing to confirm the 
presence of the desired mutation.    
Name Sequence 
CdGAP R1172A For 5’-CCTGTAAGTGTGTCAGCAGTGGCTACCTCCTTCATGGTCAAAATG-3’ 
CdGAP R1172A Rev 3’-GTAAAACTGGTACTTCCTCCATCGGTGACGACTGTGTGAATGTCC-5’ 
CdGAP R1412A For 5- CTGTTTTTACCAGCCCCAGCGTGCCTCCGTGATTCTG – 3’ 
CdGAP R1412A Rev 3´-GTCTTAGTGCCTCCGTGCGACCCCGACCATTTTTGTC-5´ 
Table 2.2 Site-directed mutagenesis primers 
 
2.2.3. Reverse-transcription PCR 
mRNA was extracted from cells grown in standard calcium medium using the GTC method 
(Chomczynski and Sacchi, 1987) and reverse transcription performed using 1µg mRNA. Specific 
primers were designed and used to amplify human proteins (Table 2.3). PCR products were resolved 
on 1% (w/v) agarose gels containing GelRedTM (Biotium, Hayward, CA) (0.1µl/ml). Products were 
visualised under UV using Gel Doc XR system (BioRad).  
2.3. Transfection techniques 
2.3.1. cDNA transfections 
For keratinocyte transfections, plasmid DNA was incubated with JetPrime buffer and JetPrime 
transfection reagent (Polyplus transfection, Illkirch, France) in a total volume of 50µl per coverslip. 
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The transfection reagent was used at a ratio of 2:1 DNA. Tubes were vortexed, centrifuged briefly 
and incubated at room temperature for 10 minutes. Cells were washed once and 350μl fresh 
medium was added to the cells. The DNA:transfection reagent mixture was incubated with the cells 
for  4 hours. Cells were washed once and medium was replaced with fresh medium. Cells were 
allowed to express DNA for a further 4-20 hours. Alternatively, plasmid DNA was diluted in Effectene 
buffer (Qiagen) and Enhancer added at a ratio of 1:8 Enhancer. Samples were vortexed and 
incubated for 5 minutes at room temperature. Effectene transfection reagent was added at a ratio 
of 1:25 Effectene and tubes vortexed prior to 5 minutes' incubation at room temperature. Standard 
medium was used to dilute the final plasmid DNA mixture and this added to cells. Medium was 
changed after 4 hours. COS-7 cells were transfected using 2.5-3.0µl of lipofectamine (Invitrogen) 
according to the manufacturers’ instructions with between 0.25µg and 8µg of CdGAP-l, CdGAP-s or 
CdGAP1160-1425 or 4µg Ajuba full-length, 3µg Ajuba Pre-LIM or 6µg Ajuba LIM domains. Media was 
changed after three hours and cells grown for approximately 24 hours. 
Target  Sequence Forward Sequence Reverse Product 
size (bp) 
ARAP1 5'-CTGGCGTCTCCAAGGTGCGG-3' 3'-GCTCTGCAAGAGCCAGGGGC-5' 372/189 
ARHGAP20 5'-ACAGACCGAAAAGCCCGCGGT-3' 3'-CCCGGCTGTCCCCCTAGAGT-5' 252 
ARHGAP26 5'-ACCCGGCCCAACTCACTCCCC-3' 3'-AGCAGTTCTGCTGGGGCCCA-5' 497/332 
ARHGAP27 5'-ACACCAACCACTTCACTCAGGAGC-3' 3'-GTGCTTCTTCCGGAGCCGCTT-5' 335/254 
DEPDC1B 5'-TACGCGCCATGGAGCATCGC-3' 3'-GCTCCACGGTCTCATTCCACAGC-
5' 
75 
GMIP 5'-TCGCCGCCAAACGGACTGAG-3' 3'-TGCCTGCACCGCCTCATTCATC-5' 95 
RacGAP1 5'-TCAAACCGGAGCTGTGGGCG-3' 3'-GAGAATCTCCACCCGGCGCA-5' 342/353
/233 
Table 2.3 RT-PCR primers used and sizes of products yielded in base pairs More than one different product 
shown is representative of multiple variants of the protein.  
2.3.2. siRNA transfections 
Oligonucleotides were dissolved in 1x siRNA buffer (containing 100mM KCl, 30mM HEPES-pH 7.5, 
1.0mM MgCl2) in RNAse-free diethylpyrocarbonate (DEPC)-treated water (Dharmacon, Thermo 
Scientific, Colorado, USA). Keratinocytes were grown to approximately 80% confluence and 
transfected with oligonucleotides designed to target CdGAP, ARAP1 or a control, non-targeting 
oligonucleoide (Table 2.4, Dharmacon or Eurogentecs, Southampton, UK). Oligonucleotides (20-
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75nM) were incubated with 2-3µl of INTERFERin (Polyplus transfection) in a total volume of 100μl of 
serum-free medium for 10 minutes at room temperature. Cells were prepared by replacing medium 
with 300μl fresh complete medium and the transfection mixture added to the cells for 4 hours. Cells 
were fixed or lysed after 48 hours. To determine the optimal time of RNAi treatment, SMART poolsTM 
consisting of four oligonucleotides targetting CdGAP or ARAP1 were transfected for between 24 and 
72 hours prior to lysis. Transfection efficiency was assessed relative to the levels of the target 
protein in the scrambled oligonucleotide control. Once the most effective time point was 
established, cells were transfected with individual oligonucleotides from the SMART poolTM (5-
75nM) to ascertain the most effective oligonucleotide and the best concentration. 
Oligonucleotide Sequence 
Non-targeting control 5’-AUGAACGUAAUUGCUCAA-3’ 
CdGAP oligo 1 5'-GCTGTGACCTGACGGAGTA-3' 
CdGAP oligo 2 5'-GGATGTAACCCATTCAGTA-3' 
ARAP1 oligo 1 5’-GAGAAGGAGUGGCCUAUUA-3’ 
ARAP1 oligo 2 5’-GCAGGGAUCUUACAUCUAU-3’ 
ARAP1 oligo 3 5’-GGAGAUCACUGCCAUUGUG-3’ 
ARAP1 oligo 4 5'-ACAAGAATCTAGAGGAGTA-3' 
ARAP1 oligo 5 5’-GTTCAGACCTCTTGGCCCA-3’ 
ARAP1 oligo 6 5'-GCATCAGGGAGAAGGACTA-3' 
Table 2.4 siRNA oligonucleotides used 
 
2.4. Electrophoresis and Western Blotting   
Sample buffer (5x stock: 0.2mM Tris pH6.8, 50% glycerol, 5% SDS, 0.25M Dithiothreitol (DTT), 250mg 
bromo-phenyl Blue dye) was added to protein samples to 1x and these boiled for 5 minutes at 95°C. 
Protein samples were separated by electrophoresis through Sodium Dodecyl Sulphate 
Polyacrylamide Gel Electrophoresis (SDS-PAGE) and transferred to a Polyvinyldifluoride (PVDF) 
membrane (Millipore) using a standard wet transfer method (buffer: 50mM Tris, 380mM glycine and 
20% methanol). For pull down assays, GST and GST-fusion proteins were visualised by amido black 
staining (Sigma-Aldrich).  
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For immunoblotting, membranes were blocked with 5% non-fat dry milk (Marvel) in Tris Buffered 
Saline (TBS) pH 7.5 containing 0.1% Tween-20 (Sigma-Aldrich) (TBS-T) or with Western Blocking 
Solution (GE Healthcare) for 30-60 minutes with agitation.  Membranes were incubated with the 
indicated primary antibodies for 1 hour at room temperature or overnight at 4°C.  Membranes were 
washed three times for 5 minutes in TBS-T followed by incubation with relevant conjugate diluted in 
5% milk/TBS-T or TBS-T for 1 hour with agitation. Blots were subject to three washes in TBS-T and 
developed with ECL or ECL plus detection kit (GE Healthcare) and exposed to Hyperfilm ECL 
(Amersham Biosciences). Alternatively, blots incubated with fluorescent secondary antibodies were 
scanned using the Ettan DIGE Imager (GE Healthcare). 
Antibody Clone name Supplier Source Dilution  
α-catenin VB1   Rabbit 1:2000 
Actin C4 Sigma-Aldrich Mouse mAb 1:100,000 
Ajuba 9104 Cell signalling Rabbit 1:300 
ARAP1  
S. Vermeren, University of 
Edinburgh Rabbit 1:2000 
β-catenin VB2   Rabbit 1:1000 
β-tubulin TUB 2.1 Sigma Mouse mAb 1:10000 
Cdc42 44/CDC42 BD Transduction Laboratories Mouse 1:1000 
CdGAP CT N. Lamarche rabbit 1:250 
E-cadherin HECD-1 CRUK Mouse mAb 1:1000 
E-cadherin ECCD2 Invitrogen Rat 1:500 
Flag-tag M2 Sigma-Aldrich Mouse mAb 1:4000 
Flag-tag 
 
Sigma-Aldrich Rabbit 1:1000 
GST GST-2 Sigma Mouse mAb 1:5000 
GFP 3-E1 CRUK Mouse mAb 1:5000 
Myc-tag 9E10 CRUK Mouse mAb 1:500 
Myc-tag A14 Santa Cruz Rabbit  1:500 
Rac 23A8 Upstate Mouse mAb 1:1000 
Rho 26C4 Santa Cruz Mouse mAb 1:1000 
V5-tag 2F11F7 Invitrogen Mouse mAb 1:200 
Table 2.5 Primary antibodies used for Western blotting and staining Details of all primary antibodies used in 
this study with information about clone name, supplier, source and dilution  
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Antibody Supplier Source Dilution  
Cyanine (Cy2)- conjugated anti-
mouse IgG 
Jackson Immuno Research 
laboratories 
Goat 1:1000 
Indocarbocyanine (Cy3)-conjugated 
anti-mouse IgG 
Jackson Immuno Research 
laboratories 
Donkey 1:5000 
Indodicarbocyanine( Cy5)-conjugated 
anti-mouse IgG 
Jackson Immuno Research 
Laboratories 
Donkey 1:1000 
Indocarbocyanine (Cy3)-conjugated 
anti-rabbit IgG 
Jackson Immuno Research 
laboratories 
Donkey 1:3000 
Indodicarbocyanine (Cy5)-conjugated 
anti-rat IgG 
Jackson Immuno Research 
laboratories 
Donkey 1:4000 
HRP-conjugated anti-mouse IgG Pierce Goat 1:5000 
HRP-conjugated anti-rabbit IgG Pierce Goat 1:5000 
HRP-conjugated anti-rat IgG Pierce Goat 1:5000 
Alkaline-phosphatase-conjugated 
anti mouse IgG 
Sigma-Aldrich Goat 1:10000 
DAPI Sigma-Aldrich  1:3000 
Phalloidin AF488 Molecular Probes  1:1000 
Table 2.6 Secondary antibodies used for Western blotting and staining Details of secondary antibodies used 
in this study with information about clone name, supplier, source and dilution.  
2.5. Immunofluoresence and microscopy 
Cells were fixed with 3% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) for 10 minutes 
at room temperate followed by permeabilisation in 0.1% Triton X-100 and 10% FCS (Sigma-Aldrich) 
in PBS for 10 minutes at room temperature. Alternatively, cells were permeabilised (10mM PIPES 
pH6.8, 50mM NaCl, 3mM MgCl2, 300mM Sucrose and 0.5% Triton X-100) for 10 minutes at room 
temperature prior to fixation as above, followed by blocking in 10% FCS for 10 minutes at room 
temperature. Coverslips or 96-well plates were incubated with primary and secondary antibodies 
(Table 2.5 and Table 2.6) diluted in 10% FCS (final concentration) in PBS sequentially for 30-60 
minutes. Following incubations, coverslips or 96-well plates were subjected to nine washes in PBS 
and three washes in water. Coverslips were mounted on glass slides (Fisher Scientific) using Mowiol 
(Calbiochem, Ca, USA). Each well of the 96-well plates was covered with 150µl Mowiol. Images were 
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acquired using an Olympus Provis AX70 microscope coupled to a SPOT RT monochrome camera 
using SimplePCI 6 software (Hamamatsu, Japan) or with a Leica SP5 inverted confocal microscope 
using Leica LAS AF Lite software. Pictures were processed using Adobe Photoshop CS6 and WCIF 
ImageJ software. 
2.6. Microinjection 
Microinjections were performed as described (Braga et al., 1997) using a phase contrast microscope 
(Axiovert 135m Zeiss Inc., Thornwood, New York) attached to an Eppendorf Microinjection Unit 
(Microinjector model 5242; micromanipulator model 5170; CO2 Controller model 3700; Heat 
Controller model 3700).  Cells were injected with DNA diluted in sterile PBS and allowed to express 
for 1-24 hours.   
2.7. Determination of Rac and Cdc42 levels in vivo 
2.7.1. PAK-CRIB pull-down assays 
Keratinocytes grown in 9cm dishes in standard calcium medium were transfected with pEGFP-
CdGAP-l, pEGFP-CdGAP-l GAP-Dead or empty vector control for 24 hours and lysed (50mM Tris-HCl 
pH7.5, 1% Triton X-100, 0.1% SDS, 150mM NaCl, 10mM MgCl2, 1mM PMSF and 1mM leupeptin, 
pepstatin and pefabloc cocktail (LPP)). Lysates were cleared by centrifugation for 2 minutes, 14268.8 
g at 4°C.  Lysates were incubated with GST-PAK-CRIB immobilised on beads for 60 minutes. Beads 
were washed three times in wash buffer (50mM Tris pH7.5, 1% Triton X-100, 150mM NaCl, 10mM 
MgCl2, 1mM of each protease inhibitor phenylmethanesulfonylfluoride (PMSF) and LPP). Samples 
were then subjected to electrophoresis and Western blotting. 
2.7.2. Fluorescence lifetime imaging-Forster-resonance energy transfer 
Keratinocytes grown in 96-well plates in standard calcium were transfected with pRK5-myc-CdGAP-l 
or pRK5-myc together with mRFP-PAK1-Rac1-GFP for 24 hours. Cells were fixed with 3% PFA and 
immediately stained for E-cadherin and myc-tagged exogenous protein. FRET in the mRFP-PAK1-
Rac1-GFP probe was measured via fluorescence lifetime imaging (FLIM) of GFP (collaboration with D. 
Kelly and S. Kumar, Imperial College London). FLIM-FRET was performed using a multiwell plate 
reader built around a widefield microscope (Olympus IX81-ZDC) (described previously (Alibhai et al., 
2013)). GFP was excited with a picosecond-pulsed supercontinuum source (Fianium UK Ltd, SC 400-
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6) to 457-480nm and fluorescence was detected in the band 503-537nm. Cy5 was excited at 590-
650nm and detected at 663-738nm; Cy5 images were integrated for 0.5s. Images were acquired 
using a long working distance Olympus 40x objective with N.A 0.6 (LUCPLFLN). Lifetime data was 
analysed using in-house software “FLIMFit” (Warren et al., 2013). Manual segmentation was 
performed using in-house software “CellSegmenter” (developed by D. Kelly). Lifetime data was fit to 
a single exponential model with background and instrument response taken into account with data 
taken from wells containing PBS and 20µM Erythrosin B, respectively (performed by D. Kelly). 
2.8. Aggregation assays 
Confluent coverslips of keratinocytes were trypsinsed in 500µl Aggregation Assay buffer (60% 
versene (v/v), 0.1% trypsin, 0.1mM CaCl2) and allowed to detach (the presence of calcium in this 
buffer prevents degradation of cadherin receptors by trypsin).  Cells were then gently pipetted to 
disrupt clusters, counted and spun down at 900rpm for 5 minutes.  The supernatant was removed 
and cells were resuspended in standard calcium medium to a density of 5 X 104cells/ml.  PBS was 
then added to the bottom of an 8cm2 dish to create a humid chamber and six drops of 20µl of the 
resuspended cells pipetted onto the lid of the dish.  The lid was placed back onto the top of the dish 
and photographs of the aggregates forming were taken 0, 60 and 120 minutes after standard 
calcium medium addition.  After 120 minutes cells were pipetted gently 6 times to disaggregate and 
images of the remaining cell aggregates were taken.  All images were taken using a phase contrast 
on an Axiovert 135m Zeiss or an Olympus CKX41 microscope linked to Colorview IIIu camera using 
cell^D v2.4 software (Olympus). The size of the aggregates and disaggregates was determined using 
ImageJ as described in (Nola et al., 2012). 
2.9. Protein production and purification 
2.9.1. Protein production from bacterial expression plasmids 
Bacterial expression plasmids used are displayed in Table 2.1. All constructs used were verified by 
sequencing carried out by Beckman-Coulter. GST-Ajuba full-length and GST-Ajuba LIM were kindly 
produced by Reiko Daigakhu (Imperial College London). 
Rosetta DE3 Escherichia coli (Novagen) cells were used for the production of GST-fusion proteins. 
Cells were freshly transformed with the desired DNA and grown on ampicillin plates. Overnight 
cultures (100ml) were set up in LB medium containing ampicillin and grown at 37°C with 220rpm 
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agitation. Cultures were then diluted to 1 litre and grown at 37°C until an optical density of between 
0.6 and 0.8 was reached (600nm) (Aquarius, Cecil Instruments, Cambridge, UK). Protein production 
was induced via the addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) according to Table 2.7. 
To assess the efficiency of induction, 1ml samples of culture were taken before and after IPTG 
addition and these pelleted at 14268.8 g. Pellets were resuspended in water and sample buffer and 
a fraction analysed by SDS-PAGE. After the time indicated in Table 2.7 bacteria were pelleted at 
2620 g for 25 minutes and resuspended in 5ml ice cold lysis buffer (Table 2.7). The resuspended 
bacterial pellet was lysed by sonication (four times of 20 seconds on ice). Bacteria were centrifuged 
at 11000 g for 30 minutes at 4°C and the supernatant incubated with glutathione sepharose 4B 
beads (Pharmacia), previously equilibrated in lysis buffer for 30 minutes at 4°C. Samples were taken 
from the supernatant prior to the addition of the beads and of the pellet for analysis. Beads were 
washed four times by centrifugation at 352.8 g for 1 minute in 10ml of buffer (Table 2.7) and 
resuspended in 60% glycerol in wash buffer.  
To elute purified proteins from beads, fusion proteins were resuspended in resuspension buffer 
(50mM Tris.HCl pH 7.5, 150mM NaCl, 5mM MgCl2, 0.1mM DTT) containing reduced glutathione 
(20mM) and incubated for 2 minutes. Beads were centrifuged at 352.8 g and the supernatant was 
collected in a separate tube. This was repeated and the two supernatent samples combined. A 
sample of the beads post-elution was collected for SDS-PAGE analysis to check elution efficiency.  
All eluted proteins were subject to dialysis. Dialysis tubing (Scientific Laboratory Supplies) with 
samples was incubated twice in 1 litre dialysis buffer (15mM Tris.HCl pH 7.5,150mM NaCl, 5mM 
MagCl2, 0.1mM DTT), initially for 2 hours at 4°C. The protein was removed from the dialysis tubing 
and centrifuged at 12303 g to remove any remaining beads and particulates. The supernatant was 
transferred to a fresh tube. Samples from each step of protein production and purification were 
analysed by SDS-PAGE and visualised by Coomassie Blue stain (0.1% Brilliant Blue dye, 45% 
methanol, 10% acetic acid). Protein concentration was calculated relative to bovine serum albumin 
(BSA) (Fluka) standards of known concentration. 
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Protein IPTG 
(mM) 
Induction 
Temp (°C) 
Induction time 
(hrs) 
Lysis 
buffer 
Wash 
buffer 
CdGAP1-221 1 30 3 A A1 
CdGAP1160-1425 1 4 O/N B 2x B + 2x B1 
CdGAP1253-1425 0.5 25 4 C 2x C + 2x C1 
CdGAP1160-1425 R1172A 1 4 O/N B 2x B + 2x B1 
PAK-CRIB 0.5 30 4 D D1 
GST 0.3 30 3.5 E E 
Table 2.7 Protein production conditions 
Buffer A: 50mM Tris HCl pH7.5, 50mM NaCl, 5mM MgCl2, 1mM DTT, 1mM LPP, 1mM PMSF 
Buffer A1: 50mM Tris HCl pH7.5, 150mM NaCl, 5mM MgCl2 1mM DTT, 1mM LPP, 1mM PMSF 
Buffer B: 50mM Tris HCl pH7.5, 100mM NaCl, 1% Triton, 1mM DTT, 1mM LPP, 2mM PMSF 
Buffer B1: 50mM Tris HCl pH7.5, 100mM NaCl, 1mM DTT, 1mM LPP, 2mM PMSF 
Buffer C: 50mM Tris HCl pH7.5, 250mM NaCl, 1% Triton, 5mM DTT, 1mM LPP, 2mM PMSF 
Buffer C1: 50mM Tris HCl pH7.5, 250mM NaCl, 1mM DTT, 1mM LPP, 2mM PMSF 
Buffer D:  50mM EDTA pH8, 0.1% Triton, 10% glycerol in PBS, 1mM DTT, 1mM LPP, 1mM PMSF 
Buffer D1: 50mM EDTA pH8, 1mM DTT in PBS 1mM DTT, 1mM LPP, 1mM PMSF  
Buffer E: 50mM Tris HCl pH7.5, 100mM NaCl,, 1mM DTT, 1mM LPP, 1mM PMSF 
O/N; Overnight incubation 
 
2.9.2. Protein production from mammalian expression plasmids 
CdGAP1160-1425, CdGAP1160-1425
R1172A and CdGAP1160-1425
R1412A
 in the mammalian expression plasmid 
pRK5-myc were in vitro translated via the SP6 promoter using the TNT® Coupled Reticulocyte Lysate 
system (Promega) according to the manufacturers’ instructions. Ajuba and Ajuba Pre-LIM in pCS2-
6myc vectors were linearised via digestion with MfeI for 1 hour at 37°C. DNA was checked on an 
agarose gel and purified using the Stratagene PCR clean up kit. The linearised DNA was in vitro 
transcribed using the RiboMax kit (Promega) as per the manufacturers’ instructions. The derived 
RNA was translated using the Retic lysate IVTTM kit (Ambion) according to the manufacturers’ 
instructions. Protein synthesis was checked by subjecting 1µl of the reaction mixtures to SDS-PAGE 
followed by Western blotting. 
 
89 
 
2.10. Pull-down assays 
2.10.1. Pull-down assays in vivo 
For pull-down assays, COS-7 cells were washed once in PBS then lysed in 250µl of lysis buffer (10mM 
TrisHCl pH 7.5 , 150mM, NaCl, 1mM MgCl2, 1% NP40 containing DTT, LPP and PMSF (1mM each) and 
sodium orthovanadate (OV) and sodium fluoride (NaF) (10mM each)) on ice, followed by 
centrifugation for 2 minutes at 4°C at 14268.8 g. The contents of two wells were pooled and the 
supernatant divided: half was incubated with 1.5µl GST and half with 10µg GST-fusion proteins in the 
presence of an additional 250µl lysis buffer. Samples were rotated at 4°C for one hour followed by 
three washes in lysis buffer. Sample buffer (0.0625M Tris-HCL pH 6.8, 0.5% SDS, 10% glycerol, 
bromophenol blue and 5% β-mercaptoethanol) was added and samples resolved using either 7.5% 
or 12% SDS-PAGE. 
2.10.2. Pull-down assays in vitro 
GST-tagged proteins, or GST alone immobilised on beads (2-5µg) were incubated with myc-tagged 
proteins produced by in-vitro translation in a total volume of 100µl (10mM Tris pH 7.5, 150mM NaCl, 
2mM MgCl2, 1% NP40, 1mM DTT, 1mM LPP, 1mM PMSF and 1mM NaF). Samples were rotated for 
between 1 and 2 hours at 4°C. Beads were washed three times in 500µl buffer (as above), and 
subjected to electrophoresis and western blotting.  Alternatively, GST-tagged CdGAP1-221 or GST 
alone was incubated with myc-tagged CdGAP1160-1425 produced by in-vitro translation, in a total 
volume of 100µl (25mM HEPES, 100mM NaCl, 10mM MgCl2, 5% glycerol, 1% NP40, 1mM OV, 10mM 
NaF,1mM PMSF, 1mM DTT and 1mM LPP).  
2.11. SPOT-peptide array experiments 
CdGAP peptides, 25 amino acids in length, (25-mers), covering amino acids 1083 to 1425 (frame 
shifted by five residues) or covering amino acids 1147-1197, 1302-1327, 1337-1362 and 1387-1412 
where each residue was sequentially mutated to an Alanine, were spot-synthesised on a 
nitrocellulose membrane using the MultiPep SPOT synthesizer (Intavis AG) (Synthesised at the 
Departamento de Bioquımica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de 
Minas Gerais, Belo Horizonte, Brazil). Membranes were blocked using 10% Western Blocking 
Reagent solution (10% purified casein protein in maleic acid) (Roche) dissolved in TBS (50mM Tris-
HCl, pH 7.0) with 5% sucrose overnight. Membranes were overlaid for 2 hours at 4°C  with in vitro 
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translated Ajuba or Ajuba Pre-LIM in 10mM Tris HCl pH 7.5, 150mM NaCl, 1mM MgCl2, 1% NP40, 
1mM DTT, 1mM LPP, 1mM PMSF, OV 10mM and NaF 10mM each. Alternatively, membranes were 
overlaid for 2 hours at 4°C with eluted GST-CdGAP1-221 (200-400 nM) or GST in 25mM HEPES, 100mM 
NaCl, 10mM MgCl2, 5% glycerol, 1% NP40, 1mM OV, 10mM NaF,1mM PMSF, 1mM DTT and 1mM 
LPP. Bound protein was detected using rabbit or mouse anti-myc or anti-GST antibodies followed by 
either alkaline phosphatase-coupled anti-mouse Ig (Sigma) or Indocarbocyanine (Cy3)-conjugated 
anti-rabbit IgG or Indocarbocyanine (Cy5)-conjugated anti-mouse IgG. Between incubations, 
membranes were washed three times for 5 minutes with TBS-T. Membranes were then incubated 
with 0.6 mM bromochloroindolylphosphate (BCIP), 0.7 mM thiazolyl blue tetrazolium bromide (MTT) 
(both Sigma) and 5 mM MgCl2 in citrate-buffered saline (CBS, 10mM sodium citrate, NaCl 137 mM, 
KCl 3 mM, pH 7.0) for up to 60 min and colour development stopped by washing membranes in Milli-
Q Water. Alternatively, bound protein detected via fluorescently conjugated secondary antibodies 
was visualised using the Ettan DIGE Imager (GE Healthcare). 
2.12. Quantifications and statistical analyses 
All experiments, unless stated in figure legends, were performed independently at least three times. 
Significance was tested using Student’s T-test or Analysis of Variance (ANOVA) depending on sample 
type and is specified in figure legends. Statistical testing was performed using Microsoft Excel or 
GraphPad Prism software. Western blots and SPOT membranes were scanned and pixel intensity 
quantified using Image J software.  
Quantification of junction disruption in CdGAP-expressing cells was performed using Image J. The 
line selection tool was used to measure the junctional length in number of pixels between two cells. 
This was then overlaid onto the area covered by E-cadherin and a second measurement taken.  The 
'E-cadherin coverage’ measurement was determined by dividing the area covered by E-cadherin by 
the total area of the junction.  
Qualitative analysis of junction disruption in cells expressing CdGAP alone or in the presence of 
Ajuba was based upon the following criteria. A highly retractive phenotype was ascribed if the cell 
possessed at least one highly retractive junction, characterised by having at least two holes between 
the cell and its neighbour. All images for the quantification were acquired on a confocal microscope. 
For the qualitative analysis of CdGAP enrichment at cell-cell contacts, a junction was classified as 
being enriched if CdGAP was present in a continuous line covering more than 30% of the junction (as 
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determined by area where E-cadherin is present) and this line was of greater intensity than the 
adjacent area.  
2.13. siRNA screen techniques 
2.13.1. siRNA screen workflow 
A primary siRNA screen had previously been conducted in the lab (A. Wheeler and J. Erasmus). A 
library of SMART poolTM oligonucleotides (Dharmacon) was used to target 70 GEFs, 46 GAPs, 3 GDIs, 
23 GTPases and 64 GTPase interactors. The primary screen was analysed in collaboration with 
Natalie Welsh. Candidate proteins identified in the primary screen were analysed in validation 
screens. The Rho GEFs were validated by N. Welsh and the GTPases and Interactors validated by S. 
Bruche. For the GAP validation screen, 27 GAPs were followed up using four single oligonucleotides 
targeting different regions of the mRNA transcript (Dharmacon) (Figure 2.1). Oligonucleotides were 
resuspended in 1 x siRNA buffer to a final concentration of 2µM. Each oligonucleotide was tested in 
three independent experiments.  
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Figure 2.1 Workflow diagram showing the siRNA screening process For the primary screen SMART pools
TM
 
were used containing four oligos targeting a particular gene (step 1). Transfections were performed on 96-well 
plates and after 72 hours cells induced to form contacts via the addition of calcium ions for 30 minutes. Cells 
were fixed and stained for E-cadherin, F-actin and the cell nucleus. Images were analysed visually (J. Erasmus) 
and using an automated custom-made program (N. Welsh and J. McCormack) (step 2). Following this analysis 
‘candidate GAP proteins’ were selected and tested in the Validation screen (step 3) (J. McCormack). At this 
point four individual oligos were used to target separate regions on the mRNA transcript. After this round of 
screening, a further stage of analysis lead to the generation of ‘final hits’ (step 5) which were then subjected to 
further characterisation (step 6).  
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2.13.2. siRNA transfections 
Prior to the start of the screen siRNA transfections were optimised (A. Wheeler and V. Braga, 
unpublished). Seventy-two hours was demonstrated to be efficient for depletion of RhoA. 
Furthermore, the transfection of kif11 (Dharmacon) was used to demonstrate effective transfection 
(kif11 depletion leads to mitotic arrest thus transfection efficiency can be visually assessed). Cells 
maintained in low calcium were transfected when they reached approximately 70% confluence. For 
the validation screen, oligonucleotide (final concentration 100nM) was incubated with 0.4µl 
RNAifect (Qiagen) per well. Cells were washed once in low calcium medium.  Following 15 minutes 
incubation, the transfection mixture in fresh low calcium medium was added to cells (final volume 
50µl). Only the central 60 wells of the 96 well plates were used to avoid edge-effects. Any unused 
central wells were mock transfected with 1 x siRNA buffer. Four hours post-transfection medium 
was replaced with fresh low calcium medium. After 72 hours, cell-cell contacts were induced by the 
addition of 1.8mM CaCl2. To prevent the influence of other signalling pathways old medium was 
used in which growth factors were depleted. Thirty minutes post-calcium stimulation cells were fixed 
using 3% PFA for 10 minutes at room temperature.  
2.13.3. Image acquisition 
For the primary screen images were acquired using GE Healthcare InCell Analyser 3000 
(collaboration with Simon Stockwell, Cell Imaging Facility, ICR, London, UK). Using an infra-red 
autofocus (offset 1µM) images were taken at three different wavelengths (E-Cadherin, 647nm, actin, 
488nm, DAPI, 364nm) at four different Z-planes 1µM apart. Exposure was 1.7ms and binning set at 
1. Images were subsequently converted from 16 bit to 8 bit using InCell Analyser 3000 file exporter. 
For the validation screen images were acquired using a Cellomics ArrayScan IV (collaboration with 
Mike Howell, High Throughput Screening Laboratory, Cancer Research UK London Research 
Institute). Images were collected at the same wavelengths as above. At least two fields of view per 
well were acquired using a 10x objective. Autofocus was used to focus at the level of actin staining. 
2.13.4. Visual analysis 
A visual analysis was performed for the E-cadherin images in order to remove any non-confluent or 
unsuitable images. Each image was scored from 0 to 2. Zero values represented wells equal to 
controls. Values of 1 indicated wells above 90% confluence and values of 2 indicated wells of less 
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than 90% confluence or poor acquisitions and were removed from future analysis. Each plate was 
scored independently by two different observers and the mean value used 
2.13.5. Computational analysis 
All images were analysed using a custom-made program developed by Chris Tomlinson 
(Bioinformatics Support Service, Biochemistry, Imperial College London). For each plate, a set of 
representative control images were selected. These were either treated with scrambled 
oligonucleotides or were mock-transfected wells. The control E-cadherin and F-actin images were 
thresholded so that any pixel of intensity lower than the threshold was removed (Figure 2.2). The 
entire plate was then globally thresholded using the same values. As the intensity of the DAPI 
staining was variable, DAPI images were thresholded locally to facilitate the effective identification 
of all stained nuclei. The three experimental parameters E-cadherin, junctional actin and cytoplasmic 
actin were obtained from further processing of the thresholded images (Figure 2.3). All the 
processed images were globally thresholded to the control set and the percentage area remaining 
following thresholding measured (percentage of the total area). These values were normalised to 
the mean of the controls (Box 1, equation 1). To compare values between plates, Z-scores were 
calculated from the normalised values (Box 1, equation 2). The Z-score was used as a measure of 
how similar an experimental image is to the control group, where a control Z-score is 0. 
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Figure 2.2 Image processing to return the percentage thresholded area value All images were analysed based 
on the percentage thresholded area (%THA). E-cadherin images are shown with example histograms above 
showing the distribution of the intensity of pixels within that image. Thresholds, set based on sets of control 
images unique to each plate, were applied to the image (dashed line right histogram). Any pixel above the 
threshold was kept (right hand side of the dashed line, dark blue, %THA) whilst any pixel below the threshold 
was removed (light purple) to give the processed image. The arrows on the images show areas where pixels 
have been removed from the processed image because these fell below the threshold.  
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Figure 2.3 Flow chart demonstrating the steps taken to generate the three experimental parameters  From 
the original E-cadherin and DAPI images (step 1) binary masks were created. Two masks were created from the 
E-cadherin image, an original mask, whereby the area covered by E-cadherin is transparent, and an inverted 
mask whereby the area covered by E-cadherin is opaque (step 2). To obtain the Junctional Actin image the E-
cadherin binary mask was overlaid onto the F-actin image (step 3a). The area covered by the transparent 
portion of the mask gives the junctional actin image, ie the pool of actin that localises at junctions. In order to 
generate the cytoplasmic actin image, the inverted E-cadherin binary mask and the nuclei binary mask were 
overlaid onto the F-actin image (step 3b). Corresponding pixels to nuclei and cell-cell contacts were subtracted 
from the F-actin image (step 4a), leaving the F-actin pool that is present in the cytoplasm. Scale bar represents 
50μm. 
 
 
 
 
97 
 
 
 
 
 
 
 
Box 1: Equations used to analyse raw data Equation 1 was applied to all values of percentage thresholded 
area in order to normalise these to the control images for that plate. Following normalisation Equation 2 was 
used to calculate the Z-score. One was subtracted from the normalised value calculated in Equation 1 and this 
value divided by the standard deviation of the controls of that plate. This allowed values to be compared 
between plates.  
 
2.13.6. Selection of hit proteins 
For each of the target proteins, the Z-scores from each replicate, and for each of the experimental 
parameters were collected. The median Z-score value of the three replicates was calculated (the 
mean was used if only two replicates were found suitable following quality control of the images). To 
select proteins for further analyses, cut-off values were set based on the standard deviation of the 
mean of the controls.  In the primary screen, samples with a median value outside of this range for 
any of the experimental parameters were classified as candidate proteins and brought forward to 
the validation screen. Four oligonucleotides targeting a single protein were tested individually in the 
validation screen. A hit protein was identified when at least two of the four tested oligonucleotides 
yielded images with Z-scores outside the cut-off. Further inspection of the individual repeats for 
each target protein was carried out to remove any unreliable z-scores. For example, if a mean z-
score was used and the standard deviation was large this protein was discarded. 
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(       )
  
 
Equation 1: Normalisation to the controls. Where xi is the percentage area remaining after 
thresholding of the ith well and c   is the mean percentage area remaining after thresholding 
of the controls 
Equation 2: Z-score. Where Normi is the value normalised to the controls of the i
th well and 
Sc is the standard deviation of the normalised controls 
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Chapter 3.  
The identification of Rho GAPs regulating cell-cell 
contact formation via a medium-throughout siRNA 
screen 
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3.1. Introduction 
The use of siRNA as a tool to screen libraries of genes in order to investigate particular cellular 
processes has led to the characterisation of countless proteins and helped uncover many novel 
signalling pathways (Berns et al., 2004; Boutros et al., 2004; Nybakken et al., 2005; Paddison et al., 
2004; Simpson et al., 2008). Cell-cell contact formation is an ideal process to be studied using a high 
to medium-throughput screening approach as very clear morphological changes are observed over a 
relatively short amount of time (30 minute calcium switch) (Adams et al., 1998; Zhang et al., 2005). 
E-cadherin staining at cell-cell contacts becomes considerably more intense over the course of 
junction formation, whilst extensive transformations occur in the actin cytoskeleton (Adams et al., 
1998; Vasioukhin et al., 2000; Zhang et al., 2005). Prior to the addition of calcium, actin appears in 
loose bundles throughout the cell. However, junction assembly triggers the appearance of thick, 
distinctive actin bundles at the site of contact. At early time points, two clear actin populations can 
be discerned (Zhang et al., 2005). Thus, defects in junction formation can be manifested as changes 
in E-cadherin staining, or in the compaction of actin bundles at the sites of contact.  
Thus far very few screens have addressed the processes of cell-cell contact formation and 
maintenance. Furthermore, these have often involved visual analysis of a relatively small library of 
genes (Elbediwy et al., 2012; Omelchenko and Hall, 2012). The GAPs SH3BP1 and Oligophrenin-1 
were identified as AJ regualtors using a screening approach that assessed phenotypes based on a 
visual analysis of junctional markers (including ZO-1, E-cadherin and α-catenin) (Elbediwy et al., 
2012). Subsequently, the function of SH3BP1 was verified and this protein found to control the 
spatial confinement of Cdc42 activity and regulate actin dynamics during cell-cell contact formation 
in a number of cell types (Elbediwy et al., 2012). However, these screens relied on the time-
consuming task of visually assessing the phenotype produced by every siRNA. Such a qualitative 
analysis may allow more complex phenotypes to be identified, but this comes at the expense of 
throughput. Ideally, as many targets as possible should be examined and a robust and reliable 
automated analysis step employed to semi-quantitate the effects of the siRNA treatment. Such an 
approach also offers the possibility of identifying proteins whose depletion may have a more subtle 
effect on morphology (Jones et al., 2009).  
Quantitative image analysis has been utilised successfully to identify, for example, regulators of cell 
shape and cell spreading (D'Ambrosio and Vale, 2010; Fuchs et al., 2010). Furthermore, the 
generation of multiple quantitative outputs allows further analysis of data in order to cluster targets 
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according to their phenotypes, possibly aiding the characterisation of signalling pathways (Bakal et 
al., 2007; D'Ambrosio and Vale, 2010; Fuchs et al., 2010). 
To identify novel regulators of cell-cell contact formation a siRNA screen targeting a library of 
GTPases, GEFs, GAPs, GDIs and Rho GTPase interacting proteins (Interactors) was performed (Jenni 
Erasmus). Perturbations in junction formation or stabilisation caused by depletion of target proteins 
were assessed by staining for E-cadherin and actin. In collaboration with Natalie Welsh, the effects 
of depletion of each of the target proteins was assessed by subjecting images to thresholding (Figure 
2.2) in order to generate three experimental parameters; E-cadherin, junctional actin and 
cytoplasmic actin. Images were then assigned Z-scores that reflected how similar these were to 
control images. Subsequently, validation screens were performed with candidate proteins identified 
in the primary screen (the GAP screen discussed in this chapter was performed by J. McCormack, 
whilst validation of the GEFs and GTPases and Interactors were performed by N. Welsh and S. 
Bruche, respectively). Prior to commencing this screen numerous rounds of optimisation ensured 
that this thresholding-based method was capable of detecting perturbations in junction organisation 
induced by proteins known to be disruptive to cell-cell contacts (A. Wheeler and V. Braga, 
unpublished).  
The thresholding-based approach meant the effects of depletion of a target protein could be 
assessed in terms of its effect on E-cadherin and two separate populations of actin. This should allow 
for the identification of proteins that can regulate diverse processes, for example the depletion of a 
protein regulating the trafficking of E-cadherin to the membrane may not show any affect on either 
actin population at early time points, but perturb E-cadherin staining. Conversely, the depletion of a 
protein regulating the organisation of actin at the contact edges during contact expansion may affect 
junctional but not cytoplasmic actin. Thus, it is hoped that by processing images in this way we may 
be able to dissect mechanistically the early stages of junction formation and stabilisation.   
3.2. Aims 
1. Analyse the results from a primary siRNA screen that had previously been performed in the 
lab (J. Erasmus) using a customised quantitative program (collaboration with N. Welsh) 
 
2. Perform a validation screen of the candidate GAP proteins identified in the primary screen 
(J.McCormack) 
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3.3. Results 
3.3.1. Primary siRNA screen 
In total 206 different proteins were targeted in the primary screen, covering GTPases, GAPs, GEFs, 
GDIs and interactors. To assess differences between siRNA treatments a thresholding-based method 
was employed (see Figure 2.2). This enabled three experimental parameters, E-cadherin, junctional 
actin and cytoplasmic actin, to be to derived and quantified for each image (Figure 2.3). Every image 
was ultimately assigned a Z-score corresponding to each of these parameters which represented the 
degree of difference between that image and controls. Z-scores from three repeats were averaged 
and these compared to control images of untransfected cells (in collaboration with Natalie Welsh).  
Before analysis of the Z-scores, we used the raw values of the percentage thresholded area (%THA) 
(Figure 2.2) to analyse the spread of the data for each of the parameters, E-cadherin, junctional 
actin, cytoplasmic actin and total actin from all screening plates, as this would dictate the statistical 
tests subsequently used on this data. The %THA represented the percentage of the image that was 
remaining after the thresholding step was performed for a particular well, and before any 
normalisation had taken place (Equation box 2.1). The %THA was used to generate histograms 
illustrating the distributions of these parameters (Figure 3.1). To test for normality D’Agostino-
Pearson omnibus tests were performed. Despite large sample sizes, none of the parameters were 
normally distributed (Figure 3.1). This is consistent with the nature of proteins selected in this 
targeted screen, as they were particularly likely to have an influence on junction morphology when 
depleted.  
3.3.2. Well confluence does not impact upon the %THA 
In order to avoid false positives being included due to artefacts of the analysis, a visual analysis of 
every well was performed to remove sub-confluent wells. A scale of 0-2 was used to classify 
confluence with 0 representing fully confluent wells, 1 representing wells 90% confluent and 2 
representing wells less than 90% confluent (Figure 3.2 A). All wells classified as 2 were removed 
from the analysis (as were any images that were out of focus or otherwise unsuitable).  
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Figure 3.1 The experimental parameters are not normally distributed The percentage thresholded area for 
each of the parameters, E-cadherin (A), Cytoplasmic actin (B), Junctional actin (C) and Total F-actin (D) were 
plotted on histograms.  Normality was tested using the D’Agostino-Pearson Omnibus test. P values, shown in 
the top right corners of the graphs, indicate that if the null hypothesis were true (that data is from a normally 
distributed population) the likelihood that this distribution would be obtained from random sampling of this 
population. Thus a significant P value indicates the null hypothesis should be rejected.  
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This is a time-consuming process, thus its automation would be desirable. We sought to determine if 
either cell count or %THA F-actin were useful predictors of confluence that may be used to remove 
automatically sub-confluent wells in future screens. Box plots were created with each confluence 
group plotted against cell count (Figure 3.2 B). The mean cell count for the wells classified as 0 
(530.8) is higher than the mean cell count for wells classified as 1 or 2 (453.7 and 296.2 respectively). 
However, a considerable overlap in the spread of this data indicates that a confluent well can 
contain a large range of cell counts (from 285 to 928). As such, cell count is not a good predictor of 
confluence and the use of cell count to remove sub-confluent wells automatically is not possible due 
to the wide range of cell counts present amongst confluent wells. 
As number of nuclei did not correlate with confluence, one possibility was to use the %THA of F-
actin, which should represent the cell cytoplasm spreading on the well.  The prediction is that 
subconfluent wells visually classified as 2 should have lower values for %THA. Box plots of the %THA 
F-actin against confluence were generated and show wells classified as 0 or 1 had similar amounts of 
F-actin (mean 99.33 and 98.03) whereas wells classified 2 had a lower mean (83.58) (Figure 3.2 C). 
Thus, confluent wells (0 or 1) included in the analysis all contained a similar overall %THA for F-actin, 
but a wide range of cell numbers. The %THA F-actin is therefore a better predictor of a confluent 
well than cell count, and could potentially be used in future analyses for the automated removal of 
sub-confluent wells. However, in order to ensure the removal of any sub-confluent well a high limit 
would have to be set, meaning that many confluent wells would also be excluded. This approach 
would not be suitable for a screen of this size, as too much data would be lost. 
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Figure 3.2 Confluence does not correlate with percentage thresholded area of F-actin A) Example images of 
E-cadherin and actin staining from wells classified 0, 1 or 2 based on confluence. Wells classified ‘0’ were 
completely confluent, wells classified ‘1’ were above 90% confluent and wells classified ‘2’ were below 90% 
confluent and were removed from analysis. Scale bar represents 50μm. B) The number of cells in each well 
was quantified with ImageJ using the ‘cell counter’ plugin and cell count plotted against confluence 
classification on box plots. Red bars indicate means. Boxes show 25th and 75th percentiles, whiskers show 
minimum and maximum values. C) The total F-actin %THA was plotted against confluence classification on box 
plots. Red bars indicate means. Boxes show 25th and 75th percentiles, whiskers show 5th to 95th percentiles, 
circles show outliers. D) Cell count was plotted on a scatter graph against total F-actin %THA. Correlation 
between these parameters was measured using Spearman’s ranked correlation coefficient and R value is 
shown in the top left corner of the graph. N=3  
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To confirm that cell count would not influence results independently of siRNA treatment, it was 
important to determine if any correlation existed between cell count and any of the experimental 
parameters (Figure 3.3 A-C). In the case of cell-count versus E-cadherin and junctional actin the 
correlations give R values approaching zero, suggesting no correlation exists. For cytoplasmic actin R 
is higher, at 0.1452, and P is significant (<0.05) indicating that this association although very low may 
not be random. As such, it is possible a very low association exists between these parameters.   
The relationship between each of the experimental parameters to total F-actin was examined to 
exclude the possibility that (particularly for the junctional and cytoplasmic actin parameters) the 
total amount of F-actin could influence the %THA of any other parameter. All parameters gave very 
low R values which are significant (p<0.05) suggesting a very weak association between these 
parameters and F-actin (Figure 3.3 D-F). Such mild associations suggest total F-actin levels do not 
influence the amount of E-cadherin, or of either actin population, the latter indicating our actin 
segmentation is sound. The lack of correlation between both the cell count data and F-actin %THA 
and each of the experimental parameters indicates that neither of these variables can influence the 
%THA of the experimental parameters. Thus any deviation from the controls can be attributed to 
siRNA treatment, rather than artefacts of the analysis program.   
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Figure 3.3 Experimental parameters do not correlate with cell count or Total F-actin Cell count was 
correlated with E-cadherin (A), Junctional actin (B) and Cytoplasmic actin (C). Total F-actin %THA was 
correlated with E-cadherin %THA (D), Junctional actin %THA (E) and Cytoplasmic actin %THA (F). The 
correlation between these variables was assessed using Spearman’s rank correlation coefficient and R values 
are shown in the top right corner of graphs.  
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3.3.3. E-cadherin, Junctional actin and cytoplasmic actin Z-scores all correlate with each 
other 
The relationship between the Z-scores from each parameter was examined for the primary screen of 
206 proteins (Figure 3.4 A) and the candidate proteins (according to functional group) (Figure 3.4 B).  
E-cadherin and junctional actin are positively correlated (R2=0.9833 and R2=0.9818 for primary and 
candidate proteins respectively) likely due to the functional relatedness of these two parameters. 
Cells with more E-cadherin are likely to have a greater amount of actin at their junctions, whereas 
junctions containing less E-cadherin may be that way due to a lack of underlying junctional actin 
(although no causality can be assigned to this relationship from the correlation analysis). 
Interestingly, cytoplasmic actin correlates negatively with both E-cadherin and junctional actin in the 
total screen (R2=-0.8019, E-cadherin and R2=-0.8190, junctional actin) and amongst the candidate 
proteins (R2=-0.7450, E-cadherin and R2=-0.7806, junctional actin). This indicates that a low score for 
cytoplasmic actin is predictive of high scores for E-cadherin and junctional actin. This is not 
unexpected as with actin compaction towards the junctions the adjacent cytoplasmic loose bundles 
appear less intense compared to the junctional pool. In all cases correlations were significant 
(P<0.0001) indicating these associations are not due to chance. 
For these correlations the candidate proteins were colour-coded according to functional group 
(Figure 3.4 B). Potentially more GAPs and GTPases are found to positively affect E-cadherin and 
junctional actin whilst negatively affecting cytoplasmic actin than other functional groups. However, 
for firm conclusions to be drawn a more thorough evaluation, for example using principal 
component analysis, would be required. 
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Figure 3.4 The experimental parameters correlate strongly with one another Z-scores for each of the 
experimental parameters E-cadherin, junctional actin and cytoplasmic actin were correlated with one another 
for all proteins in the primary screen (A) and just the candidates (B). The candidates were coloured according 
to the functional group they belonged to. White=GAPs, Black=GEFs, Grey= GDIs, Red= GTPases and Blue= 
Interactors. The degree of correlation was determined using Pearson’s correlation coefficient (R
2
).    
R2 = 0.9833, P= < 0.0001 
R2 = -0.8019, P= < 0.0001 
R2 =-0.8190, P= < 0.0001 
R2 = 0.9818, P= < 0.0001 
R2 = 0.7450, P= < 0.0001 
R2 = 0.7806, P= < 0.0001 
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3.3.4. Selection of candidate proteins 
To select candidate proteins to be taken forward to the validation screen, Z-scores of each 
parameter were ranked (Figure 3.5 A-C) and cut-off values were defined as plus or minus one 
standard deviation of the mean of the controls (the mean Z-score of the controls was 0). Any protein 
with a Z-score above or below the cut-off for any parameter was designated a candidate. Candidate 
proteins were classified as ‘positive’ or ‘negative’, reflecting whether the Z-score was higher or lower 
than the control means (Figure 3.5 A-C). Fundamentally, a positive Z-score indicates an image with a 
higher proportion of pixels above the threshold compared to the controls. For both E-cadherin and 
junctional actin, a large skew in the Z-scores is seen, with the majority of candidates having a 
negative Z-score compared to controls. Conversely, cytoplasmic actin Z-scores are skewed in the 
opposite direction, meaning that most candidates have higher Z-scores than controls. Hence the 
depletion of the majority of proteins in the screen reduced the amount of E-cadherin and/or 
junctional actin and increased cytoplasmic actin, suggesting most proteins targeted may be positive 
regulators of cell-cell contact formation. 
When candidate proteins (above and below cut off) and control Z-scores were plotted for each 
parameter there was no overlap between the inter-quartile ranges of the candidates and the 
controls (Figure 3.5 A-C). However, the range of Z-scores generated in the controls was large, due to 
the inherent variability of keratinocytes. As a relatively low cut-off value was set there was some 
overlap between the total spread of the controls and the candidate proteins. Whilst this approach 
increases the possibility of detecting false positives in the primary screen, it maximises the likelihood 
of identifying proteins causing more subtle phenotypes on junction morphology.  
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Figure 3.5 Selection of candidates from the primary screen E-cadherin (A), Junctional actin (B) and 
Cytoplasmic actin (C) Z-scores were ranked (RNAi sample) from negative (red) to positive (blue). Candidate 
proteins were selected based on cut-offs, set as one standard deviation above and below the mean of the 
controls (dashed lines). Shown alongside are box plots showing the spread of the Z-scores from controls and 
positive and negative candidate proteins for E-cadherin (A), Junctional actin (B) and Cytoplasmic actin (C). Red 
lines show mean values, boxes show 25th and 75th percentiles, whiskers show 5th to 95th percentiles, dots 
show outliers.   
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3.3.5. Summary of the candidate proteins 
From the original 206 proteins tested, 101 were classified as candidates (49%). To see how each 
parameter was affected by the depletion, candidates were grouped according to whether they 
affected one, two or all three of the parameters (Figure 3.6 A and B). The majority of the candidates 
(69%) influenced all three experimental parameters when depleted (triple). Relatively few 
candidates (8%) had an effect on two parameters (double). Of which the vast majority (75%) 
influenced E-cadherin and junctional actin. These results are consistent with the fact that these two 
parameters are highly correlated. The remaining 23% of candidates caused a change in a single 
parameter, the majority affecting cytoplasmic actin (65%). 
The original library contained a mixture of Rho GTPases, their regulators, and interacting partners. 
Interestingly, the Rho GTPases and the Rho GAPs both made up a larger percentage of the candidate 
proteins than they did the original library (from 11% and 22% of the library to 14% and 26% of the 
candidates respectively) (Figure 3.6 C). Their enrichment amongst the candidate proteins comes at 
the expense of the Rho interacting proteins, for which relative proportions dropped from 31% to 
25% and suggests the importance of these groups in cell-cell contact formation. 
A literature review was conducted on all the candidate Rho GAP proteins and GTPase specificity in 
vitro and in vivo recorded (Table 3.1). GAPs can have a very narrow specificity, acting on a single 
GTPase or multiple GTPases from different families (eg. ARAP1 (Miura et al., 2002)). Furthermore, 
activity in vitro does not necessarily translate to activity in vivo, as post-translational modification or 
protein-protein interactions can enhance or inhibit GAP activation in a cellular context (Minoshima 
et al., 2003). I collated the GTPase specificity of all candidate GAPs against the three best studied 
Rho GTPases, Rho, Rac and Cdc42 (Figure 3.6 D).  None of the candidate GAPs possessed Cdc42 
activity alone either in vitro or in vivo (although several could act on Cdc42 in conjunction with Rac 
and or Rho). This is interesting as Cdc42 is not required for cell-cell contact formation in 
keratinocytes (Erasmus et al., 2010). Rho GAPs narrowly made up the largest single group both in 
terms of in vitro and in vivo activity. 
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Figure 3.6 Summary of results from the primary screen A) Candidate proteins were grouped based on the 
number of parameters in which they had Z-scores outside of the cut-offs. For example, a candidate that 
produced changes in E-cadherin, Junctional actin and Cytoplasmic actin would be called ‘triple’ and a 
candidate affecting any combination of two parameters called ‘double’. The candidates influencing two 
parameters (double) or one parameter (single) were broken down further to show which parameters were 
most affected within these groups. B) The breakdown of the candidates is shown in the venn diagram 
displaying absolute numbers of proteins. C) All the screened proteins were grouped by function as either  
GTPase, GEF, GAP, GDI or Interactor (proteins predicted or verified as interacting with a Rho GTPase) and this 
data represented as the proportions of each group within the total RNAi screen (left pie chart) or the 
candidate proteins subset (right pie chart). D) The GTPase activity of candidate GAPs is summarised in venn 
diagrams showing the in vitro GTPase activity (top, GTPase activation assays) and in vivo GAP activity of each 
candidate GAP (effector pull-down assays or FRET).  
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Table 3.1 Summary of a literature survey of the candidate GAP proteins In vitro and in vivo GAP activity 
shown for the most studied GTPases, RhoA (grey), Rac1 (blue) and Cdc42 (maroon). Activity (if known) against 
other GTPases is shown in the ‘other’ column. In vitro activity was confirmed by GAP activity assays. In vivo 
activity was confirmed with either effector pull-downs or using FRET. For the in vivo data, the cell type in which 
activity was tested is noted and the species column shows the species the GAP construct used was (H; human, 
M; mouse). N, no GAP activity detected; *very low GAP activity; †GAP activity only when phosphorylated by 
Aurora B or ‡ dependent on phospholipids. References are listed in the appendix 1.  
 
 GTPase specificity 
 in vitro 
GTPase specificity 
 in vivo 
Refs 
Gene Protein name R
ac
 
R
h
o
 
C
d
c4
2
 
O
th
er
 
R
ac
 
R
h
o
 
C
d
c4
2
 
O
th
er
 
Cell  
type 
Sp
ec
ie
s 
In 
vitro 
In 
vivo 
ABR Active breakpoint cluster region-related protein X 
 
X Rac2 X 
  
Rac2 
Rac3 
CHO M [1, 2] [3] 
ARHGAP4 
Rho GTPase-activating protein 4 
Rho-GAP hematopoietic protein C1 
X X X        [4]  
ARHGAP6 Rho GTPase-activating protein 6  X         [5]  
ARHGAP9 Rho GTPase-activating protein 9 X  X  X   Rac2 COS-7 H [6] [7] 
ARHGAP10 Rho GTPase-activating protein 10  X X   X X  HEK293 M [8] [9] 
ARHGAP11A Rho GTPase-activating protein 11A  X X   X   U87 ? [10] [10] 
ARHGAP15 Rho GTPase-activating protein 15 X 
   
X 
   
BMDMs M [11] [12] 
ARHGAP20 Rho GTPase-activating protein 20 
 
X 
   
X 
  
NG108 H [13] [13] 
ARHGAP21 
Rho GTPase-activating protein 21 
Rho GTPase-activating protein 10  
X* X 
 
X X 
  
PC3, 
T98G 
H [14] 
[15, 
16] 
ARHGAP22 Rho GTPase-activating protein 22 
    
X 
   
A375M2 H  [17] 
ARHGAP25 Rho GTPase-activating protein 25 X 
         
[18]  
ARHGAP26 
Rho GTPase-activating protein 26 
Oligophrenin-1-like protein 
 X X      C2C12 M [19] [20] 
ARHGAP27 Rho GTPase-activating protein 27 X  X        [21]  
ARHGAP28 Rho GTPase-activating protein 28 
          
  
CENTD2 
Arf-GAP with Rho-GAP domain, ANK repeat and 
PH domain-containing protein 1 
 X X 
Arf1 
Arf5
‡
 
      [22]  
CENTD3 
Arf-GAP with Rho-GAP domain, ANK repeat and 
PH domain-containing protein 3 
X* X X* Arf6
‡ 
 X   
COS-7,  
Sf9 
H [23] [24] 
DEPDC1B DEP domain-containing protein 1B             
DLC1 
Deleted in liver cancer 1 protein 
START domain-containing protein 12 
Rho GTPase-activating protein 7 
 X X 
RhoB,  
RhoC 
 X   HEK293 H 
[25, 
26] 
[27] 
GMIP GEM-interacting protein  X    X   HEK293 H [28] [28] 
INPP5B 
Type II inositol-1,4,5-trisphosphate 5-
phosphatase 
Phosphoinositide 5-phosphatase 
N N N        [29]  
RACGAP1 
Rac GTPase-activating protein 1 
Male germ cell RacGap 
X X† X  X  X  HeLa H 
[30, 
31] 
[32] 
SH3BP1 SH3 domain-binding protein 1 X  X 
Rac2 
RhoG 
X  X  
HEK293, 
COS-7, 
A431 
H [33] 
[34, 
35] 
SRGAP1 
SLIT-ROBO Rho GTPase-activating protein 1 
Rho GTPase-activating protein 13 
     X X  HEK293 H  [36] 
SRGAP2 
SLIT-ROBO Rho GTPase-activating protein 2 
Rho GTPase-activating protein 34 
X          [37]  
SRGAP3 
SLIT-ROBO Rho GTPase-activating protein 3 
Mental disorder-associated GAP 
Rho GTPase-activating protein 14 
X  X  X  X  SHSY-5Y H [38] [39] 
STARD8 
START domain-containing protein 8 
Deleted in liver cancer 3 protein 
 X X        [40]  
TAGAP 
T-cell activation Rho GTPase-activating protein 
Rho GTPase-activating protein 47 
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3.3.6. Analysis of the validation screen 
The validation screen involved the use of four individual oligonucleotides targeting each of the 
candidate proteins. In total 27 GAP proteins were targeted. Thresholding was used as before to yield 
a Z-score for each well and mean or median Z-scores used to compare experimental wells to 
controls. The relationship between the Z-scores from each parameter was investigated (Figure 3.7). 
Strong correlations were found between all variables, although these were less than were seen in 
the primary screen. Again, the most correlated parameters were E-cadherin and junctional actin, 
whilst cytoplasmic actin correlated negatively with both E-cadherin and junctional actin. This may 
indicate that GAPs are more likely to affect a single parameter, as opposed to influencing multiple 
signalling pathways.  
To pick the final hits, cut-offs were set as ±1 standard deviation from the controls. A lower 
borderline cut-off was also set to detect more subtle phenotypes (Z-scores ±0.8 standard deviations 
of the controls). In order to be classified a ‘hit protein’ at least two of the oligonucleotides had to 
produce Z-scores above or below the borderline cut-off for at least one parameter (Figure 3.8 A-C). 
Based on these criteria 20 GAPs (74%) were classified hit proteins (Table 3.2). 
The screen has allowed the identification of both positive and negative regulators of cell-cell contact 
formation (Figure 3.9 A). ARAP1 depletion led to an overall increase in E-cadherin (with both E-
cadherin present at the junctions and the cytoplasm increased) and junctional actin levels and a 
decrease in cytoplasmic actin. Conversely, SRGAP3 depletion resulted in a large decrease in E-
cadherin and junctional actin levels compared to controls. In these images E-cadherin is lost in some 
sections of junctions or is much less intense than in control images. The same is true for junctional 
actin. Lower levels of E-cadherin or actin populations in images are clearly reflected in the Z-scores 
these images obtained. Thus, the segmentation and quantification strategy used yielded different Z-
scores that are effective in distinguishing different phenotypes.  
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Figure 3.7 Correlations between the experimental parameters of candidate proteins Z-scores for each of the 
experimental parameters E-cadherin, junctional actin and cytoplasmic actin were correlated with one another 
for all oligonucleotides targeting proteins in the validation screen. The degree of correlation was determined 
using Pearson’s correlation coefficient (R
2
).   
 
 
 
 
R2=0.8681, P=<0.0001 R
2=0.6059, P=<0.0001 
R2=0.5116, P=<0.0001 
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Figure 3.8 Bar charts showing Z-scores from each oligonucleotide tested in the validation screen  Z-scores 
from four individual oligonucleotides used to target each protein, E-cadherin (A), Junctional actin (B) and 
Cytoplasmic actin (C) plotted on bar charts. Blue, cream, grey and purple are used to represent 
oligonucleotides 1 to 4 respectively. Dotted lines represent borderline cut-offs.  
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Gene name Protein name E-Cadh Junc-A Cyto-A 
ABR Active breakpoint cluster region-related protein  –  
ARHGAP4 Rho-type GTPase-activating protein 4 
Rho-GAP hematopoietic protein C1 
+ + – 
ARHGAP9 Rho-type GTPase-activating protein 9 
  
– 
ARHGAP10 Rho- GTPase-activating protein 10 
GTPase regulator associated with focal adhesion 
kinase 2 
–  + 
ARHGAP11A Rho GTPase-activating protein 11a   – 
ARHGAP15 Rho GTPase-activating protein 15   – 
ARHGAP20 Rho GTPase-activating protein 20 – – + 
ARHGAP25 Rho GTPase-activating protein 25 – –  
ARHGAP26 Rho-type GTPase-activating protein 26 
Oligophrenin-1-like protein 
GTPase regulator associated with focal adhesion 
kinase 
+ + – 
ARHGAP27 Rho-type GTPase-activating protein 27 
CIN85-associated multi-domain-containing Rho 
GTPase-activating protein 1 
+ + 
 
ARHGAP28 Rho-type GTPase-activating protein 28 – – – 
CENTD2 Arf-GAP with Rho-GAP domain, ANK repeat and PH 
domain-containing protein 1 
+ + – 
DEPDC1B DEP domain-containing protein 1B + + 
 
DLC1 Deleted in liver cancer 1 protein 
START-domain containing protein 12 
Rho-type GTPase activating protein 7  
– 
 
RACGAP1 Rac GTPase-activating protein 1 
Male germ cell RacGap 
– – + 
SRGAP1 SLIT-ROBO Rho GTPase-activating protein 1 
Rho GTPase-activating protein 13 
 –  
SRGAP2 SLIT-ROBO Rho GTPase-activating protein 2  
Formin-binding protein 2 
Rho GTPase-activating protein 34 
+ + – 
SRGAP3 SLIT-ROBO Rho GTPase-activating protein 3 
Mental disorder-associated GAP 
Rho GTPase-activating protein 14 
– – + 
STARD8 StAR-related lipid transfer protein 8 
START domain-containing protein 8 
Deleted in liver cancer 3 protein 
 –  
TAGAP T-cell activation GTPase-activating protein 
Rho GTPase-activating protein 47 
– – + 
Table 3.2 Summary of the hit proteins from the validation screen Parameter(s) affected by each hit protein 
shown. ‘+’ denotes a Z-score above the controls and ‘-‘ denotes a Z-score below the controls.  
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All hits were grouped based on the number of experimental parameters their depletion affected 
(Figure 3.9 B). Interestingly, only 45% of GAPs affected three parameters (compared to 65% of 
proteins in the primary screen), possibly indicating a tendency of Rho GAPs to affect single, specific 
processes, rather than governing many cellular events. Consequently, 20% of hits influenced two 
parameters (up from 8% in the primary screen), of which 75% affected E-cadherin and junctional 
actin. Thirty-five percent of hits affected one parameter. Of these, none were found to affect E-
cadherin alone, suggesting that perturbations in E-cadherin will also disrupt actin populations.  
Finally, I sought to confirm the expression of a sub-set of GAPs in keratinocytes (Figure 3.10). 
Primers were designed to target ARAP1, DEPDC1B, ARHGAP20, ARHGAP26, ARHGAP27 and RacGAP1 
and RT-PCR performed using keratinocyte RNA. All the targeted GAPs were expressed in 
keratinocytes. The primers were designed such that (if possible) if separate isoforms of the protein 
existed (based on sequences deposited on NCBI gene database) these could be distinguished. For 
ARHGAP20 only one form exists and this seen at 252bp. A larger band is also present above this 
which may be due to non-specific amplification of a different product. Two isoforms exist of 
ARHGAP26 (A, 497bp and B, 332bp products). Isoform B is the predominant form expressed in 
keratinocytes. This isoform is the shorter of the two, but maintains all of the recognised functional 
domains that are present in the longer isoform. ARHGAP27 also has two isoforms (A and B) and I 
found both expressed in keratinocytes (335bp and 254bp products). Two isoforms of DEPDC1B exist, 
but the sequences differ only in that a small section is missing in the middle of the second isoform. 
As such primers were unable to distinguish between these. DEPDC1B is expressed in keratinocytes, 
but which isoform predominates is unknown. Three variants of RacGAP1 exist, but variants 1 and 2 
differ by only 11bp and could not be distinguished. The main band observed corresponds to either 
variant 1 or 2 (342 and 353bp products). However, whether or not the third variant is also expressed 
is not clear. A band around 233bp is present on the gel, but as there seems to be several 
unexplained bands here this may be non-specific. Three isoforms of ARAP1 exist. Keratinocytes 
predominantly express isoform C (372bp product) which is the longest of the isoforms.  
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Figure 3.9 Positive and negative regulators of cell-cell contact formation were identified in the screen A) 
Candidate proteins were grouped based on the number of parameters in which they had Z-scores outside of 
the cut-offs. For example, a candidate affecting E-cadherin, Junctional actin and Cytoplasmic actin would be 
called ‘triple’ and a candidate affecting any combination of two parameters called ‘double’. The candidates 
affecting two parameters (double) or one parameter (single) were broken down further to show which 
parameters were most affected within the group. B) Montage of example images from hit proteins that when 
depleted were found to positively (ARAP1) or negatively (SRGAP3) regulate E-cadherin levels. Arrow heads 
indicate normal junctions, open arrows indicate junctions enriched in E-cadherin or actin, arrows indicate gaps 
in E-cadherin or actin staining at junctions. Scale bar represents 50μm. 
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Figure 3.10 A subset of hit proteins are expressed in keratinocytes RT-PCR on keratinocyte samples amplified 
several of the hit proteins. PCR products were run on agarose gels to detect products A) Primers specific for 
ARAP1, DEPDC1B, ARHGAP20, ARHGAP26 and ARHGAP27 were used to amplify these proteins from 
keratinocyte RNA. B) PCR reactions were optimised using a temperature gradient between 51 and 55°C to 
confirm the presence of GMIP and RacGAP1 isoforms. Control reactions were run in the absence of primers. 
Ladders indicating size in basepairs of the product is shown on the left.  
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3.4. Conclusions 
In this chapter, the use of an automated analysis program for the segmentation and quantification of 
junctional proteins during cell-cell contact formation was optimised (in collaboration with N. Welsh). 
We show that this program can accurately identify differences in the amount of E-cadherin, 
junctional actin and cytoplasmic actin, and that this is independent of cell count or the total amount 
of F-actin present. Importantly, the finding that several of the Rho GAPs identified have reported 
roles in the regulation of cell-cell contact supports the efficacy of this approach. As such, this 
program may be used to assess the effects of depletion of a range of targets on cell-cell contact 
formation and the early stabilisation of junctions. With the improvement of automatic analysis 
software to detect cell boundaries, and the increasing ability of these to distinguish complex 
morphological traits, even more proteins can be analysed in similar screens.  
Multiple GAPs have been identified in this screen that can regulate the formation and early 
stabilisation of cell-cell contacts, many of which have not previously been linked to this process. 
However beyond this, these findings allude to a system that is very precisely governed; Rho and Rac 
activity is necessary for cell-cell contact formation, but the loss of several Rho and Rac-specific GAPs 
can also perturb cell-cell contacts, demonstrating that GTPase activity must be spatially constrained 
also. Possibly, the very fact that Rho/Rac activity is critical for this process necessitates the presence 
of numerous Rho-specific GAPs in order to ensure dynamic regulation of Rho GTPase activity. This 
suggests multiple Rho GAPs specific for the same GTPase are required for junction assembly to 
proceed correctly. Thus, these are likely required to govern very specific stages of complex cellular 
processes and to direct localised GTPase signalling appropriately. The diversity in terms of reported 
GTPase targets, the presence of multiple functional domains and the multitude of recorded 
functions associated with the hit proteins supports this conclusion and suggests the existence of a 
highly complex system underlying cell-cell contact formation where the inactivation of GTPase is just 
as important as its activation. 
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3.5. Discussion 
3.5.1. The use of an automated analysis program to quantify cellular features upon cell-
cell contact formation  
We have used an automated analysis program to segment E-cadherin, junctional actin and 
cytoplasmic actin and quantified these regions in relation to a selection of controls. The 
quantification of E-cadherin appeared to compare favourably to visual analysis of wells, with images 
containing more E-cadherin (assessed visually) receiving a correspondingly higher Z-score. Using this 
approach a number of Rho GAPs have been identified as potential regulators of cell-cell contact 
formation. 
This approach is useful to segment E-cadherin and quantify its levels at junctions. As such this could 
be used to segment other junctional proteins also. However, this type of analysis does have 
limitations in terms of the conclusions that should be drawn based on a Z-score. The main caveat 
associated with thresholding-based image analysis is that this relies on the assumption that E-
cadherin will be most intense in the region of the junction. Consequently, interpretation of the Z-
score is compromised in images with high levels of cytoplasmic E-cadherin, as any increase at cell-
cell contacts may not be picked up. Furthermore, a large population of cytoplasmic E-cadherin may 
interfere with the junctional and cytoplasmic actin images due to the methods used to generate 
these. Indeed, whilst the E-cadherin segmentation seemed overly accurate, the generation of 
junctional actin, and particularly the cytoplasmic actin parameters was variably successful. 
Alternatively, the accurate segmentation of actin may require images of a higher quality than those 
used, as actin is more widely distributed within cells and generally, images had higher background. 
With continually improving software, it is likely that issues with segmentation can be resolved and 
methods could be employed to selectively detect E-cadherin at the junctions, thus improving the 
detection of actin populations. As such, the fact that segmentation was less successful with our actin 
images does not mean a similar thresholding-based approach would not be suited for similar screens 
in the future.  
Overall, the method of thresholding used is well suited to identify changes in levels of a protein in a 
particular area, but unsuitable for identification of certain morphological traits, such as wavy 
junctions (unless these also have less/more of the examined protein). Potentially then, thresholding 
can be used to narrow-down from a large library a smaller subset of proteins that may subsequently 
be analysed using more time-consuming, but accurate methods.  
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3.5.2. The composition of proteins in the candidate screen 
From the primary screen, we found that the E-cadherin and junctional actin Z-scores correlate. This 
is certainly consistent with the important roles both play in junction formation and maintenance. 
Indeed, clustering of E-cadherin triggers actin recruitment to contacts, which in turn strengthens 
junctions (Adams et al., 1998; Chu et al., 2004). Conversely, cytoplasmic actin was negatively 
correlated with both junctional actin and E-cadherin. The formation and maturation of contacts sees 
numerous changes in actin dynamics in order to stabilise cadherin molecules (Adams et al., 1998; 
Yamada and Nelson, 2007; Zhang et al., 2005). Over time, cytoplasmic actin changes from being 
loosely packed in the cytoplasm to concentrating at AJs (Yamada and Nelson, 2007; Zhang et al., 
2005). Therefore, it is unsurprising that a junction with more E-cadherin and/or junctional actin has 
less cytoplasmic actin, as this has likely been redistributed to the vicinity of the junction (Yamada 
and Nelson, 2007; Zhang et al., 2005).   
The distribution of the Z-scores in the primary screen showed that both E-cadherin and junctional 
actin distributions were heavily negatively skewed, whilst the cytoplasmic actin distribution was 
positively skewed. This may suggest that most proteins targeted were positive regulators of cell-cell 
contact formation, without them less E-cadherin and junctional actin was present at sites of contact.  
Proteins positively regulating AJ formation may do so by controlling several cellular processes, for 
example by regulating the delivery of E-cadherin to sites of contact or by promoting engagement of 
E-cadherin with the cytoskeleton (Baum and Georgiou, 2011). However, loss of a protein regulating 
the coupling of E-cadherin to the cytoskeleton may not result in such a reduction of E-cadherin from 
cell-cell contacts that would yield a sufficiently different Z-score from controls (this would therefore 
be a false negative). For example, ARHGAP21 is required for the localisation of α-catenin to cell-cell 
contacts in some epithelial cell lines (Sousa et al., 2005) and loss of ARHGAP21 renders cells more 
susceptible to invasion by L. Monocytogenes (Sousa et al., 2005). However, despite apparent 
weakening of junctions and presumably less E-cadherin being coupled to α-catenin, in this case, the 
loss of ARHGAP21 does not affect the levels of E-cadherin at cell-cell contacts (Sousa et al., 2005). As 
such, it will be interesting to ascertain the nature of the positive regulators we have detected in this 
screen. 
Negative regulators of junction formation, when depleted, will result in increased levels of E-
cadherin and/or junctional actin. If these proteins control the engagement of E-cadherin rather than 
promoting its internalisation they may be more difficult to detect as surface E-cadherin levels may 
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remain unchanged. This may account for the small proportion of negative E-cadherin and junctional 
actin Z-scores obtained in this screen.  
Comparison of the composition of candidate proteins and total screen in terms of functional group 
revealed an enrichment of GAPs and GTPases amongst the candidates. The importance of GTPases in 
multiple processes based around the remodelling of the actin cytoskeleton is well established (Hall, 
2012; Watanabe et al., 2009). The enrichment of GAPs in our candidate proteins suggests this class 
of regulatory proteins play many varied roles in a large number of processes and are vital for the 
appropriate spatial and temporal regulation of GTPases (Bernards, 2003; Moon et al., 2003). This is 
substantiated by the occurrence of a varied cohort of candidate GAPs. However, there was no 
enrichment in GEFs in the screen, which is curious given the notion that the regulation of a GTPase in 
a particular process requires coordination between GEF and GAP (Rossman et al., 2005; Tcherkezian 
and Lamarche-Vane, 2007). 
Rho and Rac-specific GAPs were the most prevalent identified in the primary screen, even though 
both Rho and Rac are known to be necessary for cell-cell contact formation to occur (Braga et al., 
1997; Calautti et al., 2002; Ehrlich et al., 2002; Kovacs et al., 2002a; Yamada and Nelson, 2007). 
However, expression of constituitively active forms of both Rho and Rac can disrupt contacts (Braga 
et al., 1997; Chu et al., 2004; Jou and Nelson, 1998; Noren et al., 2003; Noren et al., 2001) indicating 
the importance of tightly regulating their activation. As such, it is not surprising that the loss of 
several Rho and Rac GAPs can disrupt AJ organisation.  
Conversely, Cdc42 is not activated upon cell-cell contact formation in keratinocytes (Erasmus et al., 
2010) (but is activated by cell-cell contact in other cell types (Chu et al., 2004; Kim et al., 2000b)). 
This implies that a Cdc42-specific GAP must be present at cell-cell contacts. However, no Rho GAPs 
specific for Cdc42 alone were identified in the primary screen, although several able to act on Cdc42 
in conjunction with another GTPase were present. As Rho GAPs can display cell-type specific 
activities it is possible that any of these identified Rac/Rho and Cdc42 GAPs act predominantly on 
Cdc42 in keratinocytes (this would have to be tested). GTPase activation occurs in precisely 
controlled zones during contact formation (Yamada and Nelson, 2007). Interestingly, the dual GEF 
and GAP ABR was a hit protein and can act simultaneously as a Cdc42 GAP and Rho GEF (Chuang et 
al., 1995; Vaughan et al., 2011). During wound healing ABR maintains the existence of localised 
zones of GTPase activity (Vaughan et al., 2011). Thus, this protein may perform a similar role in cell-
cell adhesion and inactivate Cdc42 whilst also promoting activation of Rho.  
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3.5.3. The validated hits 
The validation screen was conducted using four individual oligonucleotides targeting a total of 27 
Rho GAPs. A total of 20 candidate GAPs were validated as hits (74%). As proteins in the validation 
screen are selected based on the high likelihood (based on the primary screen) that they would 
perturb junction formation, this hit rate is expected.  
Since the completion of this screen several Rho GAPs have been implicated in the regulation of cell-
cell contact formation and maintenance (McCormack et al., 2013). Some of these GAPs were either 
not included in our screen (RICH1, PX-RICS, MyoIXB (Chandhoke and Mooseker, 2012; Nakamura et 
al., 2008; Wells et al., 2006)) or were lost in the primary screen as not enough replicates were 
gathered (MyoIXA, Oligophrenin-1, PI3KR1 (Elbediwy et al., 2012; Gurney et al., 2011; Omelchenko 
and Hall, 2012)). Whilst SH3BP1, which specifically regulates cell-cell contact formation in A431 and 
Caco-2 cells by spatially confining Cdc42 signalling yielded highly variable Z-scores in the validation 
screen making interpretation of its effects on junction formation in keratinocytes difficult (Elbediwy 
et al., 2012).   
Similarly, ARHGAP21 was classified as a candidate protein but not enough replicates were gathered 
in the validation screen, meaning the effect of depletion of this protein remains ambiguous. We may 
speculate that ARHGAP21 plays a role in stabilising cell-cell contacts as its depletion in Caco-2 and 
JEG-3 cells inhibits recruitment of α-catenin to cell-cell contacts (measured 72 hours after 
transfection in subconfluent cells) (Sousa et al., 2005). This is supported by the phenotype seen upon 
ARHGAP21 depletion in the primary screen (decrease in E-cadherin and junctional actin and an 
increase in cytoplasmic actin). In neither case are contacts prevented from forming, rather levels of 
junctional proteins are reduced, implying ARHGAP21 is not a critical for cell-cell contact formation to 
proceed, but may contribute to early stabilisation of junctional proteins. Indeed in Caco-2 cells E-
cadherin staining is not disrupted by loss of ARHGAP21, possibly by this point E-cadherin had been 
stabilised via additional mechanisms (Sousa et al., 2005). 
The related GAPs p190a and p190b have been implicated in cell-cell contact maintenance in several 
cell types and down regulate RhoA at AJs (Noren et al., 2003; Ratheesh et al., 2012; Wildenberg et 
al., 2006). Interestingly, depletion of either of these two GAPs did not produce a strong phenotype in 
keratinocytes in the primary screen, and were thus not forwarded to the validation. Assuming the 
depletion was efficient, this may reflect cell-type specific roles for these proteins. Indeed, p190a is 
necessary for cell-cell contact in NIH3T3 cells (Wildenberg et al., 2006), but in MCF-7 cells it is absent 
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from junctions, whilst p190b is prevented from localising at junctions by the centralsplindlin complex 
(Ratheesh et al., 2012). In MCF-7 cells the absence of Rac GTPase-activating protein 1 (RacGAP1) 
decreases levels of E-cadherin and active RhoA at the junctions, whilst p190b localisation at 
junctions is enhanced (Ratheesh et al., 2012). Thus, RacGAP1 plays a role in limiting the localisation 
of p190b to cell-cell contacts. Depletion of Rac GTPase-activating protein 1 (RacGAP1) (a component 
of the centralspindlin complex (Mishima et al., 2002)) decreased E-cadherin and junctional actin in 
the validation screen. As keratinocytes require active RhoA to form junctions (Braga et al., 1997; 
Calautti et al., 2002) they may employ a similar mechanism as MCF-7 cells and limit p190b 
localisation to the junctions in order to promote Rho activation. Depletion of RacGAP1 may reflect 
an increase in p190b at the junctions, and also explain why the depletion of p190b failed to induce 
any phenotype in keratinocytes (if normally this protein is inhibited). 
Other GAPs identified in the screen that have also been implicated in cell-cell contact regulation are 
the related proteins DLC1 and DLC3 (STARD8). Both are Rho-specific GAPs often found 
downregulated in different cancers and have been implicated in the positive regulation of cell-cell 
contacts (Holeiter et al., 2012; Tripathi et al., 2012; Tripathi et al., 2013). In the screen both DLC1 
and DLC3 depletion reduced the amount of junctional actin without affecting either E-cadherin or 
cytoplasmic actin. Possibly the depletion of these GAPs lead to a weakening of junctions associated 
with a migratory phenotype. 
Amongst the hit proteins were all members of the slit-robo GAPs (SRGAP1, SRGAP2, SRGAP3 and 
ARHGAP4). In c. elegans a single SRGAP homolog exists, SRGP-1, which regulates cell-cell contact 
stability via its F-BAR domain (Zaidel-Bar et al., 2010). F-BAR domains bind to and modulate 
membrane curvature, and SRGP-1 is required to increase dynamic membrane ruffling which 
promotes the establishment of cell-cell contacts during gastrulation (Zaidel-Bar et al., 2010). In the 
screen, the phenotypes seen upon depletion of each member of the SRGAP family were varied, 
possibly reflecting divergent roles for these proteins that have arisen in mammals (Table 3.2).   
3.6. Future work 
3.6.1. A bioinformatics survey of the hit proteins 
The screen has yielded a wealth of data regarding the effects of depletion of a range of GTPases, 
their regulators and their effectors on junction morphology. This data can be used to create protein-
protein interaction (PPI) networks of the candidate GAPs in order to identify novel pathways 
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regulating cell-cell contact formation, and identify underlying patterns associated with specific 
phenotypes (Wheeler et al manuscript in preparation)(Paris and Bazzoni, 2008). The analysis of large 
data sets to elucidate PPI networks facilitates the identification of novel participants in signalling 
pathways (Simpson et al., 2008; Winograd-Katz et al., 2009). Further analysis, including annotation 
of proteins with biological function and use of novel predictive tools then allows complex PPIs to be 
deconvoluted to identify, with a high degree of confidence, proteins involved in specific processes 
(Schaefer et al., 2013; Zhang et al., 2007). PPI analysis has been used successfully to uncover a range 
of candidate proteins involved in many diseases including atherosclerosis and cancer (Diez et al., 
2010; Hood et al., 2004).   
3.6.2. Re-testing the RNAi library under different conditions 
Although our screen identified numerous hit proteins, false negatives can arise if the half-life of the 
target gene is not compatible with the screening conditions. In this screen cells were fixed 72 hours 
post transfection. However, by this point levels of some proteins may already have recovered. 
Repeating the screen using shorter time points, such as 24 and 48 hours would be beneficial.  
Furthermore, the continual advances in automated image analysis mean that more sophisticated 
methods for the segmentation of E-cadherin have become available since the screen was analysed 
(Karakaya et al., 2012). Whilst these may still be too laborious to implement in a medium-
throughput screen, they could be used on a subset of hit proteins to verify the screen phenotypes. 
These may also allow more complex classification of hit proteins by grouping these into categories 
based on the morphological alterations their loss instigates (eg. wavy junctions).  
3.6.3. Validation of the hit proteins 
Although the screen identified several Rho GAPs with described functions regarding regulation of 
cell-cell junctions, the only way of truly validating the success of this method is to validate some of 
the hit proteins in keratinocytes. Initially siRNA must be optimised, as 72 hours will not yield optimal 
results for all proteins. Next, whether or not the screen phenotype can be recapitulated should be 
determined. 
Finally, the functions of hit proteins during cell-cell contact formation and maintenance will be 
addressed. This will include ascertaining which GTPase the hit protein acts upon by performing 
effector pull down assays in cells either depleted or overexpressing the hit protein. Additionally use 
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of unimolecular FRET probes of Rac, Rho or Cdc42 will facilitate spatiotemporal information 
regarding the target GTPase to be gathered during cell-cell contact formation (Itoh et al., 2002; 
Makrogianneli et al., 2009; Yoshizaki et al., 2003).  
Investigating potential interacting partners of the hit protein, which will be complemented by the 
bioinformatics networks generated, will offer clues as to the cellular processes affected by the hit 
protein.    
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Chapter 4.  
The characterisation of Rho GAPs regulating cell-cell 
contact formation and maintenance 
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4.1. Introduction 
Cell-cell contacts are governed by multiple GTPases whose actions must in turn be coordinated by a 
variety of regulators. As such, it is likely that multiple GAPs, with different specificities, are present at 
sites of contact in order to facilitate the inactivation of different GTPases.  
In the previous chapter I identified putative GAPs that regulate cell-cell contact formation via a 
siRNA screen. To decide on GAPs to further characterise several factors were considered including; i) 
that the GAP had not previously been identified as a regulator of cell-cell contacts, ii) some literature 
on the GAP was available iii) that evidence existed that the GAP may be present at the cell 
membrane iv) that some reagents were available (eg. effective antibodies) and v) that the GAP was 
expressed in keratinocytes. Based on this analysis, ARAP1 (CENTD2) was selected to further 
characterise. ARAP1 is a dual Arf and Rho-specific GAP also containing an ankyrin repeat, five PH 
domains, a SAM and a RA domain (Miura et al., 2002). ARAP1 can localise to the plasma membrane 
in several cell types (Guo et al., 2003; Simova et al., 2008; Yoon et al., 2008) where it is able to 
regulate the endocytosis of EGFR (Daniele et al., 2008; Yoon et al., 2008). EGF promotes the 
recruitment of ARAP1 to the cell periphery where it associates with EGFR in a Rab5-dependent 
manner. The depletion of ARAP1 via siRNA accelerates the association of EGF and EGFR with early 
endosomal markers and hastens the degradation of EGFR (Daniele et al., 2008; Yoon et al., 2008). 
The regulation of EGFR is particularly interesting as in the laboratory it has previously been 
demonstrated that Rac is activated by EGFR signalling downstream of cadherin adhesion (Betson et 
al., 2002). Furthermore, the ability of ARAP1 to regulate both Arf and Rho GTPases means it is well 
placed to coordinate crosstalk between multiple signalling pathways, making it an interesting 
candidate for study.  
The second GAP investigated in this chapter is ARHGAP6. ARHGAP6 is a RhoA-specific GAP 
associated with MLS (Prakash et al., 2000) and can regulate actin remodelling (Prakash et al., 2000) 
and PLCδ activity (Ochocka et al., 2008). ARHGAP6 orthologs are found in a range of species 
including D. melanogaster, C. elegans and Saccharomyces cerevisiae. To investigate a role for 
ARHGAP6 in cell-cell adhesion I have collaborated with the group of J-P Vincent (NIMR, London). 
The final protein examined in this chapter is CdGAP. CdGAP is a Rac and Cdc42 specific GAP known 
to regulate cell migration, spreading and invasion (He et al., 2011; Jenna et al., 2002; LaLonde et al., 
2006; Lamarche-Vane and Hall, 1998; Wormer et al., 2012). Mutations in the CdGAP gene were 
recently identified as being one cause of the developmental disorder Adams-Oliver Syndrome (AOS) 
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(Southgate et al., 2011). AOS is characterised by congenital absence of skin (often affecting the head 
this can vary from small hairless patches to complete loss of epidermis and underlying tissue of the 
skull) and transverse limb defects, typically affecting distal phalanges or entire digits but in extreme 
cases whole limbs can be missing (Whitley and Gorlin, 1991). A range of associated abnormalities 
have also been reported including cardiac and pulmonary complications (Snape et al., 2009). 
Mutations in the CdGAP gene were found to produce prematurely truncated proteins with enhanced 
activity for Cdc42 (Southgate et al., 2011). Although expressed at high levels in the developing heart, 
no cardiac defects were seen in subjects with the CdGAP mutations (Southgate et al., 2011) 
indicating that mutations in CdGAP do not account for the full range of AOS-associated 
abnormalities. Further, mutations in CdGAP were only found in a small proportion of subjects 
presenting with AOS. Subsequently, another Rac and Cdc42 regulator, DOCK6 (a Rho GEF), was also 
implicated in AOS. Mutations in two patients were found to result in DOCK6 truncation mutants 
lacking key catalytic domains, rendering this protein inactive (Shaheen et al., 2011). These findings 
demonstrate the importance of Rac and Cdc42 regulation in early organogenesis.  
CdGAP is also an example of a potentially oncogenic GAP as its expression can promote TGF-β-
mediated invasion in mammary explants expressing an activated ErbB2 receptor (He et al., 2011). 
Interestingly, the expression of CdGAP in these cells was found to correspond with a strong 
reduction in E-cadherin protein levels (He et al., 2011). These findings suggest that CdGAP promotes 
migration and invasion in response to TGF-β in epithelial breast cancer cells. CdGAP’s regulation of 
cell-matrix adhesions and potentially E-cadherin levels prompted us to investigate CdGAP function in 
keratinocytes at cell-cell contacts. 
4.2. Aims 
1. Validate the efficacy of the siRNA screen by investigating the function of a hit protein, ARAP1, 
in cell-cell contact formation 
  
2. Characterise the roles of the Rho GAPs ARHGAP6 and CdGAP in formation and maintenance of 
cell-cell adhesion.  
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4.3. Results 
4.3.1. ARAP1 is a positive regulator of cell-cell contact formation 
In the screen, the depletion of ARAP1 led to an increase in levels of E-cadherin and junctional actin 
and a decrease in cytoplasmic actin (Table 3.1). I sought to confirm the function of ARAP1 in cell-cell 
contact assembly. A pool of oligonucleotides targeting ARAP1 was used to determine the optimal 
time-point for the depletion of ARAP1 in keratinocytes to be 48 hours (Figure 4.1 A). Subsequently, 
this time point was used for further optimisation with individual oligonucleotides (Figure 4.1 B). 
ARAP1 was depleted from keratinocytes with about 50% efficiency. To measure the effect of ARAP1 
depletion on E-cadherin at cell-cell contacts, monolayers of cells maintained in low calcium medium 
were transfected with ARAP1 oligonucleotides 4 and 6 for 48 hours before junction formation was 
induced. Depletion of ARAP1 by both oligonucleotides considerably reduced the amount of E-
cadherin present at cell-cell contacts, as measured by a thresholding-based method (Figure 4.1 C). 
Unlike the screen phenotype, ARAP1 depletion decreased E-cadherin levels at junctions by between 
60 and 80% compared to controls transfected with non-targeting scrambled siRNA (Figure 4.1 C and 
D).   
As ARAP1 depletion reduced E-cadherin levels, I investigated if overexpression of ARAP1 could have 
the opposite effect and increase E-cadherin levels. Unfortunately, ARAP1 could not be efficiently 
expressed in cells maintained in low calcium, so expression of ARAP1 was investigated in cells with 
mature junctions. Neither expression of the wild-type protein or a PH-domain mutant that was 
unable to act as an Arf-GAP ((Campa et al., 2009) and personal communication) caused any changes 
to E-cadherin contacts in terms of the uniformity or the intensity of E-cadherin staining (based on a 
visual analysis) (Figure 4.2), indicating that ARAP1 may be a positive regulator for the earlier stages 
of contact stabilisation.  
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Figure 4.1 ARAP1 regulates cell-cell contact formation ARAP1 was depleted via RNAi using either a SMART 
pool™ consisting of four oligonucleotides (30nM) (A) or individual oligonucleotides 1-6 (20-50nM) (B).  Cells 
grown in low calcium medium were lysed after the indicated times for the pools and after 48 hours for the 
single oligonucleotides. ARAP1 and actin were detected in lysates via Western blot. Depletion efficiency was 
calculated relative to the amount of ARAP1 in cells treated with a control scrambled oligonucleotide. C) ARAP1 
was depleted using oligonucleotides 4 and 6 from cells grown in low calcium medium. Confluent monolayers 
were induced to form junctions for 30 minutes and fixed and stained for E-cadherin (Original). Images were 
processed for E-cadherin levels (Thresholded area). Scale bar = 50µm.  D) Quantification of E-cadherin levels 
following ARAP1 depletion. The mean percentage of thresholded area relative to control is shown. Standard 
error of the mean is shown. Statistical significance was assessed using one-way ANOVA with Bonferroni’s 
multiple comparison test. **, P ≤ 0.01; ***, P ≤ 0.001. Number of repeats (N) =3.  
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Figure 4.2 Exogenous expression of ARAP1 does not destabilise mature cadherin contacts myc-ARAP1 wild-
type or myc-ARAP1
K347A R348A
, a mutant deficient in PIP3 binding and so unable to act as an Arf-GAP, were 
expressed in keratinocytes with mature junctions for 8 hours. Cells were fixed and stained for E-cadherin, myc-
tagged exogenous protein and the cell nucleus with DAPI. Images were collected on a widefield microscope.  
Colour images from each channel were overlaid to create the merged image. The white box delineates zoomed 
area in adjacent image. Arrows indicate junctions with similar levels of E-cadherin as control surrounding, non-
expressing cells. Scale bars = 50µm. N=3 for wild-type and N=2 for ARAP1
K347A R348A
  
135 
 
4.3.2. ARHGAP6 expression disrupts mature cell-cell contacts 
ARHGAP6 was depleted as part of the primary siRNA screen and found to decrease E-cadherin and 
junctional actin whilst increasing cytoplasmic actin (Figure 4.3 A). However, no consistent effect was 
seen in the validation screen using individual oligonucleotides on the levels of E-cadherin or either 
population of actin (Figure 4.3 B and C). ARHGAP6 may have been a false positive in the primary 
screen. However, it is also possible that the depletion of ARHGAP6 obtained by the single 
oligonucleotides were either less effective (Parsons et al., 2009), or only one or two oligonucleotides 
were efficient in depleting ARHGAP6 and so their effect was masked by the other oligonucleotides. 
Therefore, the function of ARHGAP6 during early stages of contact formation needs to be further 
tested. 
Alternatively, ARHGAP6 is not required during the early stages of junction formation, but instead 
regulates their maintenance. ARHGAP6 was expressed in keratinocytes with mature junctions 
(Figure 4.4) and an unusual phenotype was observed. Several cells had extensive protrusions, which 
appear to grow above and below neighbouring cells. In addition, expressing cells in many cases lost 
E-cadherin from their junctions. This is in contrast to a control Rho-specific GAP that caused no such 
alterations in cellular morphology (Figure 4.4). To further characterise the nature of these 
phenotypes I looked into the expression of the Drosophila homolog of ARHGAP6 (collaboration with 
J-P Vincent, NIMR) 
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Figure 4.3 ARHGAP6 depletion does not affect cell-cell contact formation Depletion of ARHGAP6 with a pool 
of four oligonucleotides targeting separate regions of the ARHGAP6 transcript (A) or with individual 
oligonucleotides (set of representative images from oligonucleotide 3) (B) for 72 hours as part of a siRNA 
screen. Control images show wells of untransfected cells. Keratinocytes were grown in low calcium medium 
and confluent monolayers allowed to form junctions for 30 minutes prior to fixation and staining for E-
cadherin, F-actin (Original) and the nucleus with DAPI (image not shown). E-cadherin images were processed 
(described Figure 2.3) for E-cadherin present at the junctions (Thresholded area). Actin images were processed 
to isolate actin present at the junctions (Junc-A) or in the cytoplasm (Cyto-A). Scale bars represent 50μm. C) 
Table showing the Z-scores for a pool and each ARHGAP6 oligonucleotide for the parameters E-cadherin, 
junctional actin and cytoplasmic actin (control images Z=0). N=3    
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Figure 4.4 Expression of human ARHGAP6 perturbs mature cell-cell contacts Flag-ARHGAP6 or eGFP-ARAP1 
(as a control Rho-specific GAP) were expressed in keratinocytes with mature junctions for 8 hours. Cells were 
fixed and stained for E-cadherin, Flag-tagged exogenous protein and the cell nucleus with DAPI. Images were 
collected on a widefield microscope.  Colour images from each channel were overlaid to create the merged 
image. Filled arrows indicate junctions with uniform E-cadherin staining similar to E-cadherin in neighbouring, 
non-expressing control cells. Arrowheads show protrusions and open arrows show discontinuous junctions. 
Scale bar = 25µm. N=3  
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The Drosophila ARHGAP6 homolog is RhoGAP102a of which there exist three isoforms. Each of the 
isoforms is highly conserved, but only one, RD, retains the entirety of the Rho GAP domain (Figure 
4.5 A). The Rho GAP domain begins at amino acid 858 in all isoforms, but the last 10 amino acids of 
the GAP domain are missing from isoforms RC and RE. All isoforms then have a distinct N-terminal 
region. The expression of these isoforms in Drosophila wing indicates that the RD isoform is 
responsible for enhancing migration and apical extrusion (L A. Baena-Lopez and J-P. Vincent). 
Furthermore, the RD isoform also alters the localisation of RhoA and results in loss of E-cadherin at 
the tips of migrating cells (L A. Baena-Lopez and J-P. Vincent). The effects on E-cadherin being 
consistent with my findings following expression of human ARHGAP6, I tested the expression of the 
Drosophila isoforms in keratinocytes. The RE isoform was not expressed efficiently, but preliminary 
data suggests that expression of this isoform had no effect on keratinocytes (data not shown). 
Similar to the data gained from expression in Drosophila, expression of the RC isoform had little 
effect; junctions appeared largely normal (uniform E-cadherin staining) and were disrupted 
infrequently (Figure 4.5 B). However, the RD isoform resulted in about 60% of junctions being 
disrupted in expressing cells (compared to 20% with the RC) (Figure 4.5 C). Qualitatively it appeared 
that junction disruption seen in the RD expressing cells was quite distinct to that seen upon 
expression of the RC isoform. Disrupted junctions were classified as being either discontinuous, 
wavy, or with protrusions (thin, finger-like protrusions extended from the expressing cell). Upon 
expression of the RD isoform disrupted junctions often had protrusions, whereas this was very 
uncommon in the RC expressing cells (Figure 4.5 D). Thus, a complete Rho GAP domain is necessary 
to induce the distinct morphological changes associated with ARHGAP6 expression. 
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Figure 4.5 The complete Rho GAP domain is required for the Drosophila ARHGAP6 homolog to disrupt cell-
cell contacts A) A Clustal W alignment was generated of the two isoforms, (RC and RD), of the Drosophila 
ARHGAP6 homolog, RhoGAP102a.  Amino acid numbers are displayed on the far right hand side. The predicted 
GAP domain is highlighted in bold with the last amino acids of the GAP domain (only present in the RD 
isoform) coloured red. Asterisks (*) represent conserved residues. B) V5-tagged RhoGAP102a isoforms RC or 
RD were expressed in keratinocytes with mature junctions for 8 hours. A V5 empty vector control should have 
been expressed simultaneously but this contruct was not available at this time, thus no negative control was 
performed. Expressing cells were only considered if non-expressing neighbours appeared normal. Cells were 
fixed and stained for E-cadherin and V5-tagged exogenous protein. Colour images from each channel were 
overlaid to create the merged image. Arrows indicate junctions with uniform E-cadherin staining. Arrowheads 
indicate protrusions and open arrows indicate discontinuous junctions. Scale bar = 25µm C) The number of 
junctions disrupted in cells expressing the RC and RD isoforms was quantified and the mean per experiment 
expressed as a percentage. The line represents the mean. Standard error of the mean is shown. Statistical 
significance was assessed using the Student’s T-test. **,  P ≤ 0.001.  D) The disruption induced upon expression 
of the RC and RD isoforms was scored qualitatively according to morphology (panel C) as either ‘with 
protrusions’, ‘wavy’ or ‘discontinuous’. The percentage of disrupted junctions displaying each of these 
morphologies is shown. N=3 for expression of the RD isoform and N=5 for expression of the RC isoform.  
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4.3.3. CdGAP regulates AJ maintenance, not formation 
CdGAP is a Rac and Cdc42 specific GAP known to regulate cell-matrix adhesion and cell migration 
(LaLonde et al., 2006; Lamarche-Vane and Hall, 1998; Wormer et al., 2012). I sought to determine if 
CdGAP was a regulator of AJ formation or maintenance. Depletion of CdGAP via siRNA did not affect 
the total levels of proteins from the junctional complex or the GTPases Rac1, RhoA or Cdc42 (Figure 
4.6 A). However, although total cellular levels are unaffected, CdGAP depletion may potentially alter 
E-cadherin localisation at specific cellular compartments. To address this, CdGAP was depleted in 
cells maintained in low calcium where cadherins were not engaged in adhesion and junction 
formation induced for 30 minutes. I then measured the levels of E-cadherin at the membrane using a 
thresholding-based method (Figure 4.6 B and C). All data was normalised to the scrambled 
oligonucleotide control, which was set arbitrarily at 1. Depletion of CdGAP by two separate 
oligonucleotides resulted in a slight, but not significant, reduction in E-cadherin levels (0.89 and 0.91 
respectively). This indicates that CdGAP does not play a major role in the regulation of junction 
formation in keratinocytes. 
To test if CdGAP could instead regulate the maintenance of cell-cell junctions, I performed 
aggregation assays (Thoreson and Reynolds, 2002) (Figure 4.7 A). Cells are dissociated into a single 
cell suspension and allowed to form aggregates over two hours. Aggregates are then disrupted 
mechanically a fixed number of times and the size of the resulting disaggregates measured. The 
suspension of the aggregates removes any influence of cell-matrix adhesive structures and allows for 
the measurement of cell-cell contact formation (mediated by AJs or desmosomes) (ability of the cells 
to aggregate) and for the measurement of the ability of the cells to withstand the mechanical 
disruption. The depletion of CdGAP (Figure 4.7 B) had no effect on the ability of the cells to form 
aggregates after two hours (Figure 4.7 C). However, when disaggregates were measured, depletion 
of CdGAP resulted in larger sized disaggregates when compared to cells transfected with scrambled 
oligonucleotides (Figure 4.7 D). This finding was significant for one of the oligonucleotides tested. 
Whilst the other did not show a significant increase, the efficiency of this knockdown was 
comparatively lower. Thus, the depletion of CdGAP strengthens preformed cell-cell contacts and has 
no effect on the ability of cells to form junctions. 
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Figure 4.6 CdGAP does not regulate cell-cell contact formation A) Keratinocytes were depleted of CdGAP 
using two specific oligonucleotides for 48 hours. Cells grown in low calcium medium were lysed and the lysate 
probed for proteins shown on the right hand side of the panels (molecular weight markers are shown on the 
left) via Western blot analysis. B) E-cadherin levels at junctions in cells depleted of CdGAP. Confluent 
monolayers were induced to form junctions for 30 minutes and fixed and stained for E-cadherin (Original). 
Images were collected from a widefield microscope and processed for E-cadherin levels at the junction 
(Thresholded area). Scale bar = 25µm. C) The mean percentage of thresholded area E-cadherin for each 
condition was quantified relative to the control non-targeting oligonucleotide. CdGAP levels analysed by 
Western blot to confirm depletion (D). Standard error of the mean is shown. Statistical significance was 
assessed using one-way ANOVA with Bonferroni’s multiple comparison test. ns= Not significant, N=3   
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Figure 4.7 CdGAP regulates AJ maintenance CdGAP was depleted using two specific oligonucleotides and 
aggregation assays performed. A) Confluent monolayers of keratinocytes maintained in low calcium medium 
were depleted of CdGAP for 48 hours. Cells were detached from tissue culture dishes, dissociated into a single 
cell suspension and cell suspensions placed into at least six hanging drops in a humid chamber per condition 
(0hr). Cells were allowed to aggregate for 2 hours in the presence of calcium ions (2hr), dissociated by 
pipetting and all the resulting disaggregates imaged (dissociation). Images shown are representative of three 
independent experiments. Scale bar = 100µm. B) The depletion of CdGAP was verified by Western blot for 
every aggregation assay. Actin is used as a loading control. C, D) The area of aggregates formed after two hours 
(2hr) and disaggregates (dissociation) were measured using ImageJ (Nola et al., 2012). C) Average size of 
aggregates was expressed relative to control samples. D) The area of all disaggregates (dissociation) was 
corrected for the size of the initial aggregate (2hr). The average corrected size of disaggregates was expressed 
relative to control samples (Scr., set as 1). Standard error is shown. Statistical significance was assessed using 
one-way ANOVA with Bonferroni’s multiple comparison test. ns= not significant, *,  P ≤ 0.05. N=3   
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4.3.4. CdGAP expression disrupts E-cadherin contacts in a GAP-dependent manner 
Thus, the above result suggests that CdGAP could be a negative regulator of mature junctions. If this 
is the case, we would expect that expression of CdGAP in keratinocytes may reduce the amount of E-
cadherin at mature junctions, or destabilise the junctions in some way. Two CdGAP isoforms exist. 
CdGAP-l is the longest at 1425 amino acids whilst CdGAP-s is 820 amino acids long (Figure 4.8 A). I 
microinjected the longest isoform of CdGAP, CdGAP-l, into keratinocytes for different amounts of 
time and then stained cells for E-cadherin and CdGAP-l (Figure 4.8 B). I observed that non-expressing 
cells maintained continuous E-cadherin along the length of their junctions, while, in contrast, 
junctions in CdGAP-l-expressing cells lost E-cadherin staining from the corners between 
neighbouring cells after 4 hours. This effect was similar between two expressing cells, but also 
between expressing and non-expressing cells. Preliminary data (N=1) suggests that this effect was 
more evident after longer times of expression, as 24 hours post injection CdGAP-expressing cells 
developed much larger holes between cells (Figure 4.8 B). 
To compare the destabilising effect of different isoforms of CdGAP (Figure 4.8 A) I transfected 
CdGAP-l, the shorter CdGAP isoform, CdGAP-s, and the C-terminal fragment, CdGAP1160-1425 into 
keratinocytes with mature junctions and allowed them to express for 8 hours (Figure 4.8 C). Both 
CdGAP-l and CdGAP-s produced striking phenotypes; cells appeared with large gaps at junctions 
between both two expressing cells as well as between expressing cells and their non-expressing 
neighbours. Expression of the C-terminal alone, which harbours no recognised structural domain, 
had no effect on morphology. Qualitatively, the CdGAP-s isoform appeared to be more effective at 
disrupting junctions.  
Both CdGAP-l and CdGAP-s are Rac and Cdc42 GAPs, but CdGAP-s is predicted to be more active 
(Lamarche-Vane and Hall, 1998; Southgate et al., 2011; Tcherkezian et al., 2006). I hypothesised that 
junction disruption could be a GAP-dependent process, as this would explain the apparent higher 
level of disruption seen with CdGAP-s and why the C-terminal construct failed to disrupt junctions. 
GFP-tagged CdGAP-l wild-type and GAP-dead (LaLonde et al., 2006) were transfected into 
keratinocytes with mature junctions and E-cadherin stained for (Figure 4.9 A). CdGAP-l expression 
resulted in junction disruption as before, but expression of the GAP-dead construct appeared to 
have little effect on cells and E-cadherin distribution and levels appeared normal.  
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Figure 4.8 CdGAP expression disrupts mature junctions A) cDNA constructs used in this study. All constructs 
used have either a myc or GFP tag (not shown). The GAP domain is coloured light yellow, proline rich regions 
are represented as blue boxes. The GAP-dead construct has two mutations in the GAP domain, the catalytic 
arginine (R56A) and asparagine (N163V) that mean that this protein cannot catalyse the hydrolysis of GTP. 
Mutations are represented by a star. Amino acid numbers are listed below the protein. B, C). Keratinocytes 
maintained in standard calcium medium were microinjected with myc-CdGAP-l and allowed to express the 
exogenous protein for the indicated amounts of time (B) or transfected with myc-CdGAP-l, myc-CdGAP-s or 
myc-CdGAP1160-1425 constructs as indicated for 8 hours (C). Cells were fixed and stained for E-cadherin (Cy5, 
purple) and myc-tagged exogenous protein (Cy2, green) and images collected with a widefield microscope. 
Colour images from each channel were overlaid to create the merged image. Arrows show junctions with 
continuous E-cadherin staining, arrowheads show junctions with interrupted E-cadherin staining. Scale bars = 
50µm. N=1 for microinjection with expression for 24 hours, N=2 for microinjection with 4 hours expression, 
N=3 for transfections.   
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Figure 4.9 CdGAP-mediated junction disruption is dependent on the GAP domain GFP-CdGAP-l wild-type or a 
GAP-dead CdGAP-l (containing mutations in the GAP domain rendering it inactive) were expressed in 
keratinocytes with mature junctions. Cells were fixed after 8 hours and stained for E-cadherin. Images were 
collected from a widefield microscope and colour images from each channel overlaid to create the merged 
image. Arrows show junctions with continuous E-cadherin staining, arrowheads show junctions with 
interrupted E-cadherin staining. Scale bar = 50µm. B) The amount of E-cadherin covering junctions in CdGAP-
expressing cells was quantified by measuring the total length in pixels of a junction (measured corner-corner) 
(solid line) and taking a second measurement over this area that is covered by E-cadherin (dashed line). ‘E-
cadherin coverage’ was then calculated as E-cadherin (dashed line) divided by total junction length (solid line). 
C) E-cadherin coverage at junctions from CdGAP wild-type (blue) and GAP-dead (cream)-expressing cells was 
plotted on histograms (representative histogram from one experiment shown). D) The average E-cadherin 
coverage at junctions in CdGAP wild-type and GAP-dead-expressing cells. Standard error is shown. Statistical 
significance was assessed using Student’s T-test. *, P ≤ 0.05. N=3  
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The amount of E-cadherin present at junctions of CdGAP-expressing cells was quantified by 
measuring the total length of the junction and then the percentage of this area covered by E-
cadherin staining (E-cadherin coverage) (Figure 4.9 B). These results were plotted on histograms for 
each experiment to compare the spread of the data between the conditions (Figure 4.9 C). The 
mean percentage E-cadherin coverage for junctions from CdGAP-l and CdGAP GAP-dead-expressing 
cells was also plotted (Figure 4.9 D). Overall, expression of wild-type CdGAP-l resulted in more 
junctions with a lower percentage coverage of E-cadherin (average covering 59%), whereas the 
junctions from GAP-dead CdGAP-l expressing cells were almost completely covered with E-cadherin 
(89%). Thus, junction disruption induced by CdGAP expression requires a functional GAP domain.  
4.3.5. CdGAP is a Rac and Cdc42 GAP in keratinocytes and may regulate Rac at the 
membrane 
CdGAP is a GAP for both Rac and Cdc42 in vitro and in vivo (Aoki et al., 2004; Lamarche-Vane and 
Hall, 1998). However, GAP activity will depend on cell type, pathway in which the GAP is activated 
and the cellular process regulated. Thus, it is necessary to test CdGAP GAP activity in keratinocytes. 
Effector pull-down assays in cells transfected with CdGAP-l and CdGAP-l GAP-dead were performed 
to assess global levels of active Rac and Cdc42 (Figure 4.10 A and B). Using an empty GFP-vector as a 
control I found CdGAP-l was able to inactivate both Rac and Cdc42 in keratinocytes, as expression of 
the wild-type construct reduced total levels of both of these GTPases (Figure 4.10 A and B). CdGAP 
significantly reduced the amount of active Rac. However, although levels of active Cdc42 were 
reduced, this was not significant, likely due to the degree of variability of this data set. The GAP-dead 
construct had no effect on the levels of active Rac, but inconclusive effects on active Cdc42. 
Therefore the phenotype seen following expression of CdGAP could be down to misregulation of 
either Rac or Cdc42 or both. 
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Figure 4.10 CdGAP is a Rac and Cdc42-specific GAP in keratinocytes Keratinocytes were transfected with 
CdGAP-l wild-type, CdGAP GAP-dead or an empty GFP vector for 24 hours. Cells were lysed and lysates 
incubated with GST-PAK-CRIB immobilised on glutathione sepharose beads for one hour. Western blot analysis 
was used to detect active, GTP-bound Rac (A) or Cdc42 (B) bound to beads (active), total Rac or Cdc42 (2% 
total lysate volume)(total), GFP-tagged CdGAP and β-tubulin. Fold activation of Rac (C) and Cdc42 (D) in the 
presence of the CdGAP constructs was quantified by dividing the active GTPase by the total GTPase and 
normalising this value to the GFP-vector control. Statistical significance was assessed using one-way ANOVA 
with Bonferroni’s multiple comparison test. Ns= Not significant. *, P ≤ 0.05, **, P ≤ 0.01, N=3          
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Whilst effector pull-down assays are useful to assess the ability of a protein to regulate a particular 
GTPase in vivo, no information about the local regulation of GTPase is attained. I optimised the 
expression of a unimolecular probe in keratinocytes that allowed for the measure of localised 
activation of Rac through FRET (Makrogianneli et al., 2009). This probe contains the CRIB domain of 
PAK1 together with Rac1 and is fused to GFP at the C-terminal and RFP at the N-terminal. We took 
advantage of FLIM to measure the change in the lifetime of this probe in the presence of CdGAP 
(Figure 4.11) (this work was done in collaboration with Doug Kelly and Sunil Kumar, Imperial College 
London). In FLIM, only the lifetime of the donor probe (GFP) is measured, which means there is no 
issue with spectral bleed-through, fluorophore concentration, or photobleaching. In its inactive state 
Rac remains unbound to PAK and there is no FRET between GFP and RFP. Consequently, the lifetime 
of the GFP signal is longer. Upon Rac activation Rac1 binds PAK, bringing the GFP and RFP-tagged 
terminals of the probe into close proximity and facilitating FRET. This can be detected as a reduction 
in the lifetime of GFP, as energy is transferred to the close-by RFP.  
The expression of myc-tagged CdGAP-l and the Raichu probe was optimised on 96-well plates. Cells 
expressing both the Raichu probe and CdGAP-l (or vector control) were then manually segmented 
(Figure 4.11 A) and FLIM calculated in the whole cell or exclusively at the membranes (Figure 4.11 B 
and C) (lifetime measurements were computed by D. Kelly). The expression of CdGAP resulted in an 
overall increase in the lifetime of GFP, reflecting a decrease in active Rac both in whole cells and 
specifically at the membrane (Figure 4.11 B and C). This data corroborates biochemical data 
gathered from PAK-CRIB pull-downs that also show a global decrease in Rac activity in CdGAP-
expressing cells. However, it also demonstrates that CdGAP expression causes perturbation in Rac 
activation at the membrane, strengthening the hypothesis that CdGAP-induced junction disruption is 
Rac-dependent. 
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Figure 4.11 CdGAP expression inactivates Rac specifically at the membrane A) Myc- CdGAP-l or empty vector 
containing a myc tag were expressed in keratinocytes together with a dual mRFP-PAK-Rac1-GFP probe for 24 
hours. Cells were fixed and stained for exogenous myc-tagged protein with a Cy5-tagged secondary antibody. 
Cells were imaged for Cy5 and GFP. Fluorescence lifetime of GFP was measured and lifetime data analysed 
using in-house software ‘FLIMFit’ (Lifetime analysis performed by D. Kelly, Imperial College London). Cells were 
segmented manually using a custom-designed program (CellSegmenter) based on the GFP channel. The 
membrane was then defined based on this outline. Fluorescence lifetimes of GFP are shown in false colours; 
red represents low lifetime indicating active Rac and blue represents high lifetime indicating inactive Rac. Scale 
bar represents 50µm. FLIM was calculated at segmented membranes (B) and in the whole of the cell (C). 
Standard error of the mean is shown. Significance was assessed using Student’s T-test. ***, P ≤ 0.001. N=16 for 
CdGAP-expressing cells and N=11 for Vector-expressing cells in one experiment.   
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4.4. Conclusions 
In this chapter, I investigated the roles of different Rho GAPs in the related processes of cell-cell 
contact formation and junction maintenance. I have identified three different GAPs responsible for 
regulating the maintenance of cell-cell contacts in keratinocytes. 
ARAP1 is the only positive regulator I have identified, seemingly acting at the very early stages of 
contact stabilisation. I have shown that its depletion reduces levels of E-cadherin at newly formed 
cell-cell junctions. How ARAP1 is mediating this effect is unclear, but may depend on its regulation of 
Rho or Arf GTPases.  
In contrast, the Rho GAP ARHGAP6 is a negative regulator of junction maintenance. Depletion of 
ARHGAP6 had no effect on E-cadherin or F-actin during cell-cell contact formation (siRNA screen 
data). However, the expression of human ARHGAP6 as well as the Drosophila homolog RhoGAP102a 
containing the full GAP domain, had profound effects on cellular morphology, causing cells to 
generate long protrusions. The purpose of these structures is not yet clear, but evidence from 
Drosophila suggests they may be required for migration.  
Finally, I have shown that CdGAP is a regulator of cell-cell contact maintenance, and not assembly. I 
have shown that CdGAP expression specifically removes E-cadherin from the junctions and leads to 
significant morphological changes in expressing cells, most likely associated with actin remodelling. 
Conversely, the depletion of CdGAP strengthens junctions, allowing them to more readily withstand 
mechanical disruption. I have also shown that CdGAP-induced junction disruption is mediated via its 
GAP domain, and expression perturbs Cdc42 and Rac signalling both globally and (in the case of Rac) 
locally at the cell membrane. CdGAP has previously been implicated in the development of the 
ectoderm and limb bud and my findings compliment earlier studies on the function of CdGAP, 
suggesting that regulation of cell-cell, as well as cell-matrix adhesions could be important for 
development and may be hijacked in the case of epithelial cancers.  
Overall, I have identified three different Rho GAPs that all regulate the maintenance of cell-cell 
contacts. Interestingly, these all appear to operate at different times and use different mechanisms 
to exert their effects on junctions. Whether or not any of these proteins can work together or not to 
regulate the stabilisation of cell-cell contacts remains to be seen. But, it is interesting to speculate 
that the activity of ARAP1 could be balanced by CdGAP or ARHGAP6 in order to sustain a highly 
dynamic adhesive system, able to rapidly respond to external cues. Each of these GAPs harbours 
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structurally diverse domains, important for mediating protein-protein or protein-lipid interactions 
and allowing them to interact with a unique subset of proteins. Indeed, the fact that two Rho-
specific GAPs, ARAP1 and ARHGAP6 can have such diverse effects on cellular architecture illustrates 
that Rho GAPs are not simply required to inactivate GTPases, but also provide a vital scaffold for the 
direction of specific cellular processes. Together, this data highlights the vastly complex systems 
underlying cell-cell contact homeostasis that exist. 
4.5. Discussion 
4.5.1. ARAP1 as a positive regulator of the early stages of cell-cell contact stabilisation  
The depletion of ARAP1 in keratinocytes results in a significant decrease in the amount of E-cadherin 
present at cell-cell contacts following a 30 minute calcium switch (Figure 4.1 D). This is in contrast to 
the phenotype seen in the siRNA screen, in which ARAP1 depletion increased the amount of E-
cadherin at the membrane. This finding was unexpected but may be due to off target effects of the 
original oligonucleotides. Indeed, three of the four original oligonucleotides were not effective in 
consistently depleting ARAP1 levels (Figure 4.1 B). 
The depletion of ARAP1 does not prevent the formation of cell-cell contacts; rather, E-cadherin 
levels at the junctions are significantly reduced compared to control cells. Potentially ARAP1 is 
required to regulate early stabilising processes, such as contact expansion, the recruitment of 
cadherin, or actin polymerisation. As a RhoA, Arf1 and Arf5 GAP (Miura et al., 2002), ARAP1 may be 
required to influence the activity of any of these GTPases during such stabilisation processes.  
We know that Rho activity is necessary for junction formation to occur in keratinocytes; inhibition of 
RhoA, B or C via treatment with C3 transferase inhibits formation (Braga et al., 1997). Furthermore, 
in MDCK cells Rho seems to be required to drive actomyosin contractility via ROCK during cell-cell 
contact formation, which promotes contact expansion (Yamada and Nelson, 2007). However, Rho 
activity is carefully localised during this process as MDCK cells exhibit high RhoA activity at the edges 
of contacts but low RhoA activity at the actual sites of cell-cell contact (Yamada and Nelson, 2007). 
Moreover, Rho activity can also drive contact disassembly through ROCK in HTC116 epithelial 
tumour cells with mature junctions (Sahai and Marshall, 2002b). Thus Rho activity must be spatially 
constrained in order for junction formation to proceed. 
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Indeed the depletion of another Rho-specific GAP, Myo9A, inhibits contact expansion in bronchial 
epithelial cells (Omelchenko and Hall, 2012). In this case, initial contacts can form, but these are 
never stabilised and eventually disperse. Although this phenotype is partially attributed to Myo9A’s 
myosin-binding head domain, FRET analysis confirms that Myo9A depletion specifically increases 
Rho activation at sites of contact (Omelchenko and Hall, 2012). Furthermore, treatment of Myo9A-
depleted cells with Y-27632 to inhibit ROCK partially rescues the defective contact expansion 
phenotype, and cells are able to maintain some contact, no longer pulling away from one another 
(Omelchenko and Hall, 2012). 
Data from the lab has previously shown that EGFR contributes to activate Rac downstream of 
cadherin adhesion (Betson et al., 2002). Although Rac activation is reduced when EGFR is inhibited, 
junctions can still form. ARAP1 siRNA hastens the degradation of EGFR via interaction with Cbl-
interacting protein of 85 kDa (Yoon et al., 2011; Yoon et al., 2008). As such, the depletion of ARAP1 
may indirectly result in a reduction in Rac activation downstream of cadherin adhesion. As Rac 
activation is required for cadherin recruitment and stabilisation at contacts this may explain the 
reduction in E-cadherin we see, as without full activation of Rac, E-cadherin is not stabilised at the 
membrane.   
Alternatively, ARAP1 may regulate contact stabilisation via its regulation of Arf1 or Arf5. The 
reduction of E-cadherin at the junctions seen upon ARAP1 depletion may reflect a net reduction in 
the amount of cadherin delivered to, or an increase in the internalisation of cadherin from the 
plasma membrane, processes regulated by Arf GTPases. Interestingly, depletion of the Drosophila 
homolog of Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (GBF1), an 
Arf1 GEF, inhibits transport of DE-cadherin to the plasma membrane in Drosophila salivary gland 
(Szul et al., 2011). This finding indicates disruption of Arf1 activity can perturb cadherin-mediated 
adhesion. The presence of Arf1-specific GAPs is vital in regulating trafficking, as without GTP 
hydrolysis of Arf1, cargo packaging and coat disassembly are perturbed (Lanoix et al., 1999). Indeed, 
both the depletion and overexpression of Arf1-GAP ASAP1 reduces the localisation of the cell-matrix 
adhesion protein paxillin to focal adhesions (Liu et al., 2002; Liu et al., 2005). Thus any disruption in 
dynamic Arf1 cycling can impact upon cell-matrix adhesive structures. Though less well studied, Arf5 
can also regulate adhesive complexes as depletion inhibits internalisation of β1-integrin in HeLa 
cells, leading to increased cell attachment and spreading on fibronectin (Moravec et al., 2012). 
Potentially similar mechanisms may be deployed by ARAP1 to regulate E-cadherin at cell-cell 
adhesions in keratinocytes.  
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4.5.2. ARHGAP6 negatively regulates cell-cell adhesion  
Expression of both human and the longest Drosophila isoform of ARHGAP6 in keratinocytes disrupt 
mature E-cadherin contacts and induce the formation of protrusions (Figures 4.4 and 4.5). This is in 
agreement with data gathered from expression of ARHGAP6 and RhoGAP102a in Drosophila wing, 
which leads to alterations in cellular morphology, enhanced migration and disrupted Rho signalling 
(A. Baena-Lopez and J-P. Vincent). 
Previous studies of ARHGAP6 have identified GAP-independent functions for this protein, including 
regulation of actin polymerisation (Prakash et al., 2000), PLCδ activation (Ochocka et al., 2008) and 
modulation of human ether-a-go-go gene (a potassium channel) current (Potet et al., 2009). 
Furthermore, part of the ARHGAP6 gene is deleted in patients with MLS (Schaefer et al., 1997). 
However, mice with deletion of the Rho GAP domain displayed normal phenotypes, suggesting 
ARHGAP6 GAP activity does not contribute to the MLS phenotype (Prakash et al., 2000).  Thus, the 
role of the Rho GAP domain of ARHGAP6 in vivo is not clear.  
Interestingly, the complete GAP domain is required for the formation of protrusions in keratinocytes 
and to enhance migration in Drosophila wing. The expression of human ARHGAP6 and the 
Drosophila RD isoform in keratinocytes induced the formation of protrusions; potentially these 
lamellipodial-like structures represent a necessary step in migration. Indeed a mesenchymal mode of 
migration is associated with upregulation of Rac and inhibition of Rho in melanoma cells (Sanz-
Moreno et al., 2008) and expression of the RD isoform causes mislocalisation of active Rho in 
Drosophila wing. The finding that both human and Drosophila forms of the protein behave similarly 
in both keratinocytes (Figure 4.4 and 4.5) and Drosophila tissues (A. Baena-Lopez and J-P. Vincent) 
suggests an important evolutionarily conserved function.  
4.5.3. CdGAP can act as a positive regulator of epithelial-to-mesenchymal transition 
(potentially in a developmental process)? 
The expression of CdGAP in keratinocytes induces the loss of E-cadherin contacts and potentially 
extrusion from the monolayer without seeming to induce apoptosis (nuclear staining shows no 
abnormalities). This is accompanied by significant morphological changes, most likely a result of 
actin remodelling, that leads to the expressing cell appearing to retract from its neighbours. 
Potentially this could represent an early stage in epithelial-to-mesenchymal transition, as cells 
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expressing CdGAP are reminiscent of epithelial monolayers stimulated to scatter with HGF (de Rooij 
et al., 2005).  
Epithelial-to-mesenchymal transition requires close coordination between cell-cell and cell-matrix 
adhesions and CdGAP has previously been implicated in regulating cell-matrix adhesions (LaLonde et 
al., 2006; Wormer et al., 2012). However, my data suggests a specific role for CdGAP at AJs because 
1) depletion of CdGAP results in strengthening of cell-cell adhesion in aggregation assays (although 
an effect on desmosomes here cannot be excluded) (Figure 4.7), and 2) expression of CdGAP results 
in the rapid loss of E-cadherin from cell-cell contacts (Figure 4.8). I propose that the expression of 
CdGAP can promote loss of cell-cell adhesion and potentially lead to migration, whilst 
downregulation of CdGAP strengthens contacts.  
Following loss of cell-cell contacts cells undergoing epithelial-to-mesenchymal transition are 
stimulated to migrate to distant sites. Interestingly, CdGAP has previously been linked to migration, 
but seems to have cell-type specific roles in this process (Southgate et al., 2011; Wormer et al., 
2012). For example, in U2OS cells CdGAP  depletion promotes migration in wound healing assays 
(Wormer et al., 2012), but in primary dermal fibroblasts expression of a truncated form of CdGAP 
enhances speed of migration in  wound healing assays. The morphological changes I see upon CdGAP 
expression include retraction from neighbouring cells and preliminary data (not shown) suggests 
changes in actin reorganisation. These may reflect a switch to a more migratory phenotype, as the 
generation of actin-based structures such as lamellipodia and filopodia can be vital in promoting 
migration in some cell types.  
The ability of CdGAP to regulate both cell-cell adhesion and migration may contribute to phenotypes 
observed in other CdGAP-regulated processes such as in development, cell scattering and metastasis 
(He et al., 2011; Southgate et al., 2011; Togawa et al., 2010). Mutations in CdGAP identified as a 
causative factor in the developmental disorder AOS indicate that CdGAP is an important regulator of 
the development of the ectoderm and limb buds (Southgate et al., 2011). Studies using conditional 
knock-outs have revealed Rac1 and Cdc42 to play an important role in the normal development of 
the limb bud and in interdigital programmed cell death (Aizawa et al., 2012; Suzuki et al., 2009; Wu 
et al., 2008). Interestingly, truncating mutants (1-683 and 1-1087) of CdGAP causing AOS have 
enhanced activity on Cdc42 (although Rac was not tested) compared to the wild-type protein. 
Furthermore, one mutant (1-683) migrates more quickly than wild-type controls, suggesting that the 
AOS phenotype can be caused by disrupted Cdc42 (or Rac) cycling. However, CdGAP expression, as 
well as regulating migration, may be required for the disassembly of E-cadherin cell-cell contacts 
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prior to migration. This is supported by the fact that expression of either CdGAP-l or CdGAP-s (which 
should behave in a similar way to the truncating mutants) results in the dismantling of E-cadherin 
mediated contacts in keratinocytes. Furthermore, CdGAP-l expression in keratinocytes is 
accompanied by a global and membrane-specific decrease in the levels of active Rac, indicating that 
Rac inactivation may be necessary for cell-cell contact disassembly to occur. Possibly, CdGAP 
regulates the development of the ectoderm and limb buds by regulating both cell-cell contact 
disassembly and migration via regulation of Rac/Cdc42. Its early expression may be required to 
confine Rac/Cdc42 signalling necessary for the development of the growing limb. However, the 
constituitive activation or overexpression of CdGAP leads to unregulated Rac/Cdc42 signalling and 
disrupts this finely balanced process. 
CdGAP regulates several processes where coordination between cell-cell and cell-matrix adhesions is 
vital. CdGAP function on cell-cell contacts may be either cell-type specific, or regulated by stimulus. 
That a particular feature in AOS patients is loss of patches of skin, particularly the scalp, and my data 
from keratinocytes shows CdGAP-induced disassembly of contacts suggests that at least in skin cells 
hyperactivation of CdGAP is likely to have a negative effect on cell-cell adhesion. However, CdGAP 
can inhibit HGF-induced cell scattering in MDCK cells by inactivating Cdc42. Stimulation of cells with 
HGF results in inactivation of CdGAP via phosphorylation on Threonine 776 by ERK, causing cell-cell 
contacts to be dismantled and cells to scatter (Tcherkezian et al., 2005; Togawa et al., 2010). 
An early stage in metastasis involves the downregulation of E-cadherin (Berx and van Roy, 2009). As 
the expression of CdGAP provokes loss of E-cadherin from contacts without apparent induction of 
apoptosis, this may reflect a role for CdGAP in cancer progression. Whilst several examples exist of 
Rho GAPs acting as tumour suppressors, there are very few examples of Rho GAPs upregulated in 
tumours (Johnstone et al., 2004; Lahoz and Hall, 2012; Liao and Lo, 2008; Wang et al., 1997; Yuan et 
al., 1995). However, CdGAP is required for TGF-β-induced migration and invasion in mammary 
tumour explants expressing an activated form of ErbB-2 receptor (although in these cells the GAP 
domain of CdGAP is not required) revealing that Rho GAPs can also act as positive regulators of 
cancer cell migration and invasion (He et al., 2011). Intriguingly, the depletion of CdGAP in these 
cells leads to an increase in E-cadherin levels, indicating that CdGAP could regulate E-cadherin levels. 
My data is supportive of this link as expression of CdGAP in keratinocytes reduces E-cadherin at 
junctions. However, CdGAP-mediated junction disruption in keratinocytes does require the GAP 
domain, suggesting that, at least in keratinocytes, CdGAP expression could act as a positive regulator 
of migration and/or invasion via the regulation of Rac or Cdc42. One interestingly possibility is that 
following the loss of E-cadherin, CdGAP promotes migration via GAP-independent mechanisms (as 
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the GAP domain is not required for TGF-β-induced migration in breast epithelial cells). A number of 
proteins have been identified to interact with CdGAP, including the atypical GTPase Wrch1 (Naji et 
al., 2011) and these may offer insight into GAP-independent, CdGAP-mediated processes involved in 
cell migration. 
4.5.4. CdGAP regulation of Rac, Rho (?) and Cdc42 
The expression of CdGAP in keratinocytes correlates with a global decrease in Rac and Cdc42 activity 
and a specific reduction in active Rac at the membrane (Figures 4.10 and 4.11). The activation of 
GTPases is regulated both spatially and temporally meaning that a global decrease in the activity of a 
GTPase does not necessarily mean this is decreased at all cellular locations. For example, depletion 
of the Cdc42 GAP SH3BP1 leads to an increase in total Cdc42, but a decrease in Cdc42 at cell-cell 
junctions, which is where SH3BP1 exerts its effects (Elbediwy et al., 2012). Whilst we see a decrease 
in Rac activation at the membrane in CdGAP-expressing cells, there may be a localised increase in 
Rac or Cdc42 activity associated with the lamellipodial-like structures seen (as lamellipodia 
formation is driven by Rac).  
Furthermore, the complex nature of the regulatory networks governing GTPase activation means 
that inactivation of one GTPase can result in the activation of another (Nimnual et al., 2003; 
Ratheesh et al., 2012; Warner and Longmore, 2009). By reducing the levels of active Rac at AJs 
CdGAP may be indirectly releasing suppression of RhoA activity. RhoA activity can be regulated at 
AJs downstream of Rac, which promotes the localisation of the Rho GAP p190A to junctions 
(Ratheesh et al., 2012; Wildenberg et al., 2006). Cdc42 has also been described as being able to 
antagonise Rho signalling at cell-cell contacts (Warner and Longmore, 2009). In Drosophila eye, 
Cdc42 inhibits RhoA in order to reduce apical tension. Loss of Cdc42 increases phosphorylation of 
MLC at AJs and this increases cellular tension (Warner and Longmore, 2009). The activation of RhoA 
is interesting as TGF-β-induced epithelial-to-mesenchymal transition has been described to signal 
through Rho and ROCK and brings about loss of E-cadherin and actin remodelling (Bhowmick et al., 
2001). Thus, a more thorough analysis of localised GTPase activation in CdGAP-expressing cells is 
necessary.  
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4.6.  Future work 
4.6.1. Regulation of cell-cell contacts by ARAP1 
ARAP1 depletion resulted in a significant reduction in the levels of E-cadherin at cell-cell contacts. 
However, expression of ARAP1 had no effect on mature AJs. Together these findings indicate ARAP1 
regulates the early stages of cell-cell contact stabilisation. Immediate future work should address 
two broad questions. Firstly, as ARAP1 inactivates both Rho and Arf GTPases, through which 
GTPase(s) (if any) is ARAP1 regulating cell-cell contacts?  Secondly, how does depletion of ARAP1 
lead to reduction in E-cadherin at cell-cell contacts? For example, this may be through an increase in 
the rate of removal of E-cadherin from contacts, or a decrease in the rate of delivery.  
Does ARAP1 influence the levels of E-cadherin at the junctions via regulation of Arf or Rho 
GTPases? 
ARAP1 can regulate both Rho and Arf signalling. As important regulators of the cytoskeleton and 
intracellular trafficking, perturbation of Rho or Arf activation could disrupt AJs. Thus, to investigate 
the nature of E-cadherin loss in ARAP1-depleted cells it would first be informative to determine the 
involvement (if any) of these GTPases in this process. To determine Rho activity at the junctions 
FLIM-FRET can be used, taking advantage of a dual probe harbouring the binding domain of the Rho 
target, Rhotekin, together with RhoA and fused at either terminal to RFP and GFP (Heasman et al., 
2010). Arf1 activation can also be tracked using FRET by measuring FRET between activated Arf1 
(bound to CFP) and the N-terminus of its target Golgi-localised, gamma ear-containing, ARF-binding 
protein 1 fused to YFP (Beemiller et al., 2006). Such data will provide vital information on the 
localised regulation of Arf and Rho in ARAP1-depleted cells. A complementary approach could 
involve the expression of the dominant-negative forms of RhoA, Arf1 and Arf5 in cells depleted of 
ARAP1 to see if either could rescue the decrease in E-cadherin levels at cell-cell contacts. However, 
the levels of expression of these proteins would have to be carefully titrated to avoid toxic, off-
target effects. By determining which GTPase(s) ARAP1 regulates during cell-cell contact stabilisation, 
we will be better able to investigate the mechanism behind the reduction of E-cadherin at cell-cell 
contacts upon ARAP1 depletion. 
What is the mechanism behind the reduction of E-cadherin induced by ARAP1 depletion? 
The reduction in E-cadherin at junctions in the absence of ARAP1 could reflect changes in the 
amount of E-cadherin delivered to the membrane after synthesis, the rate of recycling back to the 
membrane, or the rate of removal from the membrane (Bryant and Stow, 2004). To uncouple these 
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processes will be vital in uncovering ARAP1 function at AJs.  Levels of E-cadherin on the surface and 
the rate of internalisation can be determined by performing recycling assays using cell surface 
biotinylation (Le et al., 1999). Following biotinylation of the cell surface, any remaining, unbound 
biotin is removed and cells either lysed to measure surface levels or incubated for a further time at 
37°C before lysis. Biotinylated protein detected in lysates from cells lysed immediately after 
incubation tells us of the amount of E-cadherin present on the surface, whilst biotinylated protein 
derived from lysates after incubation tell us of the amount of E-cadherin that has been internalised. 
By lysing cells at different time points the rate of internalisation and recycling can be inferred. These 
can be compared in ARAP1-depleted and control cells. 
Alternatively, FRAP can be used to determine the dynamics of E-cadherin at the membrane. In this 
method GFP-tagged E-cadherin (Adams et al., 1998) is transfected into cells and these cells imaged 
live. A small subset of fluorescent E-cadherin is photobleached and by monitoring the fluorescence 
recovery in this area two things may be inferred. Firstly, the percentage recovery is calculated, that 
is how much fluorescence returns to the site after bleaching. This can indicate how large the 
proportion of the mobile fraction of GFP-E-cadherin is. Secondly, the rate of recovery, how quickly 
the fluorescence returns to the original intensity, tells us how mobile the fraction of GFP-E-cadherin 
is. Comparison of FRAP data from cells depleted of ARAP1 with control cells can tell us if ARAP1 
depletion perturbs the recovery of E-cadherin. It would also be possible to couple this analysis with 
investigation of ARAP1 GTPase targets, for example, it would be interesting to see if expression of 
activated Arf1, Arf5 or RhoA rescued any defects seen in FRAP caused by depletion of ARAP1. 
4.6.2. Regulation of cell-cell adhesion by ARHGAP6 
ARHGAP6 expression in keratinocytes led to distinct morphological changes in expressing cells that 
meant cell-cell contacts were disrupted. The effects were conditional on the presence of a complete 
GAP domain and were seen upon expression of both human and Drosophila ARHGAP6. ARHGAP6 
also induced morphological changes upon expression in Drosophila wing, and affected migration and 
localised Rho activation. The investigation into ARHGAP6 and cell-cell adhesion should firstly focus 
on confirming in keratinocytes the phenotypes seen in Drosophila wing and should address whether 
ARHGAP6 expression can increase migration in keratinocytes and if this is due to ARHGAP6 
regulation of RhoA. 
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Does ARHGAP6 expression increase migration? 
Data from Drosophila wing and keratinocytes suggests that expression of ARHGAP6 can promote 
migration. In Drosophila, ARHGAP6-expressing cells are more migratory and in keratinocytes, E-
cadherin is lost and cells often display protrusions, which may be consistent with a migratory 
phenotype. It would be interesting to determine if ARHGAP6 could enhance cell migration by 
performing migration assays with ARHGAP6-expressing cells.  For example, wound healing assays 
could be performed with ARHGAP6-expressing cells to see if these are able to close wounds more 
rapidly than control cells. Another method to investigate the effect of ARHGAP6 expression on 
migration involves the tracking of single cells over time. Advanced algorithms are now available that 
facilitate the automation of this process. By tracking individual cells it will allows us to measure the 
rate of migration as well as providing morphological data on the studied cells, for example if these 
appear mesenchymal or ameboid (Jaqaman et al., 2008; Sanz-Moreno et al., 2008; Wilkinson et al., 
2005).   
Is localised Rho activation disrupted in ARHGAP6 expressing cells? 
Modes of migration are influenced by the activity of RhoA and Rac1. In Drosophila wing ARHGAP6 
results in Rho activity being lost apically and building up basally. This is correlated with overall 
morphological changes and enhanced migration. As ARHGAP6 is a Rho GAP it would be important to 
determine if Rho activity is perturbed in ARHGAP6-expressing keratinocytes. To do this, pull-down 
assays can be performed taking advantage of the binding between active RhoA and Rhotekin. 
Immobilisation of Rhotekin Rho binding domain (RBD) on glutathione beads allows active RhoA to be 
isolated from cells transfected with or depleted of ARHGAP6 in order to assess the global changes in 
RhoA activity. To look more specifically at RhoA signalling in keratinocytes expressing ARHGAP6 
FLIM-FRET can be performed utilising the dual RhoA-RBD probe fused to GFP and RFP at each 
terminal which allows information regarding the localised activation of RhoA to be determined 
based on the lifetime of GFP.  
4.6.3 Regulation of cell-cell adhesion by CdGAP 
CdGAP expression resulted in loss of E-cadherin from cell-cell contacts and significant morphological 
changes. This was associated with global changes in the activity of Cdc42 and Rac, and local changes 
in Rac activity at the membrane. Depletion had no effect on the levels of E-cadherin at junctions 
during cell-cell contact formation indicating CdGAP primarily regulates the maintenance of cell-cell 
contacts, and may be important in the regulation of developmental processes, particularly epithelial-
to-mesenchymal transitions. Future work should firstly address how CdGAP expression results in AJ 
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disassembly. This should be achieved by further investigating the activation of different GTPases at 
cell-cell contacts in CdGAP-expressing cells and ascertaining what effect this has on the actin 
cytoskeleton. Secondly, whether or not CdGAP is inducing epithelial-to-mesenchymal transition in 
keratinocytes should be confirmed. 
How does CdGAP expression disrupt cell-cell contacts? 
FLIM-FRET data finds CdGAP-expression significantly decreases Rac activity at the membrane. 
CdGAP-expressing cells exhibited a striking morphology, and it is unlikely that there is a uniform 
inactivation of Rac across the whole of the cell membrane in CdGAP-expressing cells. As such, it 
would be informative to look very specifically at the levels of active Rac at the tips lamellipodial-like 
protrusions seen in CdGAP-expressing cells, where only a small fraction of the junction remains. This 
should involve FLIM-FRET but using a higher magnification than used previously, followed by manual 
segmentation of areas of interest. 
As CdGAP is a Rac and Cdc42 GAP, and Cdc42 activity is globally reduced in CdGAP-expressing cells it 
will be important to determine the localised activity of Cdc42 in CdGAP-expressing cells. It is possible 
that CdGAP is localising to other sub-cellular structures, such as the Golgi, which is a site of Cdc42 
activity and it will be interesting to look at the activation of Rac and Cdc42 at such structures as well 
as sites of contact. Due to the reduction of Cdc42 and Rac seen in CdGAP expressing cells it would 
also be informative to see if Rho levels are increased as a result of CdGAP expression. This can be 
done biochemically using Rhotekin beads or using FRET to gather spatial information.  
The activation of different GTPases has different effects on the actin cytoskeleton. Cells expressing 
CdGAP are highly retractive and preliminary data (not shown) indicates that this is mediated by 
changes in the actin cytoskeleton. A comprehensive analysis of actin organisation in CdGAP-
expressing cells would be important and can be complemented by analysis of Rho GTPase activity. 
Use of EGFP-Actin would facilitate study of actin organisation in CdGAP-expressing cells, and also 
facilitate live-cell imaging. Because the morphological changes associated with CdGAP expression 
occur by 8 hours expression, live cell imaging of the entire process is potentially feasible. Mature 
cell-cell contacts have tightly packed cortical bundles of F-actin present at adhesions (Cavey and 
Lecuit, 2009). However, formation of stress fibres can often be seen in cells undergoing epithelial-to-
mesenchymal transition (Savagner, 2001). High resolution microscopy of EGFP-Actin and CdGAP-
expressing cells would allow the number, length and dynamics of any stress fibres formed to be 
quantified. It would also be possible to observe the localisation of CdGAP and if there is a direct 
association with actin filaments. Finally, through which proteins CdGAP regulates actin 
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reorganisation is unknown. The identification of novel CdGAP-binding proteins will be informative in 
this sense and may be achieved through typical protein-protein interaction screens (such as yeast 
two-hybrid) or using a more modern bioinformatics approach to identify novel proteins that may be 
expressed in similar tissues at the same time as CdGAP, or possess a similar binding region as 
previously characterised CdGAP-binding proteins (Schaefer et al., 2013). 
Is CdGAP expression inducing cells to undergo epithelial-to-mesenchymal transition? 
The expression of CdGAP causes such considerable morphological changes that it is likely multiple 
signalling pathways are affected. If CdGAP expression is able to induce epithelial-to-mesenchymal 
transition these cells should express mesenchymal proteins, such as vimentin and MMPs, as well as 
modulate E-cadherin via upregulation of transcriptional repressors (for example via Snail) (Yilmaz 
and Christofori, 2009). A full analysis of gene expression, for example via q-PCR, would ascertain if 
these cells are undergoing epithelial-to-mesenchymal transition, and if so, if other interesting 
proteins are significantly up or downregulated. This may offer clues as to which proteins CdGAP can 
regulate, or is itself regulated by, that ultimately results in junction disruption. This approach may be 
complemented by analysis of tumour databases to identify if CdGAP is upregulated in cancers or 
cells lines. These methods will confirm if CdGAP is indeed a rare example of a GAP that can also 
promote invasion.  
Cells that have undergone epithelial-to-mesenchymal transition are more motile than epithelial cells. 
Furthermore, as discussed above, CdGAP expression can have mixed effects on cell migration, with 
studies finding both increases and decreases in rates of migration upon expression of CdGAP. To 
investigate the ability of CdGAP to induce epithelial-to-mesenchymal transition by promoting 
migration in keratinocytes invasion assays can be performed. Transwell invasion assays measure the 
ability of cells to migrate through various types of matrigel. The ability of CdGAP to promote tumour 
cell invasion in breast epithelial cells does not require the GAP domain (He et al., 2011). However, I 
have shown that CdGAP-mediated junction disruption is GAP-dependent and so it will be interesting 
to determine if GAP activity is also necessary for (potentially) promoting migration and/or invasion in 
keratinocytes. 
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Chapter 5.  
CdGAP is regulated by the scaffold protein Ajuba 
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5.1. Introduction 
The maintenance of cell-cell contacts is governed by a variety of proteins. The GTPases Rac, Rho and 
Cdc42 have been implicated in cell-cell contact maintenance in various cells types and understanding 
of their regulation, directed by a host of GEFs and GAPs, has for some cases been elucidated (Citi et 
al., 2011; McCormack et al., 2013). However, the GTPases and their regulators rely on a cohort of 
additional proteins to coordinate not only their localisation, but also their temporal activation. These 
proteins can commonly be referred to as ‘scaffold’ proteins. Often lacking any catalytic activity 
themselves, they typically possess a variety of protein-protein interaction domains allowing them to 
integrate signalling between multiple pathways. Unravelling the mode of action of such scaffold 
proteins informs us as to how spatial and temporal separation of signalling pathways can be 
achieved.  
Ajuba is a scaffold protein localised to AJs via interaction with α-catenin (Marie et al., 2003). Ajuba 
plays an important role in the maintenance of AJs by ensuring Rac activation is sustained at AJs and 
by regulating actin reorganisation (Nola et al., 2011). Depletion of Ajuba in keratinocytes reduces the 
amount of active Rac at cell-cell contacts and consequently weakens cell-cell adhesions. However, 
Ajuba does not regulate Rac recruitment (Nola et al., 2011). Ajuba also regulates Rac activation in 
wound healing; Ajuba null MEFs cannot activate Rac as efficiently at the leading edge of migrating 
cells (Pratt et al., 2005). The regulation of Rac activity by Ajuba suggests that Ajuba can either 
promote the activation/localisation of a Rac GEF, or inhibit the localisation/activation of a Rac GAP. 
In order to identify candidate proteins that may act downstream of Ajuba to regulate Rac, a yeast 
two-hybrid screening approach was taken (performed by A. Ferrand and D. Birnbaum). In this 
screen, CdGAP was identified as a potential Ajuba binding partner (A. Ferrand and D. Birnbaum). 
In the previous chapter, I have shown that CdGAP regulates AJ maintenance. The expression of 
CdGAP causes severe junction disruption and a progressive loss of E-cadherin from cell-cell contacts. 
I also show that this is a GAP-dependent process, as the GAP-dead form of CdGAP fails to disrupt 
junctions. In this chapter I have sought to examine the mechanisms behind CdGAP-mediated 
junction disruption by investigating the possibility that Ajuba regulates Rac activity at cell-cell 
contacts via interaction with CdGAP. 
I have also investigated how the regulation of CdGAP at cell-cell contacts could occur by probing the 
mechanism of CdGAP auto-regulation. The two truncated CdGAP mutants associated with AOS have 
augmented activity against Cdc42, implying that that the C-terminal region of CdGAP may regulate 
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the GAP domain (Southgate et al., 2011). Indeed a CdGAP construct covering the N-terminal GAP 
domain (GFP-CdGAP1-221) was detected in immunoprecipitates of myc-tagged CdGAP C-terminal 
(CdGAP1083-1425) (Southgate et al., 2011). I sought to confirm this interaction was direct and further 
examine the binding between different regions of CdGAP.     
5.2. Aims 
1. Determine if Ajuba can influence the ability of CdGAP to perturb cell-cell contacts. I aim to 
ascertain if Ajuba can regulate the activity or localisation of CdGAP. 
 
2. Determine if CdGAP and Ajuba can interact directly and map the regions on CdGAP and Ajuba 
responsible for the interaction. 
  
3. Investigate the potential auto-inhibitory mechanism of CdGAP binding. If CdGAP is able to 
interact with itself and inhibit its activity, I wish to map in detail the binding site.  
 
5.3. Results 
5.3.1. Ajuba regulates the localisation of CdGAP and its ability to disrupt cell-cell contacts 
in keratinocytes 
The long and short isoforms of CdGAP were expressed in keratinocytes with and without Ajuba to 
see if Ajuba could influence the localisation of CdGAP, or modulate in any way the effects of CdGAP 
expression on E-cadherin junctions (Figure 5.1, 5.2). In the presence of Ajuba, CdGAP-l localised at 
cell-cell contacts in a considerable number of cells, whereas this was relatively rare in cells 
expressing CdGAP-l alone. Representative line scans highlight the co-localisation of CdGAP and E-
cadherin in an Ajuba expressing cell. Conversely, cells expressing CdGAP-l alone show fairly uniform 
CdGAP-l localisation, with no areas being specifically enriched. Interestingly, the presence of Ajuba 
seemed to have no effect on the localisation of CdGAP-s, which was enriched at junctions in a similar 
number of cells irrespective of Ajuba expression.  
To quantify these effects I first counted the number of cells with an enrichment of CdGAP at 
junctions (Figure 5.2 A). In the case of cells expressing CdGAP-l and Ajuba, CdGAP-s alone, and 
CdGAP-s and Ajuba, CdGAP was enriched at one or more junction in approximately 40% of cells. 
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However, in cells expressing CdGAP-l alone the junctional enrichment of CdGAP was much less 
frequent (17% of cells). These findings indicate Ajuba contributes to the localisation of CdGAP-l, but 
not CdGAP-s at cell-cell contacts. 
In the previous chapter, I observed that the expression of CdGAP induced a loss of E-cadherin from 
cell-cell contacts in quite a characteristic fashion; cells appeared highly retractive, with large holes 
appearing between neighbouring cells whilst remaining E-cadherin was concentrated in small 
patches at contacts.  Co-expression of CdGAP and Ajuba resulted in a reduction in the number of 
cells exhibiting this highly retracted morphology compared to cells expressing CdGAP-l alone (Figure 
5.1). Whilst in some cases small holes were seen between cells, the prevalence of very large holes 
was much lower in the Ajuba -CdGAP-l expressing cells. Again, no such effect was seen in CdGAP-s 
expressing cells as both in the presence and absence of Ajuba the highly retractive morphology was 
observed.  
Junction disruption was quantified by counting the number of cells with a highly retractive 
morphology (defined as more than two holes between cells) (Figure 5.2 B). Levels of disruption in 
cells co-expressing Ajuba and a CdGAP isoform were normalised relative to the disruption observed 
upon expression of each isoform by itself. This enabled assessment of the effect of Ajuba expression 
on the respective CdGAP isoforms independently of the ability of each isoform to disrupt junctions. 
The levels of junction disruption between CdGAP-s and CdGAP-s and Ajuba were very similar. 
However, the presence of Ajuba in CdGAP-l expressing cells significantly reduced the amount of 
disruption caused by CdGAP-l expression (Figure 5.2 B).   
CdGAP-mediated junction disruption is dependent on the GAP domain (Figure 4.10). The apparent 
ability of Ajuba to inhibit the capacity of CdGAP to disrupt junctions may be due to a direct 
regulation of CdGAP GAP activity. Preliminary experiments have been conducted to investigate this 
(these experiments were performed as part of a collaboration with Nathalie Lamarche’s group at 
McGill University, Montreal by F. Karimzadeh) which suggest that in the presence of Ajuba, CdGAP 
GAP activity is inhibited in in vitro GAP assays. However, further experiments are required to verify 
this 
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Figure 5.1 Ajuba regulates CdGAP localisation Keratinocytes with mature junctions were transfected with 
GFP-CdGAP-l or GFP-CdGAP-s in the presence or absence of RFP-Ajuba for 8 hours. Cells were fixed and stained 
for E-cadherin (Cy5, purple) and the nucleus with DAPI (blue). Images were collected on a confocal microscope. 
Merged images were created by overlaying the colour channels. Fluorescence line scans (dashed lines) were 
made over junctional areas between CdGAP-expressing and non-expressing cells. Graphs below the images 
represent fluorescence intensity for E-cadherin (purple), CdGAP (green) and Ajuba (red) over these areas. 
Arrows indicate junctions either in CdGAP-expressing cells or in neighbouring, non-expressing control cells 
with continuous E-cadherin staining. Arrowheads indicate highly disrupted junctions where E-cadherin has 
been partially lost from the junction area. Open arrows indicate regions enriched with CdGAP relative to the 
rest of the cell. Scale bar = 25µm. N=3  
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Figure 5.2 Ajuba regulates CdGAP ability to disrupt junctions and localisation in keratinocytes Keratinocytes 
expressing either CdGAP-l or CdGAP-s in the presence or absence of Ajuba (Figure 5.1) were examined in order 
to quantify the degree of junctional localisation of CdGAP (A) or number of cells with disrupted junctions (B) 
for each condition. A) The number of cells with CdGAP enriched at junctions compared to the rest of the cell 
was counted for each condition. The mean number of cells with junctional CdGAP localisation was expressed 
as a percentage of total number of cells and standard error bars shown. Statistical significance was assessed 
using one-way ANOVA with Bonferroni’s multiple comparison test. **, P ≤ 0.01. B) The number of cells with 
highly disrupted junctions (defined as more than two holes between neighbouring cells) was counted for each 
condition. The mean number of cells with disrupted junctions in the CdGAP-l + Ajuba and the CdGAP-s + Ajuba 
conditions were normalised relative to the disruption observed upon expression of each isoform by itself 
(arbitrarily set at 1). Statistical significance was assessed using Student’s T-test. *, P≤0.05; ns= Not significant. 
N=3     
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5.3.2. Ajuba interacts directly via its LIM domain with CdGAP-l C-terminal  
These results indicate that Ajuba is able to modulate the activity and localisation of CdGAP-l, but not 
CdGAP-s. Thus Ajuba likely interacts with CdGAP-l, but not CdGAP-s. To map the binding site 
between CdGAP and Ajuba, different CdGAP constructs were transfected into COS-7 cells and GST-
tagged Ajuba (full-length) used to pull-down associated protein (Figure 5.3 A). CdGAP-l was found to 
bind Ajuba, whilst CdGAP-s did not. Furthermore, the C-terminal fragment, CdGAP1160-1425 also bound 
Ajuba, indicating that the Ajuba binding site is within this region. This is in good agreement with the 
yeast two-hybrid data, which identified amino acids 1064 to 1183 of CdGAP binding to Ajuba (A. 
Ferrand and D. Birnbaum). To test if the Ajuba-CdGAP interaction is direct, CdGAP1160-1425 was in vitro 
translated and incubated with GST-Ajuba (Figure 5.3 B). GST-Ajuba was able to pull-down CdGAP1160-
1425 indicating that these proteins bind directly.  
I next located the CdGAP binding site on Ajuba. Cells were transfected with myc-tagged Ajuba 
constructs (full-length, Pre-LIM and LIM) and GST-tagged CdGAP1160-1425 used to pull down Ajuba 
from cell lysates (Figure 5.4 A). Full-length Ajuba was bound to GST-CdGAP1160-1425 as was Ajuba LIM. 
However, the Pre-LIM domain of Ajuba was unable to bind CdGAP1160-1425, confirming the LIM 
domain is sufficient for this interaction.  
To further narrow-down the Ajuba binding site on CdGAP, a second C-terminal CdGAP construct 
containing amino acids 1253 to 1425 (GST-CdGAP1253-1425) was used to establish if this region was 
sufficient to mediate the interaction (Figure 5.4 B). Cells were transfected with the different myc-
tagged Ajuba constructs and lysates incubated with GST-CdGAP1253-1425 to pull-down bound Ajuba. 
Interestingly, GST-CdGAP1253-1425 was unable to interact with Ajuba full-length and only a very small 
amount of Ajuba LIM was seen bound to CdGAP1253-1425 and only when blots were over-exposed. 
These findings were verified by in vitro translating myc-tagged Ajuba full-length and using the two 
GST-CdGAP constructs (GST-CdGAP1160-1425 and GST-CdGAP1253-1425) to pull down Ajuba (Figure 5.4 C). 
Again, GST-CdGAP1160-1425 was able to interact with Ajuba, but GST-CdGAP1253-1425 was not. These 
findings illustrate that the Ajuba binding site lies between amino acids 1160 and 1253. Further 
considering the yeast two-hybrid result, the minimal Ajuba binding site apparently lies between 
amino acids 1160 and 1183 (Figure 5.4 D).  
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Figure 5.3 CdGAP and Ajuba interact directly via CdGAP C-terminus A) COS-7 cells were transfected with 
either myc-tagged CdGAP-l, CdGAP-s or CdGAP1160-1425 for 24 hours. Cells were lysed and lysates incubated with 
GST or GST-Ajuba immobilised on glutathione sepharose beads for one hour. Western blot was used to detect 
myc-tagged CdGAP protein in input samples (5% total lysate) and bound to beads. N=3 B) myc-CdGAP1160-1425 
was produced via in vitro translation and incubated with GST or GST-Ajuba immobilised on glutathione 
sepharose beads for 2 hours. Western blot was used to detect myc-tagged CdGAP in input samples (20% total) 
and bound to beads. Molecular weight markers are shown on the left of each panel. N=3  
 
 
 
 
170 
 
 
 
 
Figure 5.4 CdGAP interacts with Ajuba LIM domain COS-7 cells transfected with myc tagged Ajuba full-length, 
preLIM or LIM domain for 24 hours were lysed and lysates incubated with GST (A and B), GST-CdGAP1160-1425 (A) 
or GST-CdGAP1253-1425 (B) immobilised to glutathione sepharose beads for one hour. Western blot was used to 
detect myc-tagged Ajuba in input samples (5% total lysate) and bound to beads. In all cases, GST-tagged 
proteins (indicated by the asterisk) were visualised by amido black staining of the membrane (shown below 
respective Western blots). C) myc-Ajuba was produced via in vitro translation and incubated with GST, GST-
CdGAP1160-1425 or GST-CdGAP1253-1425 immobilised on glutathione sepharose beads for 2 hours. Western blot 
was used to detect myc-tagged Ajuba in input samples (20% total) and bound to beads. COS-7 cells were 
transfected with either myc-tagged Ajuba full-length, Ajuba Pre-LIM or Ajuba LIM for 24 hours. IVT= in vitro 
translated. Molecular weight markers are shown on the left of each panel. N=3. D) Summary of the binding 
between CdGAP and Ajuba based on pull-down experiments. CdGAP-l (amino acids 1 to 1425) shown with GAP 
domain in pale yellow and proline-rich regions in blue. GST-CdGAP1160-1425 and GST-CdGAP1253-1425 shown 
below. Below is Ajuba with the PreLIM and LIM regions highlighted. The three LIM domains are numbered 
accordingly. The nuclear export signal (NES) is represented by the black box. The minimal binding region, based 
on pull-down experiments lies between 1160 and 1253 on CdGAP (yellow line) and maps to the LIM domain of 
Ajuba.  
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5.3.3. Ajuba interacts with CdGAP at several regions within CdGAP’s C-terminal 
The C-terminal of CdGAP does not share any similarity with other known proteins. Furthermore, 
there is no published information regarding the 3D structure of CdGAP. In order to identify specific 
residues of CdGAP mediating the CdGAP-Ajuba interaction, a library of overlapping peptides was 
prepared covering amino acids 1083 to 1425 of CdGAP. Peptides were either 15- or 25-mers each 
shifted by 2 or 5 amino acids, respectively and were SPOT-synthesised onto cellulose membranes. By 
incubating the SPOT membrane with purified Ajuba positive interactions with specific peptides can 
be observed by using a secondary antibody labelled with either a fluorescent tag or with alkaline 
phosphatase which produces coloration of the membrane. Initially a SPOT membrane comprising 15-
mers of CdGAP was used (data not shown). However, no interaction was seen between any of the 
immobilised peptides and Ajuba. As no other known binding partner for the C-terminal of CdGAP is 
known, a positive control could not be tested. However, it is possible that 15-mers are not sufficient 
to support the interaction and a larger region is needed (Bass et al., 1999).  
Thus, a second peptide array comprising a library of 25-mers was tested (Figure 5.5). In this case, at 
least four separate regions appear to be involved in mediating the CdGAP-Ajuba interaction (Ajuba 
Pre-LIM was used as a negative control and only weak coloration was observed (not shown)). Amino 
acids 1148 to 1202 (spots 13 to 20), that overlap with the region identified by both the pull-downs 
and yeast two-hybrid were identified. Within this region an obvious reduction in intensity at spots 16 
and 17 potentially indicates the existence of two discontinuous binding sites. Interestingly, other 
regions were also able to interact with Ajuba. There is a small section between amino acids 1298 to 
1337 (spots 44 to 47). Spots 46 and 47 showed a weaker interaction, suggesting amino acids located 
exclusively in spots 44 and 45 (amino acids 1298-1327) contribute to the interaction but are not vital 
for it. Additionally, several spots at the very C-terminus of CdGAP were highly reactive. Due to signal 
interruptions these could be considered as separate regions but may be bought into close proximity 
in the folded protein. I next sought to identify specific amino acids responsible for mediating this 
interaction using alanine scanning arrays. 
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Figure 5.5 Ajuba interacts with several distinct regions on CdGAP C-terminus Peptides (25-mer) covering the 
C-terminus of CdGAP (amino acids 1083-1425) with 5 amino acid overlaps were spot synthesised on a cellulose 
membrane. The membrane was overlaid with in vitro translated myc-Ajuba for 2 hours then washed and 
incubated with rabbit anti-myc antibody followed by Indocarbocyanine (Cy3)-conjugated anti-rabbit IgG. 
Positive interactions are indicated by dark colouration on the membrane, visualised using the Ettan DIGE 
Imager. SPOT number refers to the position of the 25-mer in the CdGAP C-terminal sequence. For example, 
SPOT number 1 encompasses amino acids 1083-1107, and SPOT number 2 encompasses 1088-1112 etc. The 
SPOTs present on each row of the membrane are shown on the left of the membrane. The corresponding 
amino acids covered on each row are shown on the right hand side of the membrane. The sequences of highly 
reactive SPOTs are shown below the membrane alongside their respective SPOT number and the amino acids 
they cover. Amino acids predicted to be important in the interaction are shaded in yellow. N=3   
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5.3.4. Arginine residues 1172 and 1412 of CdGAP are important for mediating the 
CdGAP-Ajuba interaction 
Several of the strongest interacting peptides from different areas of the CdGAP C-terminal were 
selected and each amino acid sequentially mutated to Alanine (Figure 5.6). Overall, the reactivity of 
the alanine scan membrane was much weaker than the previous peptide array, making quantitation 
of binding less reliable. In fact, some peptide sequences (not shown) that were highly reactive on the 
original membrane failed to bind Ajuba at all, potentially indicating a problem with the synthesis. 
However, Ajuba binding was semi-quantified relative to the wild-type peptide sequence and the 
results plotted on bar charts.  
Semi-quantitation of SPOT membranes is not trivial and intensity can be influenced by many factors 
including antibody concentration, binding time and competition between peptides for binding to the 
partner protein (Weiser et al., 2005). As such it is important to compare only relative intensity, to an 
internal control for each experiment, rather than comparing between membranes (Weiser et al., 
2005).  
For peptide 14, covering amino acids 1148 to 1172 of CdGAP, the strongest reduction in the 
interaction with Ajuba came with the mutation of arginine 1172, which reduced binding by 
approximately 50% of the wild-type (Figure 5.6 A). Other amino acids, particularly arginines 1160 
and 1161, asparagine 1162 as well as serine and valine residues 1167 and 1168 also notably 
decreased binding to Ajuba (Figure 5.6 A). This data is in good agreement with that gained from pull-
downs, the yeast two-hybrid and the previous SPOT membrane showing that the region 1148-1172 
is important for mediating binding between CdGAP and Ajuba. Peptide 62 (amino acids 1388-1412) 
was the most reactive in both the alanine scan and the original 25-mer membrane. From the alanine 
scan array, mutation of one amino acid (arginine 1412) reduced profoundly the binding of Ajuba by 
almost 90% compared to the wild-type. Several other residues within this region when mutated to 
alanine also reduced Ajuba binding by more than 50% indicating its importance (Figure 5.6 B).  
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Figure 5.6 Arginine residues 1172 and 1412 are critical for the CdGAP-Ajuba interactionPeptides (25-mer) of 
highly reactive SPOTs identified in the peptide array (Figure 5.5) were synthesised whereby every amino acid 
was sequentially mutated to alanine. Peptide 14, covering amino acids 1148-1172 of CdGAP (A) and peptide 
62, covering amino acids 1388-1412 of CdGAP (B) were overlaid with in vitro translated myc-Ajuba for 2 hours. 
Membranes were then washed and incubated with mouse anti-myc antibody followed by anti-mouse 
secondary antibody coupled to alkaline phosphatase. Bound protein was detected via the addition of alkaline 
phosphatase substrate ((bromochloroindolylphosphate (BCIP), thiazolyl blue tetrazolium bromide (MTT) MgCl2 
in citrate-buffered saline (CBS)) for up to 60 min. Positive interactions are indicated by dark colouration on the 
membrane. The reactivity of individual SPOTs was quantified by measuring intensity using ImageJ and 
subtracting background intensity. Reactivities are plotted on graphs and expressed relative to the wild-type 
(WT) sequence. The mutation present in the CdGAP sequence in each peptide is displayed underneath its 
reactivity value on the graphs. N=3  
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5.3.5. CdGAP C-terminal is able to bind directly its GAP domain and C-terminal  
The C-terminal of CdGAP is predicted to interact with its GAP domain, as myc-CdGAP1083-1425 co-
immunoprecipitates with GFP-CdGAP1-221 (Southgate et al., 2011). This interaction could provide an 
auto-inhibitory mechanism as the GAP activity of CdGAP constructs lacking the C-terminal (1-1087 
and 1-683) have increased GAP activity on Cdc42 in in vitro assays (Southgate et al., 2011). Ajuba 
interaction with CdGAP C-terminus may somehow promote this auto-inhibition in order to regulate 
CdGAP activity. To test for direct binding between CdGAP GAP domain (1-221) and C-terminal (1160-
1425), in vitro translated CdGAP1160-1425, was used to test binding to GST-CdGAP1-221 (Figure 5.7 A). 
Indeed, GST-CdGAP1-221 interacted directly with CdGAP1160-1425.  
As such, CdGAP could be folding in on itself or could form antiparallel dimers. I also tested binding of 
CdGAP C-terminal to itself, to see if CdGAP could potentially form parallel dimers. Purified myc-
CdGAP1160-1425, produced via in vitro translation, was tested for binding to GST-CdGAP1160-1425 (Figure 
5.7 B). Interestingly, these two fragments are also able to interact with one another conceivably 
presenting another regulatory mechanism. 
5.3.6. The CdGAP-CdGAP interaction is mediated by the same regions of CdGAP as the 
CdGAP-Ajuba interaction and these are well conserved across different species 
The interaction between CdGAP1-221 and CdGAP1160-1425 may present an auto-inhibitory mechanism 
that Ajuba binding may exploit. To investigate this I utilised the SPOT-synthesised peptide array of 
CdGAP 25-mers covering amino acids 1083 to 1425 to explore the CdGAP-CdGAP binding region on 
CdGAP’s C-terminal (Figure 5.7 C). GST-CdGAP1-221 was incubated with the membrane and binding 
observed. Several distinct binding regions within the C-terminal were detected (GST-tag alone 
produced only weak binding so this is a specific interaction). Remarkably, these were highly similar 
to those found to be important for the CdGAP-Ajuba interaction. Specifically, amino acids 1138 and 
1202, amino acids 1368 to 1202 and amino acids 1388 to 1422 were all highly reactive. Interestingly, 
whilst the regions themselves seem well conserved between Ajuba and CdGAP, the contribution of 
specific peptides was different. For example in the first common region (1138 to 1202) Ajuba 
reacted most strongly with the latter amino acids 1168 to 1202, whilst CdGAP reactivity in this area, 
whilst high, was less than with spots harbouring amino acids 1138 to 1172.  
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Figure 5.7 CdGAP interacts with itself in multiple regions myc-CdGAP1160-1425 was produced via in vitro 
translation and incubated with GST (A and B), GST-CdGAP1-221 (A) or GST-CdGAP1160-1425 (B) immobilised on 
glutathione sepharose beads for 2 hours. Western blot was used to detect myc-tagged CdGAP in input samples 
(20% total) and bound to beads. GST-tagged proteins were visualised by amido black staining of the 
membrane. IVT= in vitro translated. Molecular weight markers are shown on the left of each panel. N=3 C) 25-
mer peptides covering the C-terminus of CdGAP (amino acids 1083-1425) with 5 amino acid overlap were spot 
synthesised on a cellulose membrane. The membrane was overlaid with GST-CdGAP1-221 for 2 hours then 
washed and incubated with mouse anti-GST antibody followed by Indocarbocyanine (Cy5)-conjugated anti-
mouse IgG. Positive interactions are indicated by dark colouration on the membrane, visualised using the Ettan 
DIGE Imager. SPOT no. refers to the position of the 25-mer in the CdGAP C-terminal sequence. For example, 
SPOT no. 1 encompasses amino acids 1083-1107, SPOT no. 2 encompasses 1088-1112 etc. The SPOTs present 
on each row of the membrane are shown left of the membrane. The corresponding amino acids are shown 
right of the membrane. The sequences of highly reactive SPOTs are shown below the membrane alongside 
their respective SPOT number and the amino acids they cover. Amino acids predicted to be important in the 
interaction are shaded in pink. N=3  
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To assess the contribution of the individual amino acids I again made use of the alanine scanning 
peptide arrays, this time incubating them with CdGAP1-221 (Figure 5.8). For peptide 14 (amino acids 
1148-1172, Figure 5.8 A) the most effective mutation in disrupting binding was arginine 1172 to 
alanine, which also perturbed the CdGAP-Ajuba interaction. Interestingly, mutation of any amino 
acid between 1160 and 1172 severely compromise binding of CdGAP1-221 indicating this is probably 
an important regulatory region. Comparison of the CdGAP and Ajuba binding profiles was facilitated 
by tabulation of the relative reactivities of each spot relative to wild-type (Table 5.1). Two amino 
acids, proline 1165 and valine 1166, when mutated to alanine had very little effect on the ability of 
Ajuba to bind CdGAP (95% and 105% respectively relative to wild-type) but reduced CdGAP binding 
considerably (both bound 13% relative to wild-type). Thus these may be important in CdGAP, but not 
Ajuba binding. 
However, the alanine scanning arrays contained several peptides of wild-type sequence (as wild-type 
alanines were not mutated to any other amino acid) which gave varying results in terms of reactivity. 
One SPOT (A1164) had one of the lowest reactivities compared to the reference wild-type used in 
the CdGAP-CdGAP interaction. This may be a false negative, but could also indicate problems with 
the peptide synthesis, which may also explain the lower reactivity seen with the alanine scans 
compared to the original membrane. 
For peptide 62 (amino acids 1388 to 1412 (Figure 5.8 B)), a pattern similar to that seen with Ajuba 
binding was observed. The most effective mutation was arginine 1412 to alanine which completely 
abolished binding of CdGAP1-221 to CdGAP. Furthermore, mutation of any amino acid between 
positions 1392 and 1397 reduced binding by approximately 50%. The considerable overlap in the 
binding sites for CdGAP GAP domain and Ajuba on the C-terminus (Table 5.1) may prevent a 
simultaneous interaction with the GAP domain and Ajuba occurring. It will be interesting to 
determine if Ajuba and CdGAP1-221 may compete for binding to CdGAP’s C-terminal region.  
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Figure 5.8 Residues crucial for the CdGAP-Ajuba interaction also regulate the CdGAP-CdGAP interaction 25-
mer peptides of highly reactive SPOTs identified in the peptide array (Figure 5.7) were synthesised whereby 
every amino acid was sequentially mutated to alanine. Peptide 14, covering amino acids 1148-1172 of CdGAP 
(A) and peptide 62, covering amino acids 1388-1412 of CdGAP (B) were overlaid with GST-CdGAP1-221 GST-
CdGAP1-221 expressed in and purified from E.coli for 2 hours. Membranes were then washed and incubated 
with mouse anti-GST antibody followed by anti-mouse secondary antibody coupled to alkaline phosphatase. 
Bound protein was detected via the addition of alkaline phosphatase substrate (BCIP, MTT and MgCl2 in CBS) 
for up to 60 min. Positive interactions are indicated by dark colouration on the membrane. The reactivity of 
individual SPOTs was quantified by measuring intensity using ImageJ and subtracting background intensity. 
Reactivities are plotted on graphs and expressed relative to the wild-type (WT) sequence. The mutation 
present in the CdGAP sequence in each peptide is displayed underneath its reactivity value on the graphs. N=1  
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Peptide 14 Peptide 62 
Mutation CdGAP binding 
(% reactivity WT)  
Ajuba binding (% 
reactivity WT) 
Mutation CdGAP binding 
(% reactivity WT) 
Ajuba binding (% 
reactivity WT) 
Q1148 95 89  N1388 103 112 
D1149 87 94 K1389 93 106 
L1150 90 112 M1390 82 96 
D1151 78 93 T1391 72 74 
I1152 63 65 I1392 62 84 
V1153 65 67 P1393 65 78 
A1154 52 63 K1394 68 71 
H1155 55 53 N1395 68 67 
T1156 79 59 G1396 73 82 
L1157 100 78 Q1397 65 63 
T1158 85 57 R1398 87 83 
G1159 89 70 L1399 90 90 
R1160 33 63 E1400 91 96 
R1161 24 53 T1401 85 104 
N1162 39 59 S1402 87 117 
S1163 47 77 T1403 87 117 
A1164 11 57 S1404 84 115 
P1165 13 75 C1405 83 95 
V1166 13 80 F1406 84 103 
S1167 49 53 Y1407 95 130 
V1168 41 42 Q1408 91 119 
S1169 38 61 P1409 108 133 
A1170 44 86 Q1410 103 132 
V1171 24 80 R1411 62 71 
R1172 -21 89 R1412 14 25 
Table 5.1 Comparison of residues important for mediating the CdGAP-CdGAP and CdGAP-Ajuba interactions 
The alanine scanning arrays containing peptide 14, covering amino acids 1148-1172 of CdGAP and peptide 62, 
covering amino acids 1388-1412 of CdGAP where each amino acids was sequentially mutated to alanine were 
overlaid with in vitro translated myc-Ajuba (Figure 5.6) or GST-CdGAP1-221 expressed in and purified from E.coli 
(Figure 5.8). The reactivity of individual SPOTs was quantified by measuring intensity using ImageJ and 
subtracting background intensity. Reactivities are expressed as a percentage of the wild-type SPOT and 
summarised for each peptide in reaction to either myc-Ajuba or GST-CdGAP1-221.  
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Amino acid sequences important for protein regulation are often conserved both between species 
and in related proteins. The CdGAP sequences from several species were aligned and amino acids 
important for binding between CdGAP C-terminal region and Ajuba or GAP domain highlighted 
(Figure 5.9). Overall the C-terminus of several mammalian CdGAP is quite conserved. However, the 
highlighted regions (shaded in blue) show particular conservation across all species, implying that 
these are important, evolutionarily conserved regions. 
The sequences of CdGAP (human and mouse) and closely related proteins (ARHGAP30, ARHGAP32 
(RICS) and ARHGAP33) were also aligned. Interestingly, arginine 1412 is found within a sequence of 
four conserved amino acids present in all family members (Figure 5.10 A). This region may represent 
a conserved motif of Q(T/R/S)R(S/T). The presence of either a serine or threonine will confer 
relatively similar properties to a protein, structurally (the only difference being serine contains a 
hydrogen in place of the methyl group on threonine), and both may be phosphorylated. Mutation in 
arginine 1412 abolishes binding of CdGAP C-terminus to the GAP domain and Ajuba, this highly 
conserved sequence may represent an important regulatory region. 
5.3.7. Mutations of arginines 1172 and 1412 on CdGAP severely compromise binding to 
Ajuba 
To verify the results from the peptide arrays, mutations were made in the wild-type CdGAP protein. 
Without any knowledge of 3D structure other tools were used to predict with as high a confidence 
as possible the likelihood that these regions would be surface exposed. CdGAP is heavily 
phosphorylated on serine and threonine residues (Danek et al., 2007; Tcherkezian et al., 2005) so 
phosphorylation sites within this region were searched for based on the assumption that these 
would be on the surface. Serine 1163 and serine 1413 have both been identified via mass 
spectrometry in several screens (Huttlin et al., 2010; Villen et al., 2007; Zanivan et al., 2008) 
searching for phosphorylated proteins, suggesting these sites may be exposed.  
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Figure 5.9 The CdGAP and Ajuba binding regions are highly conserved across species A Clustal W alignment 
was generated of the CdGAP C-terminal sequence from various species.  Regions shaded in blue were 
identified in the peptide scanning arrays (Figures 5.5 and 5.7) as important for CdGAP interactions with either 
Ajuba or the GAP domain. Residues shown in red were found to be critical for mediating these interactions as 
identified from the alanine scanning arrays (Figures 5.6 and 5.8). Asterisks (*) represent conserved residues, 
colons (:) represent conserved substitutions (amino acids of strongly similar property) and full stops (.) 
represent semi-conserved substitutions (amino acids of weakly similar property). Amino acid number is shown 
on the right.  
 
 
182 
 
Arginines 1172 and 1412 were mutated to alanines as these mutations had the most profound effect 
on binding in the alanine scans. Furthermore, arginines are large, charged amino acids that can be 
important in mediating protein-protein interactions via electrostatic interactions (Bogan and Thorn, 
1998). 
In vitro translated Ajuba full-length was tested for binding in in vitro pull-down assays using purified 
GST-CdGAP1160-1425 wild-type or GST-CdGAP1160-1425
R1172A (Figure 5.10 B). Although the R1172A 
mutation did not abolish binding of Ajuba to CdGAP, far less Ajuba was precipitated with this GST-
CdGAP construct than the wild-type. Indeed, quantification (Figure 5.10 C) shows that this mutation 
significantly reduces the amount of Ajuba bound to CdGAP, indicating that this point mutation is 
sufficient to reduce binding of Ajuba by approximately 75%.  
To confirm this result the reverse experiment was performed using GST-Ajuba LIM domain and in 
vitro translated CdGAP1160-1425 wild-type, R1172A and R1412A (Figure 5.10 D). Although preliminary 
(N=1), it confirmed the previous result as GST-Ajuba LIM pulls down less of CdGAP1160-1425
R1172A when 
compared with CdGAP wild-type. Interestingly, the effect was even more profound with the 
CdGAP1160-1425
R1412A mutant, of which very little was bound to Ajuba. Thus, both arginines 1172 and 
1412 appear to be important for the Ajuba-CdGAP interaction. A summary of the binding regions is 
shown in Figure 5.11. 
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Figure 5.10 CdGAP arginine residues 1172 and 1412 are important for the Ajuba-CdGAP interaction A) A 
ClustalW alignment of the human and mouse CdGAP sequences, ARHGAP30, ARHGAP32 and ARHGAP33 
(human). Conserved arginine (1412 in mouse CdGAP) highlighted in red and surrounding conserved amino 
acids shaded in blue. (*), conserved residues; (:) conserved substitutions. Amino acid number is shown on the 
right. B-C) In vitro translated myc-Ajuba full-length was incubated with GST, GST-CdGAP1160-1425 wild-type 
(CdGAP, WT) or mutated on arginine 1172 (CdGAP R1172A) immobilised on glutathione sepharose beads. 
Precipitated associated proteins were detected by probing with anti-myc antibody. Amido black shows GST-
tagged proteins. C) The amount of Ajuba precipitated with different CdGAP proteins in B was calculated by 
densiometry using ImageJ. Bound Ajuba was expressed as a percentage of the total Ajuba. Error bars show 
standard error of the mean. Statistical significance was assessed using Student’s T-test. *, P ≤ 0.05. N=3 D) 
myc-CdGAP1160-1425 wild-type, myc-CdGAP1160-1425
R1172A 
or myc-CdGAP1160-1425
R1412A
 were produced via in vitro 
translation and incubated with GST or GST-Ajuba LIM domain. Input sample represents 20% of total. Amido 
black shows GST-tagged proteins. Preliminary data N=1. Molecular weight markers are shown on the left of 
blots.  
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5.4. Conclusions 
Rho GAPs are vital regulators of GTPases, and as such coordinate multiple cellular processes. This 
means that understanding how GAP proteins themselves are regulated is crucial if we are to fully 
unravel the complex pathways governing cellular processes regulated by GTPases. In this chapter I 
have attempted to discern the mechanism underlying the ability of CdGAP to disrupt E-cadherin cell-
cell contacts by probing CdGAP interaction with the scaffold protein Ajuba. Ajuba modulates the 
localisation of CdGAP-l at junctions and also partially rescues junction disruption caused by CdGAP-l 
expression. Furthermore, preliminary data suggests that Ajuba is able to directly regulate the GAP 
activity of CdGAP against Rac.  
The LIM domain of Ajuba and the C-terminal of CdGAP mediated the interaction. Fascinatingly, the 
Ajuba binding site is highly similar to the site bound by CdGAP’s GAP domain and the highly 
conserved nature of these regions could mean they represent important regulatory sites. 
Overall these findings suggest that Ajuba coordinates CdGAP activity in order to maintain Rac 
activation at the membrane for the maintenance of cell-cell contacts. By directly binding to CdGAP, 
Ajuba is not only able to regulate its localisation, by sequestering CdGAP at the junctions, but also 
control its activity. The collection of Rac and a Rac GAP at the region of the junction is an elegant 
means of finely-tuning Rac activity in a confined area allowing for dynamic regulation of Rac at cell-
cell contacts.  
5.5. Discussion 
5.5.1. Probing the binding sites on CdGAP C-terminal of Ajuba and CdGAP GAP domain 
Several techniques have been used to firstly confirm and then to investigate the CdGAP-CdGAP and 
CdGAP-Ajuba binding sites. Pull-down assays both in vitro and from cell lysates confirmed the 
existence of these interactions. Subsequent use of peptide arrays then allowed specific regions 
responsible for these interactions to be identified. Peptide arrays have been used extensively to 
identify and characterise protein-protein interactions (Baillie et al., 2007; Gingras et al., 2005; 
Primeau et al., 2011). However, this technique does have its limitations. Interactions are detected 
between the chosen protein and a linearised portion of the target protein, devoid of tertiary 
structure. Thus more favourable, stable binding will be conferred in the properly assembled protein 
meaning false negatives are possible. False positive binding, as a result of non-specific electrostatic 
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interactions are also a possibility. Thus, drawing conclusions regarding the reactivity of specific 
SPOTs must be approached with caution (Katz et al., 2011; Weiser et al., 2005).  
For this reason, any conclusions regarding the contributions of individual amino acids should be 
made based on the relative binding compared to wild-type, should be taken only as a guide, and 
must be confirmed using other methods (Katz et al., 2011). Despite these drawbacks, several regions 
were identified that mediate binding between CdGAP-CdGAP and CdGAP-Ajuba. Crucially, these 
findings were verified using pull-down assays with mutated proteins, thus validating the use of this 
method.  
Both the Ajuba-CdGAP and the CdGAP-CdGAP binding sites appear to involve regions between 
amino acids 1138 and 1202 and between amino acids 1338 and 1422. However, disruptions in the 
signal were observed within both of these areas, indicating these may be composed of shorter, 
discontinuous sites that are brought together when the protein is folded. Without knowledge of the 
3D structure and whether the regions identified are surface exposed it is impossible to ascertain this. 
The first region identified (1138-1202) is in good agreement with data from pull-down assays which 
predicted the minimal binding site for Ajuba to lie between amino acids 1160-1253 and the yeast 
two-hybrid which identified amino acids 1064-1183 (Figure 5.11). The second region, in the C-
terminal may not be essential for binding between CdGAP and Ajuba, as CdGAP1253-1425 does not bind 
Ajuba. However identification of this region in the peptide arrays cannot be a false positive as 
mutation of arginine 1412 to alanine severely compromises binding. Rather, the more C-terminal 
region may be necessary, but not sufficient for interaction with Ajuba (Figure 5.11). 
Individual subsets of amino acids, often composed of arginine, tryptophan or tyrosine residues are 
termed hotspots, as they frequently contribute the majority of the energy necessary for binding 
within a protein-protein interaction interface  (Bogan and Thorn, 1998; Castro and Anderson, 1996). 
Mutation of arginine 1172 or arginine 1412 profoundly reduced binding of both Ajuba and CdGAP 
GAP domain to CdGAP C-terminus, indicating that these sites may form part of a hotspot. Both 
residues are well conserved in CdGAP homologs, but interestingly, arginine 1412 is also found in 
related GAP proteins ARHGAP30, ARHGAP32 and ARHGAP33. Thus this region, may also facilitate 
auto-inhibition of CdGAP-related proteins, or alternatively constitute a novel Ajuba binding site. 
Indeed, ARHGAP30 and CdGAP are known to share binding partners; both can interact with 
intersectin (via a basic region adjacent to the GAP domain) (Primeau et al., 2011) and Wrch-1, and 
can signal downstream of this GTPase (Naji et al., 2011).   
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Figure 5.11 Summary of the CdGAP-Ajuba binding site The domain structures of CdGAP and Ajuba. CdGAP is 
shown on top with the GAP domain in pale yellow and proline-rich regions in light blue. Ajuba is shown below 
CdGAP with the PreLIM and LIM regions highlighted. The three LIM domains are numbered accordingly. The 
nuclear export signal (NES) is represented by the black box. Several methods were used to identify the minimal 
Ajuba binding site on CdGAP. Yeast two-hybrid identified binding of a fragment between amino acids 1064 and 
1183 (navy blue line). The pull-down assays revealed Ajuba binding required amino acids from 1160 to 1253 
(yellow line). Peptide arrays identified multiple, shorter sites, within the C-terminal (grey lines). Shown are the 
two longest and most reactive regions identified; the first between amino acids 1138 and 1202 and the second 
between 1338 and 1422. The importance of these regions was verified using pull-downs with CdGAP mutants 
with mutations R1172A and R1412A. The minimal binding site on CdGAP is delineated by the dashed black 
lines, highlighting amino acids 1160 to 1183. The locations of the two arginine mutations are shown above 
CdGAP. The Ajuba binding site was mapped to the LIM domain.  
 
 
 
 
 
 
187 
 
There is a clear overlap between the binding sites on CdGAP C-terminus for its GAP domain and to 
Ajuba. However, these sites may rely on slightly different amino acids to facilitate binding. For 
example, when values are normalised to internal controls for each binding protein, within the first 
binding region (peptides 12-20, amino acids 1138-1202) peptides 18-20 were much more reactive 
for Ajuba binding, whilst peptides 12-14 reacted most strongly with CdGAP. However, the close 
proximity of the bind sites makes it highly likely that binding of either Ajuba or CdGAP-GAP domain 
would preclude binding of the other.  
5.5.2. The regulation of CdGAP localisation to AJs by Ajuba 
The co-expression of CdGAP-l and Ajuba partially rescues junction disruption mediated by CdGAP-l. 
By binding CdGAP, Ajuba could regulate the recruitment of CdGAP to a specific cellular area or 
control its retention at AJs. The finding that CdGAP-s (which cannot bind Ajuba) is also found at cell-
cell contacts and its localisation here is unaffected by Ajuba expression means Ajuba is unlikely to be 
necessary for CdGAP recruitment, which may be regulated by as yet unidentified proteins. Probably 
CdGAP and Ajuba are recruited separately to the junction and only associate once there.  
Potentially junctional localisation is dictated by activation status. CdGAP-l can interact with itself not 
only via its C-terminus and GAP domains, but also via binding between two C-terminal regions. 
Therefore, CdGAP may exist in a folded conformation, as an anti-parallel dimer or as a parallel dimer. 
The prevailing conformation in vivo remains to be determined, but it seems likely that CdGAP-l is 
predominantly retained in an inactive state. Conversely, although both CdGAP isoforms can be 
regulated by other mechanisms (eg via interaction with Intersectin, or phosphorylation (Jenna et al., 
2002; Tcherkezian et al., 2005), the absence of the C-terminal region on CdGAP-s indicates reduced 
ability for auto-inhibition with this isoform. The activation of CdGAP may somehow trigger its 
localisation to junctions, and would explain why a larger proportion of CdGAP-s is present here 
whilst CdGAP-l localisation is more diffuse. 
Once localised to cell-cell contacts, the role of Ajuba may be to retain CdGAP-l here. However, the 
fact the co-expression of Ajuba and CdGAP-l reduces junction disruption implies that the enrichment 
of CdGAP-l seen at junctions when co-expressed with Ajuba represents an inactive pool of CdGAP. 
Ajuba binds CdGAP through Ajuba LIM domain, whereas Rac binding occurs via the Pre-LIM (Nola et 
al., 2011), meaning Ajuba may be able to simultaneously bind both CdGAP and Rac. The gathering of 
Rac and a Rac GAP would allow Ajuba to fine-tune Rac signalling and mean Ajuba could promote Rac 
activation at sites of contact but may also be induced to release CdGAP to quickly and locally reduce 
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Rac activity if required (for example targeting Ajuba for degradation could be a means of releasing 
CdGAP). A similar mechanism may be observed for the RhoA GEF GEF-H1 binding to cingulin, which 
results in inactivation and sequestration of GEF-H1 at TJs (Aijaz et al., 2005). Interestingly, GEF-H1 is 
required for disassembly of AJ and TJ in SK-CO15 cells in response to calcium removal (Samarin et al., 
2007). Thus maintaining this Rho GEF in an inactive state at cell-cell contacts may facilitate rapid 
modulation of GTPase activation in response to external stimuli (in this case the removal of calcium) 
(Samarin et al., 2007). 
Alternatively, that CdGAP-l is able to efficiently disrupt junctions despite relatively little localising 
here may indicate that junctional localisation is not necessary for CdGAP to perturb cell-cell 
contacts. PX-RICS can modulate cell-cell contacts in HeLa cells via regulation of endoplasmic 
reticulum to Golgi transport of β-catenin and N-cadherin, thereby influencing the amount of N-
cadherin present at the cell surface (Nakamura et al., 2008). Whilst we cannot exclude the possibility 
of CdGAP disruption being mediated from the cytoplasm, there is no obvious enrichment of CdGAP 
at any other regions of the cell, implying this is not the case. Rather, it is likely that low 
concentrations of CdGAP are sufficient to disrupt junctions, and/or that CdGAP is only retained at 
junctions for a short amount of time.  
5.5.3. The regulation of CdGAP activity by Ajuba 
CdGAP activity can be regulated directly via protein-protein interaction (Jenna et al., 2002; Primeau 
et al., 2011), phosphorylation (Danek et al., 2007; Tcherkezian et al., 2005) and via binding PIP3 
(Karimzadeh et al., 2012). Thus, Ajuba binding may utilise any of these mechanisms to inhibit CdGAP. 
Simultaneous binding of Ajuba and the GAP domain to CdGAP C-terminus would suggest that Ajuba 
could maintain CdGAP in its closed conformation, whereas if Ajuba binding out-competes the GAP 
domain, a conformational change in CdGAP upon Ajuba binding is more likely responsible for the 
reduction in activity. The close proximity of the Ajuba and GAP domain binding sites on the C-
terminus of CdGAP mean it is unlikely both Ajuba and the GAP domain can bind simultaneously. 
Thus, if Ajuba is able to directly inhibit CdGAP activity it is more likely it does so by inducing distinct 
conformational changes within CdGAP that result in shielding of the GAP domain. 
A possible mechanism via which Ajuba may facilitate CdGAP inactivation is via phosphorylation 
(Danek et al., 2007; Tcherkezian et al., 2005; Tcherkezian et al., 2006). CdGAP is heavily 
phosphorylated and some regulatory phosphorylation sites have been characterised, including 
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phosphorylation of threonine 776 by GSK3β, ERK1/2 and Ribosomal protein S6 kinase (RSK1) (Danek 
et al., 2007; Tcherkezian et al., 2005). Interestingly, both Ajuba and CdGAP are able to interact with 
GSK3β (Danek et al., 2007; Haraguchi et al., 2008). GSK3β can act downstream of Ajuba in order to 
negatively regulate Wnt signalling (Haraguchi et al., 2008). Interestingly, GSK3β phosphorylation of 
β-catenin requires the presence of Ajuba (Haraguchi et al., 2008). Further, as well as being 
phosphorylated by GSK3β, CdGAP protein levels are also regulated in a GSK3β-dependent manner in 
response to serum (Danek et al., 2007). Thus, CdGAP can be regulated in two ways by the actions of 
GSK3β. Alternatively, CdGAP may be a novel PAK1 substrate, a kinase we know is present at the 
junctions in keratinocytes and phosphorylates Ajuba (Nola et al., 2011), although no PAK1 sites have 
yet been identified on CdGAP.  
Together, a picture emerges whereby upon activation, CdGAP is localised to cell-cell contacts where 
it inactivates Rac (and potentially Cdc42) leading to the removal of E-cadherin from the junctions. In 
the presence of Ajuba, CdGAP is sequestered in an inactive form at junctions which prevents 
junction disassembly and also explains how Ajuba depletion can decrease Rac activation at cell-cell 
contacts (Nola et al., 2011) (Figure 5.12).  
5.5.4. Other processes CdGAP and Ajuba might regulate 
Ajuba has been implicated in a range of cellular processes regulating development and homeostasis 
(Das Thakur et al., 2010; Hou et al., 2008; Kanungo et al., 2000; Langer et al., 2008; Nola et al., 2011; 
Pratt et al., 2005). Conceivably, Ajuba may be required to regulate CdGAP activity in other cellular 
processes controlled by Rac (or Cdc42), where it is necessary to spatially confine signalling. In U2OS 
cells the depletion of CdGAP promotes migration in wound healing assays and cells display 
lamellipodia that rapidly extend and retract (LaLonde et al., 2006; Wormer et al., 2012). Conversely, 
Ajuba null MEFs, when stimulated with platelet-derived growth factor (PDGF) to migrate in wound 
healing assays, exhibit reduced activation of Rac at the leading edge and display defective 
lamellipodia resulting in retarded migration (Pratt et al., 2005). In these cells Ajuba signals upstream 
of p130Cas and is required to promote its localisation at focal adhesions (Pratt et al., 2005). A 
second role of Ajuba may be to inhibit CdGAP activity. Indeed, CdGAP is phosphorylated (and 
inhibited) in vivo in response to PDGF treatment in Swiss 3T3 fibroblasts (Tcherkezian et al., 2005). 
Perhaps Ajuba is required to facilitate phosphorylation of CdGAP in migrating cells downstream of 
PDGF, leading to inactivation of CdGAP at the leading edge and promoting Rac activation required 
for migration. 
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Figure 5.12 Summary of the potential mechanism employed by Ajuba to regulate CdGAP at junctions 
Fluorescent images shown above the diagram are representative of cells expressing CdGAP (left) or co-
expressing CdGAP and Ajuba (right) (scale bar is 25um). The expression of CdGAP results in inactivation of Rac 
at the membrane, shifting the balance in favour of Rac.GDP. E-cadherin is removed from the junctions and 
cells retract from their neighbours (left side). In cells expressing CdGAP and Ajuba junctions remain intact. 
CdGAP is accumulated at cell-cell contacts but is recruited separately from Ajuba. Ajuba binds to CdGAP at the 
C-terminus and may inhibit CdGAP activity either directly or indirectly via co-localising CdGAP with a kinase or 
another protein that can shield its GAP domain.  
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Ajuba is the first protein described able to interact with the C-terminal of CdGAP and thus the first 
able to exclusively regulate CdGAP-l and not CdGAP-s activity. Beyond knowledge of their tissue-
specific expression patterns little is known about the isoform-specific roles of CdGAP (Tcherkezian et 
al., 2005; Tcherkezian et al., 2006) but potentially tissue-specific roles may be partially explained by 
an interaction with Ajuba.  
5.6. Future work 
I have shown that Ajuba is able to inhibit CdGAP’s GAP activity and prevent CdGAP-mediated 
junction disruption. Future work should initially aim to better characterise the mechanism behind 
Ajuba’s regulation of CdGAP. The Ajuba-binding-deficient mutants, as well as CdGAP peptides can be 
utilised to achieve this. Specifically, whether Ajuba induces conformational changes in CdGAP or 
regulates CdGAP activity via phosphorylation should be confirmed. Following this, a more thorough 
analysis of the dynamic CdGAP-Ajuba interaction, including how CdGAP may be released from Ajuba 
to inactivate Rac should be investigated. Finally, a role for Ajuba in AOS should be examined.  
5.6.1. Characterisation of the Ajuba-binding deficient mutants 
A useful tool to investigate the role of Ajuba in CdGAP regulation will be the CdGAP mutants that 
cannot bind Ajuba as efficiently as wild-type. Firstly, this result needs to be confirmed for the 
R1412A mutant, as data is only preliminary. Secondly, it may be necessary to create further mutants 
that have further reduced capacity for Ajuba binding (as the current mutants can still bind weakly to 
Ajuba). This may be achieved by mutation of two or more amino acids within the critical binding 
regions. 
Given the similarity in the CdGAP-Ajuba and CdGAP-CdGAP binding sites these mutations are also 
likely to prevent or inhibit binding to CdGAP GAP domain, and thus could represent hyperactivated 
constructs. It will be important to determine this before any analysis is done in vivo as this will 
greatly influence the interpretation of results.  
If CdGAP mutants do bind to the GAP domain normally, but are unable to bind Ajuba, these should 
be co-expressed with Ajuba in cells and their effects on cell-cell contacts observed. If Ajuba is 
required to inhibit CdGAP, these mutants should disrupt E-cadherin contacts with the same 
efficiency as cells expressing CdGAP-l alone and also not be retained at the junctions. If this is not 
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the case it would be interesting to investigate the possibility of other CdGAP-binding partners that 
may control localisation and/or activity.  
Also, to confirm that the GAP activity of the non-binding mutants is not affected by the presence of 
Ajuba, in vitro GAP assays can be performed. If mutants can neither bind Ajuba or the GAP domain, 
we may expect these to induce even more junction disruption than the wild-type, but it will be 
difficult to interpret results from such mutants.  
5.6.2. How does Ajuba regulate the localisation of CdGAP – recruitment vs retention? 
Expression of CdGAP mutants that are unable to bind Ajuba can confirm whether Ajuba regulates 
the recruitment of CdGAP-l to cell-cell contacts. If Ajuba has no role in recruitment, the localisation 
of the mutant CdGAP should mirror that of wild-type CdGAP-l in the absence of Ajuba.   
My data suggests that Ajuba does not recruit CdGAP to cell-cell contacts, but may instead contribute 
to the retention of CdGAP in this region. FRAP experiments can be used to measure the mobility of 
GFP-CdGAP in the presence and absence of Ajuba. If Ajuba is holding CdGAP-l at contacts then we 
can expect the mobility of GFP-CdGAP to be reduced in the presence of Ajuba. The use of a GFP-
tagged CdGAP mutant that is deficient in Ajuba binding will also corroborate this result as this 
construct should be more mobile than the wild-type CdGAP if Ajuba is required to maintain CdGAP 
at contacts. 
5.6.3. How does Ajuba regulate the activity of CdGAP – directly or indirectly? 
Ajuba inhibits CdGAP’s GAP activity and prevents CdGAP-mediated junction disruption. I envisage 
this regulation could occur either by a direct interaction that prevents CdGAP opening or changes 
the conformation of CdGAP, or indirectly by localising CdGAP with a kinase that phosphorylates and 
inhibits CdGAP.  
To formally demonstrate if direct interaction with Ajuba inhibits CdGAP, GAP assays using purified 
proteins could be performed. This would rule out the influence of other mechanisms of regulation, 
such as post-translational modification, which may occur in cells. 
To understand how Ajuba is able to inhibit CdGAP it will be important to learn if Ajuba and CdGAP 
GAP domain can bind simultaneously to the C-terminus. To address this question, plates coated with 
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CdGAP C-terminus can be incubated with equal amounts of GAP domain and Ajuba to determine 1) 
whether both are able to bind and 2) which binds preferentially by observing the proportions of each 
protein bound. By varying the amounts of GAP domain and Ajuba, we can test for competition 
between these proteins for interaction with the C-terminus of CdGAP. By maintaining the 
concentration of GAP domain, and adding increasing amounts of Ajuba it will be possible to see if 
Ajuba can displace the GAP domain for binding to C-terminus.  
Peptides have been synthesised covering the strongest binding regions of the C-terminal. It would be 
most informative though, to characterise a range of peptides with different affinities for Ajuba and 
CdGAP GAP domain in order to fully separate signalling downstream of CdGAP activation dependent 
on Ajuba. These can be used to test for competition between CdGAP and Ajuba for binding of the C-
terminus. It would then be useful to determine if these peptides could out-compete the C-terminal 
protein for binding to either Ajuba or the GAP domain. With the necessary modifications these 
peptides could then be used in vivo to disrupt these interactions.  
As CdGAP activity is regulated in part by its C-terminal domain, visualisation of the activation of 
CdGAP may be ideally suited for FRET (Che et al., 2005; Itoh et al., 2002). This could be an important 
tool for monitoring how and where CdGAP is activated and how Ajuba can regulate this. By creating 
a unimolecular CdGAP construct harbouring GFP and RFP tags on the C- and N-terminals it may be 
possible to visualise activation using FLIM-FRET. The placing of the tags is critical as these must be 
sufficiently close to the protein that FRET is possible, but far away enough that their presence does 
not influence binding of the C- to the N-terminal. As amino acids in the very C-terminal of CdGAP are 
important for the interaction, this may be problematic. However, if these criteria can be met several 
things could be inferred. Firstly, in vitro experiments can be performed whereby the purified CdGAP 
probe is incubated with purified Ajuba and FRET is measured would complement in vitro GAP assays; 
if Ajuba inhibits CdGAP via changes in the conformation of CdGAP this will be reflected by a decrease 
in FRET, as the C- and N-terminal domains come closer together. Secondly, expression of the CdGAP 
probe in keratinocytes and measurement of FLIM-FRET at different regions of cell will reveal where 
CdGAP activity is highest. Finally, co-expression of the CdGAP probe and Ajuba and measurement of 
FLIM-FRET will uncover whether Ajuba expression reduces CdGAP activity in vivo.  
Ajuba may also or additionally regulate CdGAP via directing its phosphorylation. CdGAP has the 
potential to be heavily phosphorylated (Tcherkezian et al., 2005), and phosphorylation by RSK1, 
ERK1/2 and GSK3β can all result in inactivation of CdGAP (Danek et al., 2007; Tcherkezian et al., 
2005; Tcherkezian et al., 2006). It would be interesting to determine if and on which residues CdGAP 
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is phosphorylated on at cell-cell contacts and if this is altered in the presence of Ajuba. Keratinocytes 
transfected with CdGAP and Ajuba or CdGAP alone could be labelled with [P32]orthophosphate 
before lysis and immunoprecipitation of CdGAP. By detecting radiolabelled proteins by 
autoradiography (using SDS-PAGE), it would be possible to see if Ajuba enhances the degree of 
phosphorylation of CdGAP. In vitro kinase assays could be performed to determine if CdGAP is 
phosphorylated by GSK3β or PAK1 in keratinocytes, and if this is influenced by the presence of 
Ajuba.  
5.6.4. How is Rac and Cdc42 activity influenced by Ajuba and CdGAP? 
As Ajuba seems to inhibit CdGAP GAP activity on Rac, it would be useful to determine if this 
translates to an increase in Rac activity at the membrane of cells co-expressing CdGAP and Ajuba. 
Co-expression of wild-type or mutant CdGAP unable to bind Ajuba with the unimolecular Rac1-PAK1 
probe tagged with GFP and RFP would allow spatial data to be gathered to answer this question. If 
Ajuba binding is required to modulate Rac signalling through CdGAP, the CdGAP mutant unable to 
bind Ajuba will have a different lifetime to the wild-type construct. We would predict that this 
mutant is more active, and thus have a decreased lifetime compared to wild-type. 
5.6.5. Does the regulation of CdGAP by Ajuba have clinical relevance in AOS or cancer?   
Mutations in Rac and Cdc42 regulators DOCK6 and CdGAP have been found to cause AOS (Shaheen 
et al., 2011; Southgate et al., 2011). However, CdGAP mutations only account for a fraction of AOS 
cases (Southgate et al., 2011). Therefore, mutations in proteins necessary for regulating CdGAP may 
yet be identified in cases of AOS. It would therefore be interesting to see if any mutations in the 
Ajuba gene are associated with this disorder, using a similar approach to that used to identify CdGAP 
mutations (Southgate et al., 2011).   
As CdGAP expression promotes invasion in breast epithelial cells (He et al., 2011) and my data shows 
CdGAP expression perturbs cell-cell contacts, CdGAP may play a role in cancer progression in some 
cells types. In this case it would be interesting to determine if CdGAP expression could be negatively 
correlated with Ajuba expression in tumours. 
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Chapter 6.  
Final Discussion 
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6.1. Summary 
Using both traditional (yeast two-hybrid) and contemporary (RNAi) screening methods, numerous 
Rho GAPs have been identified that can regulate distinct stages in the formation, maintenance and 
disassembly of AJs in keratinocytes (Figure 6.1). The siRNA screen utilised novel thresholding-based 
image analysis software to assess the effects of depletion of 206 proteins (46 GAPs) on junction 
formation. The efficacy of this screen is verified via the presence in the hit proteins of several Rho 
GAPs known to regulate cell-cell contacts and through characterisation of the function of one hit 
protein, ARAP1, in keratinocytes.  
Additionally, I have shown that CdGAP regulates the maintenance of AJs and may participate in the 
disassembly of cell-cell contacts during development or in a pathological setting. The expression of 
CdGAP in keratinocytes severely disrupts AJs due to the misregulation of either (or both) of Rac and 
Cdc42. CdGAP binding to the scaffold protein Ajuba was first demonstrated in a yeast two-hybrid 
screen (A. Ferrand and D. Birnbaum) and I have confirmed that this interaction is direct and 
mediated by a seemingly well-conserved region on the CdGAP C-terminus. Ajuba is known to 
regulate Rac activity both at cell-cell contacts and during migration (Nola et al., 2011; Pratt et al., 
2005). At AJs, Ajuba functions to maintain Rac activation at cell-cell contacts, but does not regulate 
the recruitment of Rac (Nola et al., 2011). I demonstrate that Ajuba may be required to sequester 
CdGAP at AJs in order to inhibit its activity against Rac, therefore promoting Rac activation and 
maintaining cell-cell adhesion.    
6.2. Too many GAPs 
Previous screens conducted to identify regualtors of cell-cell contacts have involved the visual 
analysis of target genes, or used embryo lethality as a single readout (Elbediwy et al., 2012; Lynch et 
al., 2012; Omelchenko and Hall, 2012). However, a far more comprehensive understanding of 
cellular systems is gained from gathering multiparametric data (Fuchs et al., 2010; Winograd-Katz et 
al., 2009). We have optimised the use of an automated analysis program that is able to effectively 
segment junctional E-cadherin and used this to measure three experimental parameters associated 
with junction formation. This approach can therefore be be used in the future to identify additional 
regulators of cell-cell contacts, with the possibility of segmenting different junctional proteins (eg. α-
catenin). Using this method several Rho GAPs were identified that have been described 
subsequently as regulators of cell-cell contacts (eg. (Ratheesh et al., 2012; Tripathi et al., 2012)).  
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Figure 6.1 Summary of potential Rho GAP signalling pathways regulating junction formation, stabilisation, 
maintenance and disassembly The Rho GAPs studied in this thesis, ARAP1, ARHGAP6 (AG6) and CdGAP are 
shown in ovals. A) GAPs identified as regulators of junction formation or stabilisation via the siRNA screen 
(hits) are shown in red (positive regulators; depletion reduced E-cadherin and/or junctional actin) or black 
(negative regulators; depletion increased E-cadherin and/or junctional actin). Hits for which a role in cell-cell 
contacts has not previously been described are shown in the box. Hits previously demonstrated to regulate 
cell-cell contacts are SRGP-1 (Zaidel-Bar et al., 2010), of which the mammalian homologs SRGAP1-3 and 
ARHGAP4 are shown, RacGAP1 (Ratheesh et al., 2012), DLC1 (Tripathi et al., 2012; Tripathi et al., 2013) and 
DLC3 (Holeiter et al., 2012). ARAP1 regulates the formation or early stabilisation of cell-cell contacts. Possible 
functions of ARAP1 may be to inhibit Rho activity at the centre of the nascent contact (arrows indicate the 
direction of contact expansion) or to regulate Arf1 or Arf5 to control E-cadherin trafficking. B) At mature cell-
cell contacts AG6 and CdGAP are likely inhibited to prevent local inactivation of Rho and Rac/Cdc42 
respectively. It is unknown how AG6 is inhibited but CdGAP may be inhibited by Ajuba either directly, or via a 
kinase, possibly GSK3β. C) Junctions may be disassembled as a result of overactivation of AG6 or CdGAP to 
imbalance levels of active Rho and Rac/Cdc42. Possibily extracellular signals (eg. Wnt) trigger Ajuba is 
degradation (Haraguchi et al., 2008) leading to the release of CdGAP, or the loss of phosphorylation signals (eg. 
from GSK3β, which is regulated by Wnt and Ajuba (Haraguchi et al., 2008). Free CdGAP may then inactivate 
Rac at the membrane and promote junction disassembly. 
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Rho regulators (the GAPs and GEFs) considerably outnumber their GTPase targets and this is likely 
due to these proteins performing specific functions in specialised processes (Bernards, 2003; 
Rossman et al., 2005; Tcherkezian and Lamarche-Vane, 2007). Rho GAPs and GEFs possess wide-
ranging characteristics that allow them to control Rho GTPase signaling specificity by influencing 
GTPase localisation, receiving upstream signals and recruiting downstream effectors (Rossman et al., 
2005; Tcherkezian and Lamarche-Vane, 2007). Consequently, multiple Rho regulators are required to 
correctly regulate complex cellular processes that rely on GTPase signaling, such as cell-cell contact 
formation, neuronal morphogenesis and migration (McCormack et al., 2013; Tolias et al., 2011; 
Tomar and Schlaepfer, 2009). Thus, the identification of 20 Rho GAPs potentially regulating cell-cell 
contact formation and stabilisation is not necessarily surprising. Examination of this group revealed a 
diverse set of proteins with disparate functions in other cellular processes which likely reflects the 
requirement of cells to coordinate a multitude of processes in order to correctly assemble cell-cell 
contacts.  
Although a certain level of redundancy exists between related GAPs, even highly similar proteins 
fulfill niche functions that mean their loss cannot be compensated for in certain scenarios.  For 
example, ABR and BCR are highly similar proteins involved in regulation of the immune response 
(Cho et al., 2007; Cunnick et al., 2009; Voncken et al., 1995) and comparison of macrophages derived 
from ABR-, BCR- and double ABR/BCR-null mice reveal that to an extent, loss of one protein can 
compensate for the other. ABR or BCR-null single knockouts show no difference in the release of 
granules from neutrophils compared to wild-type, whilst this is significantly enhanced in double 
knockout mice (Cunnick et al., 2009). However, macrophages from BCR-null and double knockout 
mice produce more ROS than wild-type controls whereas ABR-null mice do not (Cunnick et al., 2009; 
Voncken et al., 1995). This suggests ABR and BCR have some overlapping functions, but also regulate 
distinct processes (Cunnick et al., 2009).  
The identification of several related GAPs (for example SRGAPs 1-3 and ARHGAP4) in our screen 
suggests that these proteins may all regulate similar underlying processes, indeed SRGAPs1-3 are 
known to share binding partners (Wong et al., 2001). However, the fact that loss of any one of these 
proteins can alter E-cadherin and/or actin populations at cell-cell contacts illustrates that they 
cannot compensate for each other. Interestingly, these proteins are active on different GTPases 
(Endris et al., 2002; Foletta et al., 2002; Guerrier et al., 2009; Wong et al., 2001; Yang et al., 2006) 
and the BAR domains of SRGAPs 1-3 can all induce different effects on membrane curvature 
(Coutinho-Budd et al., 2012), implying these may perform novel roles in the regulation of cell-cell 
contact formation and stabilisation.  
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It is likely that a range of Rho GAPs, specific for different GTPases, with different interacting 
domains, binding partners and enzymatic capabilities are necessary for cell-cell contact formation. 
The subsequent characterisation of ARAP1 and ARHGAP6 at cell-cell contacts illustrates that the 
shared ability to regulate a GTPase, in this case Rho, is not always a good predictor of functional 
outcome downstream of regulator and/or GTPase activation/inactivation. 
6.3. Rho GAPs with opposing functions at AJs: ARHGAP6 and ARAP1 
The requirement for Rho at cell-cell contacts is somewhat controversial. In keratinocytes Rho is 
required for contact formation (Braga et al., 1997; Calautti et al., 2002) whilst Rho-mediated 
actomyosin contractility can drive contact expansion in MDCK cells (Yamada and Nelson, 2007). 
However, Rho is downregulated in some systems downstream of adhesion, and activation can 
promote contact disassembly following certain stimuli (Noren et al., 2003; Noren et al., 2001; Sahai 
and Marshall, 2002b; Samarin et al., 2007). What is clear is that spatial constraint of Rho signaling is 
vital. For example, inhibition of ROCK prevents contact expansion, but does not result in disassembly 
of the contact (Yamada and Nelson, 2007). This implies that following initial contact formation Rho 
signaling is required at the edges of expanding contact but either not at the initial site, or is required 
to signal through a different subset of effectors in this region.  
It is interesting that two Rho-specific GAPs, ARAP1 and ARHGAP6, are found to regulate cell-cell 
adhesions in keratinocytes but seem to have opposite effects (Figure 6.1). Loss of ARAP1 does not 
prevent junction formation, but reduces the amount of E-cadherin present at junctions, whilst the 
overexpression of ARAP1 has no effect on junction morphology. These findings suggest that ARAP1 is 
not required for formation, but more likely supports the stabilisation of nascent AJs. In contrast, the 
expression of ARHGAP6 severely disrupts E-cadherin and results in the generation of protrusions. 
Studies of ARHGAP6 expression in Drosophila compliment these findings, and show expression of 
ARHGAP6 promotes migration and disrupts Rho activation (L A. Baena-Lopez and J-P. Vincent). In 
both cases the GAP domain is required. ARHGAP6 therefore, negatively regulates AJs.  
The interaction of GTPases with their downstream effectors determines the cellular outcome of their 
activation, and Rho activation has been shown to both promote and disrupt cell-cell junctions 
depending on which effector it binds (Sahai and Marshall, 2002b). Rho regulators can influence 
downstream signaling by recruiting effector proteins, thus it will be interesting to determine if Rho 
interacts with a different subset of effector proteins in ARAP1-depleted cells compared to in wild-
type cells.  
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Currently, far more work is needed in order to characterise the functions of these proteins at cell-
cell contacts. Whilst ARHGAP6 appears to act via inactivation of Rho (expression of ARHGAP6 
isoforms lacking the complete Rho GAP domain does not perturb junctions), the function of ARAP1 
may be to inactivate Arf1 or Arf5 (Miura et al., 2002). For example, depletion of the Arf1 GEF GBF1 in 
Drosophila perturbs DE-cadherin trafficking (Szul 2011) and loss of both Arf1 and Arf5-specific GAPs 
can disrupt cell-matrix adhesive complexes (Liu 2002, 2005, Moravec 2012). Overall, these findings 
hint at the existence of a highly dynamic system that would allow cells to respond rapidly to 
extracellular cues to inactivate Rho and bring about very specific downstream effects depending on 
the GAP protein activated. If two Rho-specific GAPs are able to elicit such different responses, then 
regulation of the localisation and activation of GAP proteins must clearly be tightly controlled. 
6.4. CdGAP and Ajuba regulation of AJs 
In chapters 4 and 5 I have presented evidence for the involvement of CdGAP in the stabilisation of 
AJs. Depletion of CdGAP results in cells better able to withstand trituration in aggregation assays 
(although at this point we cannot exclude the possibility that loss of CdGAP leads to an increase in 
desmosome-mediated adhesion also), whilst expression of CdGAP severely perturbs morphology and 
leads to the rapid loss of E-cadherin from junctions. Subsequently, I have shown that CdGAP 
interacts directly with Ajuba, a scaffold protein known to regulate Rac activity at cell-cell contacts 
(Marie et al., 2003; Nola et al., 2011). Taken together, these data compliment previous studies of 
CdGAP and points towards an important role for CdGAP in the development of the ectoderm via 
regulation of both cell-cell and cell-matrix adhesions (LaLonde et al., 2006; Southgate et al., 2011; 
Wormer et al., 2012). Furthermore, the observation that CdGAP expression rapidly induces loss of 
cell-cell contacts supports the notion that CdGAP activity maybe hijacked in epithelial cancers to 
promote migration and invasion (He et al., 2011). 
Expression of CdGAP in keratinocytes leads to the removal of E-cadherin from AJs and causes cells to 
display a severely retracted morphology. Interestingly, cells expressing CdGAP do not seem to 
undergo apoptosis and appear reminiscent of cells stimulated with HGF that are undergoing 
epithelial-to-mesenchymal transition (de Rooij et al., 2005). The co-expression of CdGAP with Ajuba 
limits disruption and also results in increased levels of CdGAP at junctions. Several questions remain 
regarding how Ajuba may regulate CdGAP in order to promote maintenance of cell-cell contacts. As 
CdGAP-s (which cannot interact with Ajuba) is still able to localise to AJs, Ajuba is unlikely to regulate 
the recruitment of CdGAP, which must be mediated by an as yet unidentified mechanism. 
Presumably then, Ajuba regulates CdGAP activity and maintains CdGAP in an inactive state at 
201 
 
junctions. The inactivation of CdGAP may be mediated by 1) a direct interaction with Ajuba that 
induces conformational changes in CdGAP such that the GAP domain is obscured, 2) Ajuba may 
colocalise CdGAP with a kinase that phosphorylates CdGAP (Figures 6.1 and 6.2) (eg. (Jenna et al., 
2002; Okabe et al., 2003; Tcherkezian et al., 2005; Wells et al., 2006). 
I have shown Ajuba and CdGAP interact directly, and this interaction depends on several regions 
within the C-terminus of CdGAP that also appear to be conserved across species, and possibly in the 
related proteins, ARHGAP30, ARHGAP32 and ARHGAP33. This region is important for CdGAP auto-
regulation (Southgate et al., 2011). However, the close proximity of the binding sites for CdGAP N-
terminus and Ajuba on the C-terminus does imply that simultaneous binding of both Ajuba and the 
GAP domain to the C-terminal region of CdGAP would be unlikely. As such, it is unlikely that Ajuba 
simply maintains CdGAP in its inactive conformation (although its binding may still induce 
conformational changes in CdGAP that renders it inactive). Ultimately, in order to better understand 
both the Ajuba-CdGAP and the potential auto-inhibited CdGAP conformation more information 
regarding the 3D structures of these proteins is required. 
A second possibility is that Ajuba facilitates the action of a kinase on CdGAP, as CdGAP is heavily 
phosphorylated and this negatively regulates its activity (Danek et al., 2007; Tcherkezian et al., 2005; 
Tcherkezian et al., 2006). The kinases GSK3α, GSK3β, ERK1/2 and RSK1 have all been identified as 
targeting CdGAP (Danek et al., 2007; Tcherkezian et al., 2005; Tcherkezian et al., 2006) and further 
kinases may also be identified able to phosphorylate CdGAP. As well as negatively regulating CdGAP, 
GSK3β also interacts with Ajuba (Danek et al., 2007; Haraguchi et al., 2008). Ajuba binds to β-catenin 
and promotes its interaction with GSK3β, resulting in phosphorylation and degradation of β-catenin, 
which ultimately prevents β-catenin from translocating to the nucleus to activate Wnt-dependent 
genes (Haraguchi et al., 2008). Thus, Ajuba may utilise a similar approach to inactivate CdGAP and 
maintain cell-cell contacts. Sequestering CdGAP in an inactive state at AJs may mean cells are able to 
rapidly respond to cues to locally inactivate Rac. Potentially, under certain stimuli Ajuba releases 
CdGAP which would result in the rapid and specific inactivation of Rac at these sites (Figure 6.2).  
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Figure 6.2 Possible mechanism for the regulation of CdGAP by Ajuba at cell-cell junctions The cellular 
outcomes on AJs are compared in CdGAP or CdGAP and Ajuba expressing cells. Representative images are 
shown at the top; scale bar 25μm. Expression of CdGAP alone induces loss of E-cadherin at junctions and 
inactivation of Rac at the membrane, thus the balance of active to inactive Rac is shifted in the favour of 
inactive, GDP-bound Rac. Co-expression of CdGAP and Ajuba shifts the balance in favour of active Rac, via 
either direct or indirect inactivation of CdGAP. 1. CdGAP is largely found in the cytoplasm where it is likely 
inactive. I speculate that CdGAP may exist in several conformations that could potentially shield the GAP 
domain; a folded monomer, a parallel dimer or an anti-parallel dimer. 2. How CdGAP is localised to junctions is 
not clear but does not require Ajuba. Junctional localisation may be triggered by activation, as more CdGAP-s 
(which may be hyperactivated) is found at junctions than CdGAP-l. 3. In the absence of Ajuba, CdGAP causes 
junction disassembly via inactivation of Rac at the membrane. 4. In the presence of Ajuba CdGAP is 
sequestered at junctions and presumably inactivated. Ajuba may inactivate CdGAP directly, via conformational 
changes, or indirectly, by colocalising CdGAP with a kinase (such as GSK3β). 
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 The finding that mutations in CdGAP that result in truncated, hyperactive protein are a cause of AOS 
reveals a role for CdGAP in the developing limb bud (patients present with loss of skin from the 
scalp, defects in limb and digit formation and sometimes heart or pulmonary complications (Snape 
et al., 2009; Southgate et al., 2011). The formation of the limb bud requires precise control of Rac 
and Cdc42 activities (Aizawa et al., 2012; Suzuki et al., 2009; Wu et al., 2008) and CdGAP may be 
important in spatial constraint of Rac and Cdc42 signalling to control migration (Southgate et al., 
2011) and AJ disassembly (this work). Interestingly, Wnt signalling is vital for the formation of the 
apical ectodermal ridge, an important signalling centre that controls growth and patterning of the 
limbs (Barrow et al., 2003; Hill et al., 2006) and a lack of Wnt, or conditional loss of β-catenin also 
result in the formation of truncated limbs (Barrow et al., 2003; Hill et al., 2006). In order to enhance 
the stabilisation of β-catenin (necessary so that it may localise to the nucleus and regulate 
transcription), Wnt signalling promotes the degradation of Ajuba (Haraguchi et al., 2008).  
It is interesting therefore to speculate that Wnt signalling may also regulate CdGAP activity indirectly 
by modulating the levels of Ajuba and GSK3β, and could be the signal required to release CdGAP 
from Ajuba, leading to junction disassembly. This would result in inactivation of Rac/Cdc42 at 
junctions and may promote epithelial-to-mesenchymal transition and early detachment from 
neighbouring cells prior to migration. The activation of CdGAP must be carefully localised as 
hyperactivation of CdGAP is detrimental to limb bud formation (Southgate et al., 2011) and loss of 
Rac inhibits the localisation of β-catenin to the nucleus (Wu et al., 2008). However, the 
sequestration of CdGAP at AJs by Ajuba may ensure that CdGAP activity is appropriately restricted 
and further (as yet unidentified) mechanisms are likely also to be in place (Figure 6.3).  
Negative feedback loops must exist that later inhibit CdGAP, potentially by stabilising GSK3β which in 
turn stabilises Ajuba (Haraguchi et al., 2008). Alternatively, as GSK3β can also upregulate CdGAP 
mRNA (Danek et al., 2007), loss of GSK3β may result in decreased levels of CdGAP, meaning only a 
limited amount of CdGAP is available to initially inactivate Rac/Cdc42. Such a regulatory network 
may also be exploited in epithelial cancers, as CdGAP is upregulated in mammary tumour explants 
and promotes migration and invasion of these cells (He et al., 2011). Possibly, upregulation of CdGAP 
leads to junction disassembly, loss of cell-cell contacts and epithelial-to-mesenchymal transition. It 
would therefore be of interest to determine if Ajuba or GSK3β are downregulated in mammary 
epithelial cancers that show increased levels of CdGAP, or if expression of Ajuba or GSK3β can inhibit 
TGF-β-induced migration and invasion (He et al., 2011).  
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Figure 6.3 Possible signalling pathways regulating CdGAP activity A) In the presence of Ajuba, CdGAP activity 
may be inhibited either directly, or through facilitating the activity of GSK3β on CdGAP, which phosphorylates 
and inactivates CdGAP (Danek et al., 2007). Ajuba is also phosphorylated by GSK3β, which stabilises Ajuba and 
prevents its degradation (Haraguchi et al., 2008) (possibly to maintain CdGAP inactivation). The inhibition of 
CdGAP by either means may prevent CdGAP inactivating Rac/Cdc42 thus supporting the maintenance of AJs. B) 
Wnt signaling inhibits GSK3β and promotes the degradation of Ajuba. As well as promoting β-catenin 
translocation to the nucleus and the upregulation of Wnt genes, I speculate that this may lead to an increase in 
CdGAP activity. CdGAP may then inactivate Rac and/or Cdc42 resulting in junction disassembly. Black arrows 
indicate cellular outcome, red arrows indicate inhibition and green arrows indicate activation. Dotted lines 
represent unconfirmed inhibition. P indicates phosphorylation events. Proteins in bold typeface represent an 
increase in either their levels or their activity status.  
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6.5. Conclusions 
What emerges from this thesis and other studies is that Rho GAPs are not only required to control 
the inactivation of their target GTPases (including where, when and for how long activation persists), 
but also strongly influence the outcome of GTPase activation. Time and time again activation of the 
classical GTPases Rac, Rho and Cdc42 is shown to result in downstream signalling though the same 
few effectors (ROCK, PAK, LIMK etc) but with vastly different consequences. Indeed, my findings 
demonstrate that two Rho GAPs, ARAP1 and ARHGAP6 can have completely different effects on cell-
cell junctions. As such, the regulation of the activity and localisation of Rho GAPs may be just as 
important as the regulation of their GTPase targets.  
I have shown that CdGAP potently induces cell-cell contact disassembly. Misregulation of CdGAP can 
have devastating consequences, as it spatially constrains Rac and Cdc42 activity in different cellular 
processes, developmental and pathological events (He et al., 2011; Jenna et al., 2002; LaLonde et al., 
2006; Southgate et al., 2011; Wormer et al., 2012). The identification of Ajuba as a regulator of 
CdGAP activity provides new insight into how Rac activity is regulated at cell-cell contacts, and may 
also aid our understanding of how CdGAP activity can be regulated in developmental and 
pathological settings. Much remains to be understood regarding the regulation of GAP proteins in 
different cellular contexts, including which GAPs are activated at cell-cell adhesions. What is clear is 
that this class of regulator is not simply around to terminate signaling from GTPases. Rather, GAPs 
control many diverse signaling processes via inactivation (and indirectly activation) of their GTPase 
substrates.  
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